Ebix (EBIXQ) 10-K 16 Mar 15 2014 FY Annual report Financial data

Document_and_Entity_Informatio

Document and Entity Information Document (USD $)	12 Months Ended
	Dec. 31, 2014	Mar. 13, 2015	Jun. 30, 2014
Document and Entity Information [Abstract]
Entity Registrant Name	EBIX INC
Entity Central Index Key	814549
Current Fiscal Year End Date	-19
Entity Filer Category	Accelerated Filer
Document Type	10-K
Document Period End Date	31-Dec-14
Document Fiscal Year Focus	2014
Document Fiscal Period Focus	FY
Amendment Flag	FALSE
Entity Common Stock, Shares Outstanding		35,262,631
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Public Float			$487,396,783

Consolidated_Statements_of_Inc

Consolidated Statements of Income (USD $)	12 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Income Statement [Abstract]
Operating revenue	$214,321	$204,710	$199,370
Operating expenses:
Costs of services provided	47,388	40,471	38,133
Product development	26,860	26,798	24,825
Sales and marketing	13,840	15,848	16,687
General and administrative (see Note 3)	36,880	36,480	33,562
Amortization and depreciation	9,681	10,107	9,155
Total operating expenses	134,649	129,704	122,362
Operating income	79,672	75,006	77,008
Interest income	379	518	441
Interest expense	-3,034	-1,226	-1,541
Non-operating income - put options	296	342	190
Non-operating expense - securities litigation	-690	-4,226	0
Foreign exchange gain (loss)	829	-262	1,931
Income before income taxes	77,452	70,152	78,029
Income tax provision	-13,894	-10,878	-7,460
Net income	$63,558	$59,274	$70,569
Basic earnings per common share (in dollars per share)	$1.68	$1.58	$1.91
Diluted earnings per common share (in dollars per share)	$1.67	$1.53	$1.80
Basic weighted average shares outstanding (in shares)	37,809	37,588	36,948
Diluted weighted average shares outstanding (in shares)	38,040	38,642	39,100

Consolidated_Statements_of_Com

Consolidated Statements of Comprehensive Income (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Statement of Comprehensive Income [Abstract]
Net income	$63,558	$59,274	$70,569
Other comprehensive income (loss):
Foreign currency translation adjustments	-5,855	-5,376	-2,394
Total other comprehensive income (loss)	-5,855	-5,376	-2,394
Comprehensive income	$57,703	$53,898	$68,175

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Current assets:
Cash and cash equivalents	$52,300	$56,674
Short-term investments	281	801
Trade accounts receivable, less allowances of $1,619 and $1,049, respectively	41,100	39,070
Deferred tax asset, net	2,113	256
Other current assets	8,067	5,548
Total current assets	103,861	102,349
Property and equipment, net	24,661	8,528
Goodwill	402,220	337,068
Intangibles, net	49,371	50,734
Indefinite-lived intangibles	30,887	30,887
Deferred tax asset, net	18,758	12,194
Other assets	4,553	3,682
Total assets	634,311	545,442
Current liabilities:
Accounts payable and accrued liabilities	40,121	17,818
Accrued payroll and related benefits	5,280	6,482
Short term debt	0	13,062
Liability – securities litigation settlement	0	4,226
Contingent liability for accrued earn-out acquisition consideration	887	4,137
Current portion of long term debt and capital lease obligation, net of discount of $7 and $10, respectively	936	827
Put option liability	0	845
Deferred revenue	22,192	18,918
Current deferred rent	268	254
Other current liabilities	102	106
Total current liabilities	69,786	66,675
Revolving line of credit	120,465	22,840
Other long term debt and capital lease obligation, less current portion, net of discount of $7 and $38, respectively	593	20,124
Contingent liability for accrued earn-out acquisition consideration	4,480	10,283
Deferred revenue	2,496	391
Long term deferred rent	2,091	2,185
Other liabilities	2,179	4,719
Total liabilities	202,090	127,217
Commitments and Contingencies, Note 6
Temporary equity, Note 20	0	5,000
Stockholders’ equity:
Convertible Series D Preferred stock, $.10 par value, 500,000 shares authorized, no shares issued and outstanding at December 31, 2014 and 2013	0	0
Common stock, $.10 par value, 60,000,000 shares authorized, 36,232,074 issued and 36,191,565 outstanding at December 31, 2014 and 38,088,391 issued and 38,047,882 outstanding at December 31, 2013	3,619	3,805
Additional paid-in capital	137,101	164,216
Treasury stock (40,509 shares as of December 31, 2014 and December 31, 2013)	-76	-76
Retained earnings	309,726	257,574
Accumulated other comprehensive loss	-18,149	-12,294
Total stockholders’ equity	432,221	413,225
Total liabilities, temporary equity and stockholders’ equity	$634,311	$545,442

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets (Parentheticals) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, except Share data, unless otherwise specified
Current Assets:
Allowance for doubtful accounts	$1,619	$1,049
Unamortized debt discount, current	7	10
Unamortized debt discount, noncurrent	$7	$38
Stockholders' Equity:
Preferred stock, par value (per share)	$0.10	$0.10
Preferred stock, shares authorized	500,000	500,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value (per share)	$0.10	$0.10
Common stock, shares authorized	60,000,000	60,000,000
Common stock, shares issued	36,232,074	38,088,391
Common stock, shares outstanding	36,191,565	38,047,882
Treasury stock, shares	40,509	40,509

Consolidated_Statements_Stockh

Consolidated Statements Stockholders' Equity (USD $)	Total	Common Stock	Treasury Stock	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Loss
In Thousands, except Share data, unless otherwise specified
Beginning Balance, Value at Dec. 31, 2011	$316,115	$3,638	($76)	$179,518	$137,559	($4,524)
Beginning Balance, Issued Shares at Dec. 31, 2011		36,418,385
Beginning Balance, Treasury Shares at Dec. 31, 2011			-40,509
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	70,569				70,569
Cumulative translation adjustment	-2,394					-2,394
Exercise of stock options, Shares		1,361,542
Exercise of stock options	1,020	137		883
Deferred compensation and amortization related to options and restricted stock	2,083			2,083
Shares subscribed for business acquisition, Shares		296,560
Shares subscribed for business acquisition	0	30		-30
Repurchase of common stock, Shares		-983,818
Repurchase of common stock	-18,374	-99		-18,275
APIC adjustment for stock options	1,162			1,162
Vesting of restricted stock, Shares		89,308
Vesting of restricted stock	0	8		-8
Forfeiture of certain shares to satisfy exercise costs and the recipients income tax obligations related to stock options exercised and restricted stock vested, Shares		-50,200
Forfeiture of certain shares to satisfy exercise costs and the recipients income tax obligations related to stock options exercised and restricted stock vested	-992	-5		-987
Dividends paid	-7,034				-7,034
Ending Balance, Value at Dec. 31, 2012	362,155	3,709	-76	164,346	201,094	-6,918
Ending Balance, Issued Shares at Dec. 31, 2012		37,131,777
Ending Balance, Treasury Shares at Dec. 31, 2012			-40,509
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	59,274				59,274
Cumulative translation adjustment	-5,376					-5,376
Exercise of stock options, Shares		1,251,633
Exercise of stock options	2,161	125		2,036
Deferred compensation and amortization related to options and restricted stock	1,941			1,941
Repurchase of common stock, Shares		-250,900
Repurchase of common stock	-2,492	-25		-2,467
APIC adjustment for stock options	37			37
Vesting of restricted stock, Shares		76,576
Vesting of restricted stock	0	8		-8
Forfeiture of certain shares to satisfy exercise costs and the recipients income tax obligations related to stock options exercised and restricted stock vested, Shares		-120,695
Forfeiture of certain shares to satisfy exercise costs and the recipients income tax obligations related to stock options exercised and restricted stock vested	-1,681	-12		-1,669
Dividends paid	-2,794				-2,794
Ending Balance, Value at Dec. 31, 2013	413,225	3,805	-76	164,216	257,574	-12,294
Ending Balance, Issued Shares at Dec. 31, 2013	38,088,391	38,088,391
Ending Balance, Treasury Shares at Dec. 31, 2013			-40,509
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	63,558				63,558
Cumulative translation adjustment	-5,855					-5,855
Exercise of stock options, Shares		450,000
Exercise of stock options	788	45		743
Deferred compensation and amortization related to options and restricted stock	1,792			1,792
Repurchase of common stock, Shares		-2,146,488
Repurchase of common stock	-31,854	-215		-31,639
Vesting of restricted stock, Shares		52,384
Vesting of restricted stock	0	5		-5
Forfeiture of certain shares to satisfy exercise costs and the recipients income tax obligations related to stock options exercised and restricted stock vested, Shares		-2,557
Forfeiture of certain shares to satisfy exercise costs and the recipients income tax obligations related to stock options exercised and restricted stock vested	-41	0		-41
Shares reaquired in connection with put option, Shares		-209,656
Shares reaquired in connection with put option	-2,986	-21		-2,965
Reclassification of shares previously reported as temporary equity in connection with an acquisition	5,000			5,000
Dividends paid	-11,406				-11,406
Ending Balance, Value at Dec. 31, 2014	$432,221	$3,619	($76)	$137,101	$309,726	($18,149)
Ending Balance, Issued Shares at Dec. 31, 2014	36,232,074	36,232,074
Ending Balance, Treasury Shares at Dec. 31, 2014			-40,509

Consolidated_Statements_of_Cas

Consolidated Statements of Cash Flow (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Net income	$63,558	$59,274	$70,569
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation and amortization	9,681	10,107	9,155
Provision for doubtful accounts	1,600	1,147	442
Provision for deferred taxes	-1,966	-10,368	-7,505
Unrealized foreign exchange (gain)/losses	-741	-237	443
Unrealized gain on put option	-296	-341	-191
Share-based compensation	1,792	1,941	2,083
Debt discount amortization on convertible debt	35	42	39
Reduction of acquisition earn-out contingent liability	-10,237	-10,253	-699
Changes in current assets and liabilities, net of acquisitions:
Accounts receivable	-1,530	-3,347	-2,023
Other assets	-4,765	80	-371
Accounts payable and accrued expenses	14,670	1,135	730
Accrued payroll and related benefits	1,811	-1,866	-594
Deferred rent	-324	-87	-132
Reserve for potential uncertain income tax return positions	-9,723	6,817	2,745
Liability – securities litigation settlement	-3,528	4,226	0
Other liabilities	-221	-225	-2,384
Deferred revenue	-1,306	-983	-12
Net cash provided by operating activities	58,510	57,062	72,295
Cash flows from investing activities:
Purchases of marketable securities	0	0	-785
Maturities of marketable securities	495	107	1,466
Capital expenditures	-16,277	-1,230	-1,965
Net cash used in investing activities	-77,786	-8,840	-63,375
Cash flows from financing activities:
Proceeds from / (Repayment) to line of credit, net	97,625	-15,000	6,090
Proceeds from term loan	0	0	45,000
Proceeds from the issuance of note payable	0	0	161
Principal payments on term loan obligation	-31,938	-8,938	-19,125
Repurchase of common stock	-31,854	-2,492	-18,374
Payments of long term debt	-345	-665	-600
Payments for capital lease obligations	-231	-277	-284
Excess tax benefit from share-based compensation	-3,200	3,237	1,044
Proceeds from exercise of common stock options	788	2,161	1,020
Forfeiture of certain shares to satisfy exercise costs and the recipients income tax obligations related to stock options exercised and restricted stock vested	-41	-1,681	-992
Cash consideration for shares reacquired in connection with put option	-3,535	0	0
Dividends paid	-11,406	-2,794	-7,034
Net cash provided (used) by financing activities	15,863	-26,449	6,906
Effect of foreign exchange rates on cash and cash equivalents	-961	-1,548	-3,073
Net change in cash and cash equivalents	-4,374	20,225	12,753
Cash and cash equivalents at the beginning of the year	56,674	36,449	23,696
Cash and cash equivalents at the end of the year	52,300	56,674	36,449
Supplemental disclosures of cash flow information:
Interest paid	1,290	1,169	1,350
Income taxes paid	11,433	13,779	8,590
BSI
Cash flows from investing activities:
Investments in acquired businesses, net of cash acquired	0	0	-992
Taimma
Cash flows from investing activities:
Investments in acquired businesses, net of cash acquired	0	0	-5,003
Payments of acquisition earn-out contingencies	-2,250	-2,250	0
Fintechnix
Cash flows from investing activities:
Investments in acquired businesses, net of cash acquired	0	0	-4,713
Planetsoft
Cash flows from investing activities:
Investments in acquired businesses, net of cash acquired	0	0	-35,078
TriSystems
Cash flows from investing activities:
Investments in acquired businesses, net of cash acquired	0	0	-9,277
Payments of acquisition earn-out contingencies	-563	0	0
Curepet, Inc.
Cash flows from investing activities:
Investments in acquired businesses, net of cash acquired	3	0	0
Investment in CurePet, Inc.	0	0	-2,000
ADAM
Cash flows from investing activities:
Investments in acquired businesses, net of cash acquired	-5,856	0	0
Vertex
Cash flows from investing activities:
Investments in acquired businesses, net of cash acquired	-27,547	0	0
Oakstone
Cash flows from investing activities:
Investments in acquired businesses, net of cash acquired	-23,791	0	0
I3
Cash flows from investing activities:
Investments in acquired businesses, net of cash acquired	-2,000	0	0
MCN
Cash flows from investing activities:
Payments of acquisition earn-out contingencies	0	0	-1,537
Qatarlyst
Cash flows from investing activities:
Investments in acquired businesses, net of cash acquired	0	-4,740	0
USIX
Cash flows from investing activities:
Payments of acquisition earn-out contingencies		-727	-1,466
Health Connect Systems
Cash flows from investing activities:
Payments of acquisition earn-out contingencies	0	0	-2,000
Facts
Cash flows from investing activities:
Payments of acquisition earn-out contingencies	$0	$0	($25)

Description_of_Business_and_Su

Description of Business and Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2014
Accounting Policies [Abstract]
Description of Business and Summary of Significant Accounting Policies	Description of Business and Summary of Significant Accounting Policies
	Description of Business— Ebix, Inc. and its subsidiaries (“Ebix” or the “Company”) is an international supplier of on-demand software and e-commerce solutions for the insurance industry. Ebix provides various software solutions and products for the insurance industry including data exchanges, carrier systems, and agency systems, as well as custom software development for business entities across the insurance industry. The Company's products feature fully customizable and scalable on-demand software designed to streamline the way insurance professionals manage distribution, marketing, sales, customer service, and accounting activities. The Company has its headquarters in Atlanta, Georgia and also conducts operating activities in Australia, Canada, India, New Zealand, Singapore, United Kingdom and Brazil. International revenue accounted for 31.0%, 31.8%, and 29.3% of the Company’s total revenue in 2014, 2013, and 2012, respectively.
	The Company’s revenues are derived from four product/service groups. Presented in the table below is the breakout of our revenue streams for each of those product/service groups for the years ended December 31, 2014 , 2013 and 2012.
		For the Year Ended
		December 31,
	(dollar amounts in thousands)		2014				2013				2012
	Exchanges		$	169,437			$	163,925			$	159,678
	Broker Systems		17,948				18,378				18,612
	Risk Compliance Solutions (“RCS”), fka Business Process Outsourcing (“BPO”)		21,813				15,678				16,140
	Carrier Systems		5,123				6,729				4,940
	Totals		$	214,321			$	204,710			$	199,370
	Summary of Significant Accounting Policies
	Basis of Presentation— The consolidated financial statements include the accounts of Ebix and its wholly owned subsidiaries. The effect of inter-company balances and transactions has been eliminated.
	Use of Estimates—The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America ("GAAP") requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and reported amounts of revenue and expenses during those reporting periods. Management has made material estimates primarily with respect to revenue recognition and deferred revenue, accounts receivable, acquired intangible assets, annual impairment reviews of goodwill, indefinite-lived intangible assets, and investments. contingent earnout liabilities in connection with business acquisitions, and the provision for income taxes. Actual results may be materially different from those estimates.
	Reclassification—Certain of the reported balances and results for prior year or prior quarters, including the notes thereto, have been reclassified to conform to the current year presentation. The change in reserve for potential uncertain income tax return positions had been previously netted against the provision for deferred taxes line in the consolidated statements of cash flows, it is now shown separately. Also, beginning in 2014 the Company has applied the new provisions under Financial Accounting Standard ("FAS") update No. 2013-11, Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, A Similar Tax Loss, or a Tax Credit Carryforward Exists and as more fully described in Note 8 "Income Taxes". A portion of potential uncertain income tax return positions previously reported in "Other Liabilities" on the consolidated balance sheets are now netted against the "Deferred tax asset, net" line in the long term asset section of the consolidated balance sheets. Finally the excess tax benefits from share-based compensation is now reported as a component of financing cash flows rather than being netted against the provision for deferred taxes as a component of operating cash flows in the consolidated statements of cash flows.
	Segment Reporting—Since the Company, from the perspective of its chief operating decision maker, allocates resources and evaluates business performance as a single entity that provides software and related services to a single industry on a worldwide basis, the Company reports as a single segment. The applicable enterprise-wide disclosures are included in Note 16.
	Cash and Cash Equivalents—The Company considers all highly liquid investments with an original maturity of three months or less at the time of purchase to be cash equivalents. Such investments are stated at cost, which approximates fair value. The Company does maintain cash balances in banking institutions in excess of federally insured amounts and therefore is exposed to the related potential credit risk associated with such cash deposits.
	Short-term Investments—The Company’s short-term investments consist of certificates of deposits with established commercial banking institutions with readily determinable fair values. Ebix accounts for investments that are reasonably expected to be realized in cash, sold or consumed during the year as short-term investments that are available-for-sale. The carrying amount of investments in marketable securities approximates their fair value. The carrying value of our short-term investments was $281 thousand and $801 thousand at December 31, 2014 and 2013, respectively.
	Fair Value of Financial Instruments—The Company follows the relevant GAAP guidance regarding the determination and measurement of the fair value of financial instruments in which fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction valuation hierarchy which requires an entity to maximize the use of observable inputs when measuring fair value. The guidance describes the following three levels of inputs that may be used in the methodology to measure fair value:
	•	Level 1 — Quoted prices available in active markets for identical investments as of the reporting date;
	•	Level 2 — Inputs other than quoted prices in active markets, which are either directly or indirectly observable as of the reporting date; and,
	•	Level 3 — Unobservable inputs, which are to be used in situations where there is little or no market activity for the asset or liability and wherein the reporting entity makes estimates and assumptions related to the pricing of the asset or liability including assumptions regarding risk.
	A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.
	As of December 31, 2014 and 2013 the Company has the following financial instruments to which it had to consider fair values and had to make fair assessments:
	•	Common share-based put option for which the fair value was measured as Level 2 instrument.
	•	Short-term investments for which the fair values are measured as a Level 1 instrument.
	•	Contingent accrued earn-out business acquisition consideration liabilities for which fair values are measured as Level 3 instruments. These contingent consideration liabilities were recorded at fair value on the acquisition date and are remeasured periodically based on the then assessed fair value and adjusted if necessary. The increases or decreases in the fair value of contingent consideration payable can result from changes in anticipated revenue levels and changes in assumed discount periods and rates. As the fair value measure is based on significant inputs that are not observable in the market, they are categorized as Level 3.
	Other financial instruments not measured at fair value on the Company's consolidated balance sheets at December 31, 2014 and 2013 but which require disclosure of their fair values include: cash and cash equivalents, accounts receivable, accounts payable and accrued expenses, accrued payroll and related benefits, capital lease obligations, debt under the former revolving line of credit and term loans with Citibank, and debt under the existing revolving line of credit with Regions Bank . The estimated fair value of such instruments at December 31, 2014 and 2013 reasonably approximates their carrying value as reported on the consolidated balance sheets.
	Additional information regarding the Company's assets and liabilities that are measured at fair value on a recurring basis is presented in the following tables:
			Fair Values at Reporting Date Using*
	Descriptions		Balance at December 31, 2014			Quoted Prices in Active Markets for Identical Assets or Liabilities (Level 1)			Significant Other Observable Inputs (Level 2)			Significant Unobservable Inputs (Level 3)
			(In thousands)
	Assets
	Available-for-sale securities:
	Commercial bank certificates of deposits		$	281		$	281		$	—		$	—
	Total assets measured at fair value		$	281		$	281		$	—		$	—
	Liabilities
	Derivatives:
	Common share-based put option (a)		$	—		$	—		$	—		$	—
	Contingent accrued earn-out acquisition consideration (b)		5,367			—			—			5,367
	Total liabilities measured at fair value		$	5,367		$	—		$	—		$	5,367
	(a) In connection with the acquisition of PlanetSoft effective June 1, 2012, Ebix issued a put option to the PlanetSoft's three shareholders. The put option, which expired in June 2014, was exercisable during the thirty-day period immediately following the two-year anniversary date of the business acquisition, which if exercised would enable them to sell the underlying 296,560 shares of Ebix common stock they received as part of the purchase consideration, back to the Company at a price of $16.86 per share, which represents the per-share value established on the effective date of the closing of Ebix's acquisition of PlanetSoft. The inputs used in the valuation of the put option include term, stock price volatility, current stock price, exercise price, and the risk free rate of return. During the months of July and August 2014 the former shareholders of PlanetSoft elected to exercise their put option rights with respect to the remaining 209,656 shares of Ebix common stock they still held. Accordingly the shareholders put those shares back to the Company at $16.86 per share plus interest at the rate of 20% as per the PlanetSoft acquisition agreement. The total consideration paid by the Company in connection with the exercise of these put options was $3.6 million.
	(b) The income valuation approach is applied and the valuation inputs include the contingent payment arrangement terms, projected cash flows, rate of return, and probability assessments.
	* During the year ended December 31, 2014 there were no transfers between fair value Levels 1, 2 or 3.
			Fair Values at Reporting Date Using*
	Descriptions		Balance at December 31, 2013			Quoted Prices in Active Markets for Identical Assets or Liabilities (Level 1)			Significant Other Observable Inputs (Level 2)			Significant Unobservable Inputs (Level 3)
			(In thousands)
	Assets
	Available-for-sale securities:
	Commercial bank certificates of deposits		$	801		801			—			—
	Total assets measured at fair value		$	801		$	801		$	—		$	—
	Liabilities
	Derivatives:
	Common share-based put option (a)		$	845		—			845			—
	Contingent accrued earn-out acquisition consideration (b)		14,420			—			—			14,420
	Total liabilities measured at fair value		$	15,265		$	—		$	845		$	14,420
	(a) In connection with the acquisition of PlanetSoft effective June 1, 2012, Ebix issued a put option to the PlanetSoft's three shareholders. The put option, which expires in June 2014, is exercisable during the thirty-day period immediately following the two-year anniversary date of the business acquisition, which if exercised would enable them to sell the underlying 296,560 shares of Ebix common stock they received as part of the purchase consideration, back to the Company at a price of $16.86 per share. The inputs used in the valuation of the put option include term, stock price volatility, current stock price, exercise price, and the risk free rate of return. During the months of July and August 2014 the former shareholders of PlanetSoft elected to exercise their put option rights with respect to the remaining 209,656 shares of Ebix common stock they still held. Accordingly the shareholders put those shares back to the Company at $16.86 per share plus interest at the rate of 20% as per the PlanetSoft acquisition agreement. The total consideration paid by the Company in connection with the exercise of these put options was $3.6 million.
	(b) The income valuation approach is applied and the valuation inputs include the contingent payment arrangement terms, projected cash flows, rate of return, and probability assessments.
	* During the year ended December 31, 2013 there were no transfers between fair value Levels 1, 2 or 3.
	For the Company's assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3), the following table provides a reconciliation of the beginning and ending balances for each category therein, and gains or losses recognized during the year.
	Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
	Contingent Liability for Accrued Earn-out Acquisition Consideration		Balance at December 31, 2014				Balance at December 31, 2013
			(in thousands)
	Beginning balance		$	14,420			17,495
Total remeasurement adjustments:
(Gains) or losses included in earnings **		(10,237		)		(10,253		)
(Gains) or losses recorded against goodwill		—				—
Foreign currency translation adjustments ***		(314		)		730
Acquisitions and settlements
Business acquisitions		4,312				9,425
Settlements		(2,814		)		(2,977		)
Ending balance		$	5,367			$	14,420
The amount of total (gains) or losses for the year included in earnings or changes to net assets, attributable to changes in unrealized (gains) or losses relating to assets or liabilities still held at year-end.		$	(8,911	)		$	(9,954	)
** recorded as a component of reported general and administrative expenses
*** recorded as a component of other comprehensive income within stockholders' equity
Quantitative Information about Level 3 Fair Value Measurements
The significant unobservable inputs used in the fair value measurement of the Company's contingent consideration liabilities designated as Level 3 are as follows:
(in thousands)		Fair Value at  December 31, 2014		Valuation Technique		Significant Unobservable
						Input
Contingent acquisition consideration:		$5,367		Discounted cash flow		Expected future annual revenue streams and probability of achievement
(Vertex, i3 Software, HealthCare Magic, and Qatarlyst acquisitions)
(in thousands)		Fair Value at  December 31, 2013		Valuation Technique		Significant Unobservable
						Input
Contingent acquisition consideration:		$14,420		Discounted cash flow		Expected future annual revenue streams and probability of achievement
(Taimma, PlanetSoft, TriSystems, and Qatarlyst acquisitions)
Sensitivity to Changes in Significant Unobservable Inputs
As presented in the table above, the significant unobservable inputs used in the fair value measurement of contingent consideration related to business acquisitions are forecasts of expected future annual revenues as developed by the Company's management and the probability of achievement of those revenue forecasts. The discount rate used in these calculations is 1.75%. Significant increases (decreases) in these unobservable inputs in isolation would likely result in a significantly (lower) higher fair value measurement.
Revenue Recognition and Deferred Revenue—The Company derives its revenues primarily from professional and support services, which includes revenue generated from subscription and transaction fees pertaining to services delivered over our exchanges or from our application service provider (“ASP”) platforms, software development projects and associated fees for consulting, implementation, training, and project management provided to customers using our systems, and risk compliance solutions ("RCS"). Sales and value-added taxes are not included in revenues, but rather are recorded as a liability until the taxes assessed are remitted to the respective taxing authorities.
The Company follows the relevant technical accounting guidance regarding revenue recognition as issued by the Financial Accounting Standards Board ("FASB") and the Securities and Exchange Commission's ("SEC"). The Company considers revenue earned and realizable when: (a) persuasive evidence of the sales arrangement exists, (b) the arrangement fee is fixed or determinable, (c) service delivery or performance has occurred, (d) customer acceptance has been received or is reasonably assured, if contractually required, and (e) collectability of the arrangement fee is probable. The Company typically uses signed contractual agreements as persuasive evidence of a sales arrangement. We apply the provisions of the relevant FASB accounting pronouncements related to all transactions involving the license of software where the software deliverables are considered more than inconsequential to the other elements in the arrangement. For contracts that contain multiple deliverables, we analyze the revenue arrangements in accordance with the appropriate authoritative guidance, which provides criteria governing how to determine whether goods or services that are delivered separately in a bundled sales arrangement should be considered as separate units of accounting for the purpose of revenue recognition. Deliverables are accounted for separately if they meet all of the following criteria: a) the delivered item has value to the customer on a stand-alone basis; b) there is objective and reliable evidence of the fair value for all arrangement deliverables; and c) if the arrangement includes a general right of return relative to the delivered items, the delivery or performance of the undelivered items is probable and substantially controlled by the Company. Under the relevant accounting guidance, when multiple-deliverables included in an arrangement are to be separated into different units of accounting, the arrangement consideration is allocated to the identified separate units of accounting based on their relative fair values. We determine the relative selling price for a deliverable based on vendor-specific objective evidence of selling price (“VSOE”), if available, or third-party evidence ("TPE") in the alternative if available, or finally our best estimate of selling price (“BESP”), if VSOE or TPE is not available.
The Company begins to recognize revenue from license fees for its exchange (SAAS) and ASP products upon granting customer access to the respective processing platform. Transaction services fee revenue for this use of our exchanges or ASP platforms is recognized as the transactions occur and are generally billed in arrears. Revenues from RCS arrangements, which include data entry and call center services, and insurance certificate creation and tracking services, are recognized as the services are performed. Service fees for hosting arrangements are recognized over the requisite service period. Revenue derived from the licensing of third party software products in connection with sales of the Company’s software licenses is recognized upon delivery together with the Company’s licensed software products. Fees for training, data conversion, installation, and consulting services fees are recognized as revenue when the services are performed. Revenue for maintenance and support services are recognized ratably over the term of the support agreement.
Software development arrangements involving significant customization, modification or production are accounted for in accordance with the appropriate technical accounting guidance issued by the FASB using the percentage-of-completion method. The Company recognizes revenue using periodic reported actual hours worked as a percentage of total expected hours required to complete the project arrangement and applies the percentage to the total arrangement fee.
Deferred revenue includes payments or billings that have been received or made prior to performance and, in certain cases, cash collections and primarily pertain to maintenance and support fees, initial setup or registration fees under hosting agreements, software license fees received in advance of delivery and acceptance, and software development fees paid in advance of completion and delivery. Approximately $5.8 million and $6.7 million of deferred revenue were included in billed accounts receivable at December 31, 2014 and 2013, respectively.
Accounts Receivable and the Allowance for Doubtful Accounts Receivable—Reported accounts receivable as of December 31, 2014 include $32.4 million of trade receivables stated at invoice billed amounts (net of a $1.62 million estimated allowance for doubtful accounts receivable), and $8.5 million of unbilled receivables. Reported accounts receivable at December 31, 2013 include $31.2 million of trade receivables stated at invoice billed amounts (net of a $1.05 million estimated allowance for doubtful accounts receivable), and $7.9 million
of unbilled receivables. The unbilled receivables pertain to certain professional service engagements and system development projects for which the timing of billing is tied to contractual milestones. The Company adheres to such contractually stated performance milestones and accordingly issues invoices to customers as per contract billing schedules. Accounts receivable are written off against the allowance for doubtful accounts receivable when the Company has exhausted all reasonable collection efforts. Management specifically analyzes the aging of accounts receivable and historical bad debts, write-offs, customer concentrations, customer credit-worthiness, current economic trends, and changes in our customer payment patterns when evaluating the adequacy of the allowance for doubtful accounts receivable. Bad debt expense was $1.6 million, $1.1 million, and $442 thousand for the year ended December 31, 2014, 2013, and 2012, respectively.
Costs of Services Provided—Costs of services provided consist of data processing costs, customer support costs including personnel costs to maintain our proprietary databases, costs to provide customer call center support, hardware and software expense associated with transaction processing systems and exchanges, telecommunication and computer network expense, and occupancy costs associated with facilities where these functions are performed. Depreciation expense is not included in costs of services provided.
Goodwill and Indefinite-Lived Intangible Assets - Goodwill represents the cost in excess of the fair value of the identifiable net assets from the businesses that we acquire. In accordance with the relevant FASB accounting guidance, goodwill is tested for impairment at the reporting unit level on an annual basis or on an interim basis if an event occurred or circumstances change that would indicate that fair value of a reporting unit decreased below its carrying value. Potential impairment indicators include a significant change in the business climate, legal factors, operating performance indicators, competition, customer retention and the sale or disposition of a significant portion of the business. Starting in 2011, the Company applied the then new guidance concerning goodwill impairment evaluation. In accordance with that new technical guidance the Company first assessed certain qualitative factors to determine whether the existence of events or circumstances would indicate that it is more likely than not that the fair value of any of our reporting units was less than its carrying amount. If after assessing the totality of events or circumstances, we were to determine that it is not more likely than not that the fair value of a reporting unit is less than its carrying amount, then we would not perform the two-step quantitative impairment testing described further below.
The aforementioned two-step quantitative testing process involves comparing the reporting unit carrying values to their respective fair values; we determine fair value of our reporting units by applying the discounted cash flow method using the present value of future estimated net cash flows. If the fair value of a reporting unit exceeds its carrying value, then no further testing is required. However, if a reporting unit’s fair value were to be less than its carrying value, we would then determine the amount of the impairment charge, if any, which would be the amount that the carrying value of the reporting unit’s goodwill exceeded its implied value. We perform our annual goodwill impairment evaluation and testing as of September 30 each year. In 2014 the goodwill residing in the Exchange reporting unit, the Carrier Systems reporting unit, were evaluated for impairment based on an assessment of certain qualitative factors, and were determined not to have been impaired.  In 2014 the goodwill residing in the Risk Compliance Solutions reporting unit and Broker Systems reporting unit were evaluated for impairment using step-one of the quantitative testing process described above. The fair value of both of these reporting units were found to be greater than their carrying value, and thusly there was no need to proceed to step-two, as there was no impairment indicated.  The Risk Compliance Solutions reporting unit fair value in excess of its carrying value was relatively close (based on revenue growth assumption  of 2% to 3% and discount rate of 16%) while the Broker Systems reporting unit had a significantly higher fair value in excess of its carrying value. During the years ended December 31, 2014, 2013, and 2012, we had no impairment of any our reporting unit goodwill balances.
Projections of cash flows are based on our views of revenue growth rates, operating costs, anticipated future economic conditions, the appropriate discount rates relative to risk, and estimates of residual values and terminal values. We believe that our estimates are consistent with assumptions that marketplace participants would use in their estimates of fair value. The use of different estimates or assumptions for our projected discounted cash flows (e.g., revenue growth rates, future economic conditions, discount rates, and estimates of terminal values) when determining the fair value of our reporting units could result in different values and may result in a goodwill impairment charge. As a practice, the Company closely monitors any reporting units that do not have a significantly higher fair value in excess of their carrying value.
The following table summarizes the goodwill recorded in connection with the acquisitions that occurred during 2014 and 2013:
Company acquired		Date acquired		(in thousands)
CurePet, Inc. ("CurePet")		Jan-14		$	2,687
HealthCare Magic Private Limited ("HealthCare Magic")		May-14		5,619
Vertex, Incorporated ("Vertex")		Oct-14		27,728
Oakstone Publishing, LLC ("Oakstone")		Dec-14		28,769
DCM Group Inc. (d.b.a. i3 Software) ("i3")		Dec-14		3,700
Total during 2014				$	68,503
Qatarlyst ("Qatarlyst")		Apr-13		$	11,136
Total during 2013				$	11,136
Changes in the carrying amount of goodwill for the years ended December 31, 2014 and 2013 are as follows:
	December 31, 2014				December 31, 2013
	(in thousands)
Beginning Balance	$	337,068			$	326,748
Additions, net (see Note 3)	68,503				11,136
Foreign currency translation adjustments	(3,351		)		(816		)
Ending Balance	$	402,220			$	337,068
The Company’s indefinite-lived assets are associated with the estimated fair value of the contractual customer relationships existing with the property and casualty insurance carriers in Australia using our property and casualty ("P&C") data exchange and with certain large corporate customers using our client relationship management (“CRM”) platform in the United States. Prior to these underlying business acquisitions Ebix had pre-existing contractual relationships with these carriers and corporate clients. The contracts are renewable at little or no cost, and Ebix intends to continue to renew these contracts indefinitely and has the ability to do so. The proprietary technology supporting the P&C data exchange and CRM platform that is used to deliver services to these carriers and corporate clients, cannot feasibly be effectively replaced in the foreseeable future, and accordingly the cash flows forthcoming from these customers are expected to continue indefinitely. With respect to the determination of the indefinite life, the Company considered the expected use of these intangible assets, historical experience in renewing or extending similar arrangements, and the effects of competition, and concluded that there were no indications from these factors to suggest that the expected useful life of these customer relationships would be finite. The Company concluded that no legal, regulatory, contractual, or competitive factors limited the useful life of these intangible assets and therefore their life was considered to be indefinite, and accordingly the Company expects these customer relationships to remain the same for the foreseeable future. The fair values of these indefinite-lived intangible assets were based on the analysis of discounted cash flow (“DCF”) models extended out fifteen to twenty years. In that indefinite-lived does not imply an infinite life, but rather means that the subject customer relationships are expected to extend beyond the foreseeable time horizon, we utilized fifteen to twenty year DCF projections, as the valuation models that were applied consider a fifteen to twenty year time frame to be an indefinite period. Indefinite-lived intangible assets are not amortized, but rather are tested for impairment annually. We perform our annual impairment testing of indefinite-lived intangible assets as of September 30th of each year. During the years ended December 31, 2014, 2013, and 2012, we had no impairments to the recorded balances of our indefinite-lived intangible assets. We perform the impairment test for our indefinite-lived intangible assets by comparing the asset’s fair value to its carrying value. An impairment charge is recognized if the asset’s estimated fair value is less than its carrying value.
Purchased Intangible Assets—Purchased intangible assets represent the estimated fair value of acquired intangible assets from the businesses that we acquire in the U.S. and foreign countries in which we operate. These purchased intangible assets include customer relationships, developed technology, informational databases, and trademarks. We amortize these intangible assets on a straight-line basis over their estimated useful lives, as follows:
	Life
Category	(yrs)
Customer relationships	20-Jul
Developed technology	12-Mar
Trademarks	15-Mar
Non-compete agreements	5
Database	10
Intangible assets as of December 31, 2014 and December 31, 2013, are as follows:
	December 31,
	2014				2013
	(In thousands)
Finite-lived intangible assets:
Customer relationships	$	66,783			$	62,408
Developed technology	15,664				14,630
Trademarks	2,751				2,646
Non-compete agreements	751				538
Backlog	140				140
Database	212				212
Total intangibles	86,301				80,574
Accumulated amortization	(36,930		)		(29,840		)
Finite-lived intangibles, net	$	49,371			$	50,734
Indefinite-lived intangibles:
Customer/territorial relationships	$	30,887			$	30,887
Income Taxes— The Company follows the asset and liability method of accounting for income taxes pursuant to the pertinent guidance issued by the FASB. Deferred income taxes are recorded to reflect the tax consequences on future years of differences between the tax basis of assets and liabilities, and operating loss and tax credit carry forwards, and their financial reporting amounts at each period end using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. In assessing the realizability of the deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. A valuation allowance is recorded, if necessary, for the portion of the deferred tax assets that are not expected to be realized based on the levels of historical taxable income and projections for future taxable income over the periods in which the temporary differences will be deductible.
The Company follows the provisions of FASB accounting guidance on accounting for uncertain income tax positions. The guidance utilizes a two-step approach for evaluating tax positions. Recognition (“Step 1”) occurs when an enterprise concludes that a tax position, based solely on its technical merits is more likely than not to be sustained upon examination. Measurement (“Step 2”) is only addressed if Step 1 has been satisfied. Under Step 2, the tax benefit is measured at the largest amount of benefit, determined on a cumulative probability basis that is more likely than not to be realized upon final settlement. As used in this context, the term “more likely than not” is interpreted to mean that the likelihood of occurrence is greater than 50%.
Foreign Currency Translation—The functional currency for the Company's foreign subsidiaries in India and Singapore is the U.S. dollar because the intellectual property research and development activities provided by its Singapore subsidiary, and the product development and information technology enabled services activities for the insurance industry provided by its India subsidiary, both in support of Ebix's operating divisions across the world, are transacted in U.S. dollars.
The functional currency of the Company's other foreign subsidiaries is the local currency of the country in which the subsidiary operates. The assets and liabilities of these foreign subsidiaries are translated into U.S. dollars at the rates of exchange at the balance sheet dates. Income and expense accounts are translated at the average exchange rates in effect during the period. Gains and losses resulting from translation adjustments are included as a component of accumulated other comprehensive loss in the accompanying consolidated balance sheets. Foreign exchange transaction gains and losses that are derived from transactions denominated in a currency other than the subsidiary's functional currency are included in the determination of net income.
Advertising—Advertising costs are expensed as incurred. Advertising costs amounted to $1.7 million, $1.0 million, and $1.4 million in 2014, 2013, and 2012, respectively, and are included in sales and marketing expenses in the accompanying Consolidated Statements of Income.
Sales Commissions —Certain sales commission paid with respect to subscription-based revenues are deferred and subsequently amortized into operating expenses ratably over the term of the related customer subscription contracts. As of December 31, 2014 and 2013, $398 thousand and $434 thousand, respectively, of sales commissions were deferred and included in other current assets on the accompanying Consolidated Balance Sheets. During the years ended December 31, 2014 and 2013 the Company amortized $913 thousand and $915 thousand, respectively, of previously deferred sales commissions and included this expense in sales and marketing costs on the accompanying Consolidated Statements of Income.
Property and Equipment—Property and equipment is stated at cost less accumulated depreciation and amortization. Depreciation and amortization are computed using the straight-line method over the assets estimated useful lives. Leasehold improvements are amortized over the shorter of the expected life of the improvements or the remaining lease term. Repairs and maintenance are charged to expense as incurred and major improvements that extend the life of the asset are capitalized and depreciated over the expected remaining life of the related asset. Gains and losses resulting from sales or retirements are recorded as incurred, at which time related costs and accumulated depreciation are removed from the Company’s accounts. Fixed assets acquired in acquisitions are recorded at fair value. The estimated useful lives applied by the Company for property and equipment are as follows:
	Life
Asset Category	(yrs)
Computer equipment	5
Furniture, fixtures and other	7
Buildings	30
Leasehold improvements	Life of the lease
Recent Accounting Pronouncements
The following is a summary brief discussion of recently released accounting pronouncements that are pertinent to the Company’s business:
In November 2014, the FASB issued Accounting Standards Update No. 2014-17 "Business Combinations: Pushdown Accounting - a consensus of the Emerging Issues Task Force". This accounting standard applies to the separate financial statements of an acquired entity and its subsidiaries that are a business upon the occurrence of an event in which an acquirer obtains control of the acquired entity. The amendments in this accounting standards update provide an acquired entity with an option to apply pushdown accounting in its separate financial statements upon occurrence of an event in which an acquirer obtains control of the acquired entity. An acquired entity may elect the option to apply pushdown accounting in the reporting period in which the change-in-control event occurs. An acquired entity should determine whether to elect to apply pushdown accounting for each individual change-in-control event in which an acquirer obtains control of the acquired entity. If pushdown accounting is not applied in the reporting period in which the change-in-control event occurs, an acquired entity will have the option to elect to apply pushdown accounting in a subsequent reporting period to the acquired entity’s most recent change-in-control event. An election to apply pushdown accounting in a reporting period after the reporting period in which the change-in-control event occurred should be considered a change in accounting principle. If pushdown accounting is applied to an individual change-in-control event, that election is irrevocable. If an acquired entity elects the option to apply pushdown accounting in its separate financial statements, it should disclose information in the current reporting period that enables users of financial statements to evaluate the effect of pushdown accounting. The amendments in this accounting standards update are effective on November 18, 2014. After the effective date, an acquired entity can make an election to apply the guidance to future change-in-control events or to its most recent change-in-control event. The Company will apply this accounting standards update to any separately issued or filed 2014 financial statement for its acquired subsidiaries and is still evaluating the impact of its adoption.
In May 2014 the FASB issued Accounting Standards Update ("ASU") No. 2014-09, "Revenue from Contracts with Customers". ASU 2014-09 affects any entity using U.S. GAAP that either enters into contracts with customers to transfer goods or services or enters into contracts for the transfer of non-financial assets unless those contracts are within the scope of other standards (e.g., insurance contracts or lease contracts). This ASU will supersede the revenue recognition requirements in Topic 605, Revenue Recognition, and most industry-specific guidance. This ASU also supersedes some cost guidance included in Subtopic 605-35, Revenue Recognition—Construction-Type and Production-Type Contracts. In addition, the existing requirements for the recognition of a gain or loss on the transfer of non-financial assets that are not in a contract with a customer (e.g., assets within the scope of Topic 360, Property, Plant, and Equipment, and intangible assets within the scope of Topic 350, Intangibles—Goodwill and Other) are amended to be consistent with the guidance on recognition and measurement (including the constraint on revenue)in this ASU.
The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. To achieve that core principle, an entity should apply the following steps:
Step 1: Identify the contract(s) with a customer.
Step 2: Identify the performance obligations in the contract.
Step 3: Determine the transaction price.
Step 4: Allocate the transaction price to the performance obligations in the contract.
Step 5: Recognize revenue when (or as) the entity satisfies a performance obligation.
For a public entity, the amendments in this ASU are effective for annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period. Early application is not permitted.
An entity should apply the amendments in this ASU using one of the following two methods:
1. Retrospectively to each prior reporting period presented and the entity may elect any of the following
practical expedients:
• For completed contracts, an entity need not restate contracts that begin and end within the
same annual reporting period.
• For completed contracts that have variable consideration, an entity may use the transaction
price at the date the contract was completed rather than estimating variable consideration
amounts in the comparative reporting periods.
• For all reporting periods presented before the date of initial application, an entity need not
disclose the amount of the transaction price allocated to remaining performance obligations
and an explanation of when the entity expects to recognize that amount as revenue.
2. Retrospectively with the cumulative effect of initially applying this ASU recognized at the date of initial
application. If an entity elects this transition method it also should provide the additional disclosures in reporting
periods that include the date of initial application of:
• The amount by which each financial statement line item is affected in the current reporting
period by the application of this ASU as compared to the guidance that was in effect before
the change.
• An explanation of the reasons for significant changes.
The Company will adopt this new accounting standard effective January 1, 2017 and it has not presently determined the impact that the adoption of ASU No. 2014-09 will have on its income statement, balance sheet, or statement of cash flows. Furthermore, the Company has not yet determined the method of retrospective adoption it will use as described in paragraphs 1 and 2 immediately above.
In July 2013, the FASB issued Accounting Standards Update No. 2013-11, "Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists". This accounting standard states that an unrecognized tax benefit, or a portion of an unrecognized tax benefit, should be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward, except as follows. To the extent a net operating loss carryforward, a similar tax loss, or a tax credit carryforward is not available at the reporting date under the tax law of the applicable jurisdiction to settle any additional income taxes that would result from the disallowance of a tax position or the tax law of the applicable jurisdiction does not require the entity to use, and the entity does not intend to use, the deferred tax asset for such purpose, the unrecognized tax benefit should be presented in the financial statements as a liability and should not be combined with deferred tax assets. This accounting standards update applies to all entities that have unrecognized tax benefits when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists at the reporting date. The accounting standards update is effective for fiscal years, and interim periods within those years, beginning after December 15, 2013. Early adoption is permitted. The amendments should be applied prospectively to all unrecognized tax benefits that exist at the effective date. Retrospective application is permitted. The Company adopted this new standard in 2014, and it effected how unrecognized tax benefits were accounted for and presented in the Company's balance sheet.
In July 2012, the FASB issued Accounting Standards Update No. 2012-02, "Testing Indefinite-Lived Intangible Assets for Impairment" (the revised standard). The revised standard is intended to reduce the cost and complexity of testing indefinite-lived intangible assets other than goodwill for impairment. It allows companies to perform a qualitative assessment to determine whether further impairment testing of indefinite-lived intangible assets is necessary, similar in approach to the goodwill impairment test. If, after assessing the totality of events and circumstances, an entity concludes that it is not more likely than not that the indefinite-lived intangible asset is impaired, then the entity is not required to take further action. However, if an entity concludes otherwise, then it is required to determine the fair value of the indefinite-lived intangible asset and perform the quantitative impairment test by comparing the fair value with the carrying amount in accordance the related technical accounting guidance. The revised standard is effective for annual and interim impairment tests performed for fiscal years beginning after September 15, 2012. Early adoption is permitted. The Company adopted this new financial accounting standard in 2014 for use in its annual impairment evaluations of indefinite-lived intangible assets, which are performed as of September of each year.
In February 2013 The FASB has issued Accounting Standards Update (ASU) No. 2013-02, "Comprehensive Income Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income", to improve the transparency of reporting these reclassifications. Other comprehensive income includes gains and losses that are initially excluded from net income for an accounting period. Those gains and losses may later be reclassified out of accumulated other comprehensive income into net income. The amendments in this ASU do not change the current requirements for reporting net income or other comprehensive income in financial statements. The new amendments requires an organization to:
•Present (either on the face of the statement where net income is presented or in the notes) the effects on the line items of net income of significant amounts reclassified out of accumulated other comprehensive income - but only if the item reclassified is required under U.S. GAAP to be reclassified to net income in its entirety in the same reporting period.
•Cross-reference to other disclosures currently required under U.S. GAAP for other reclassification items (that are not required under U.S. GAAP) to be reclassified directly to net income in their entirety in the same reporting period. This would be the case when a portion of the amount reclassified out of accumulated other comprehensive income is initially transferred to a balance sheet account instead of directly to income or expense.
The amendments apply to all public and private companies that report items of other comprehensive income. Public companies are required to comply with these amendments for all reporting periods (interim and annual).
The amendments were effective for reporting periods beginning after December 15, 2012 for public companies. Early adoption was permitted. The Company adopted this new standard in 2013 and it did not have effect on its financial statements.

Supplemental_Schedule_of_Nonca

Supplemental Schedule of Noncash Financing Activities	12 Months Ended
	Dec. 31, 2014
Supplemental Cash Flow Elements [Abstract]
Supplemental Schedule of Noncash Financing Activities	Supplemental schedule of noncash financing activities:
	Effective January 27, 2014 Ebix acquired the entire business of CurePet, Inc. ("CurePet") in an asset purchase agreement with the total purchase consideration being in the amount of $6.35 million of which includes a possible future one time contingent earnout payment of up to $5.0 million based on earned revenues over the subsequent thirty-six month period following the date of the acquisition. This contingent earnout liability is currently estimated to have a fair value of zero. Additional required cash consideration of $1.35 million was offset against open receivable balances due to Ebix, Inc. from CurePet, and thusly no actual cash outlay was made by Ebix, Inc. Previously during 2012, Ebix acquired a minority19.8% interest in CurePet for cash consideration in the amount of $2.0 million.
	Effective June 1, 2012, Ebix acquired PlanetSoft, Inc. for aggregate consideration in the amount of $40.0 million. Under terms of the merger agreement, the former PlanetSoft shareholders received, as part of the aggregate purchase consideration, 296,560 shares of Ebix common stock with a fair value of $5.0 million.

Earnings_per_Share

Earnings per Share	12 Months Ended
	Dec. 31, 2014
Earnings Per Share [Abstract]
Earnings per Share	Earnings per Share
	The basic and diluted earnings per share (“EPS”), and the basic and diluted weighted average shares outstanding for all periods as presented in the accompanying Consolidated Statements of Income are shown below :
		For the year ended
		December 31,
		(In thousands, except per share amounts)
	Earnings per share:	2014			2013			2012
	Basic earnings per common share	$	1.68		$	1.58		$	1.91
	Diluted earnings per common share	$	1.67		$	1.53		$	1.8
	Basic weighted average shares outstanding	37,809			37,588			36,948
	Diluted weighted average shares outstanding	38,040			38,642			39,100
	Basic EPS is equal to net income divided by the weighted average number of shares of common stock outstanding for the period. Diluted EPS takes into consideration common stock equivalents which for the Company consist of stock options and restricted stock. With respect to stock options, diluted EPS is calculated as if the Company had additional common stock outstanding from the beginning of the year or the date of grant or issuance, net of assumed repurchased shares using the treasury stock method. Diluted EPS is equal to net income divided by the combined sum of the weighted average number of shares outstanding and common stock equivalents. At December 31, 2014, 2013, and 2012 there were 135,000, 315,000, and 90,000 potentially issuable shares with respect to stock options which could dilute EPS in the future but which were excluded from the diluted EPS calculation because presently their effect is anti-dilutive. Diluted shares outstanding are determined as follows for each years ending December 31, 2014, 2013, and 2012:
		For the year ended
		December 31,
		(in thousands)
		2014		2013			2012
	Basic weighted average shares outstanding	37,809		37,588			36,948
	Incremental shares for common stock equivalents	231		1,054			2,152
	Diluted shares outstanding	38,040		38,642			39,100

Business_Acquisitions

Business Acquisitions	12 Months Ended
	Dec. 31, 2014
Business Combinations [Abstract]
Business Acquisitions	Business Acquisitions
	The Company’s business acquisitions are accounted for under the purchase method of accounting in accordance with the FASB’s accounting guidance on the accounting for business combinations. Accordingly, the consideration paid by the Company for the businesses it purchases is allocated to the assets and liabilities acquired based upon their estimated fair values as of the date of the acquisition. The excess of the purchase price over the estimated fair values of assets acquired and liabilities assumed is recorded as goodwill. Recognized goodwill pertains in part to the value of the expected synergies to be derived from combining the operations of the businesses we acquire including the value of the acquired workforce.
	The Company's practice is that, immediately after a business acquisition is consummated, all functions are tightly integrated including infrastructure, sales and marketing, administration, product development, so as to ensure that efficiencies are maximized and redundancies eliminated. Furthermore the Company centralizes certain key functions such as product development, information technology, marketing, sales, human resources, finance, and other general administrative functions after an acquisition, in order to rapidly leverage cross-selling opportunities and to quickly realize cost efficiencies. By executing this integration strategy it becomes neither practical nor feasible to accurately and separately track and disclose the earnings from the business combinations we have executed after they have been acquired.
	A significant component of the purchase price consideration for many of the Company's business acquisitions is a potential future cash earnout based on reaching certain specified future revenue targets. The Company recognizes these potential obligations as contingent liabilities as reported on its Consolidated Balance Sheets. As discussed in more detail in Note 1, these contingent consideration liabilities are recorded at fair value on the acquisition date and are remeasured quarterly based on the then assessed fair value and adjusted if necessary. During each of the years ending December 31, 2014, 2013 and 2012, respectively, these aggregate contingent accrued earn-out business acquisition consideration liabilities, were reduced by $10.2 million, $10.3 million and $699 thousand, respectively, due to remeasurements as based on the then assessed fair value and changes in the amount and timing of anticipated future revenue levels. These reductions to the contingent accrued earn-out liabilities resulted in corresponding reduction to general and administrative expenses as reported on the Consolidated Statements of Income.
	As of December 31, 2014, the total of these contingent liabilities was $5.4 million, of which $4.5 million is reported in long-term liabilities, and $887 thousand is included in current liabilities in the Company's Consolidated Balance Sheet. As of December 31, 2013 the total of these contingent liabilities was $14.4 million of which $10.3 million is reported in long-term liabilities, and $4.1 million is included in current liabilities in the Company's Consolidated Balance Sheet.
	During 2012 the Company received a termination fee in connection with a failed business acquisition. In this regard the Company recorded a reduction to general and administrative expense in the approximate amount of $971 thousand (net of directly related internal operating costs incurred by the Company and a portion of the fee that was paid to our investment banker).
	2014 Acquisitions
	CurePet - On January 27, 2014, Ebix acquired CurePet. CurePet was a developmental-stage enterprise that developed an insurance exchange that connects pet owners, referring veterinarians, animal hospitals, academic institutes, and suppliers of medical and general pet supplies, while providing a wide variety of services related to pet insurance to each constituent including practice management, electronic medical records, and billing. Previously Ebix had a minority investment in CurePet. Ebix acquired the entire business of CurePet in an asset purchase agreement with total purchase consideration being $6.35 million which includes a possible future one time contingent earnout payment of up to $5.0 million based on earned revenues over the subsequent thirty-six month period following the effective date of the acquisition. This contingent earnout liability is currently estimated to have a fair value of zero. Additional required cash consideration of $1.35 million was offset against open accounts receivable balances due to the Company from CurePet, and no actual cash outlay was made by the Company.
	HealthCare Magic - On May 21, 2014, Ebix acquired HealthCare Magic Private Limited ("HealthCare Magic"), a medical advisory service with an online network of approximately fifteen thousand General Physicians and Surgeons spread across fifty specialties including alternative medicine. The Company acquired HealthCare Magic for aggregate cash consideration in the amount of $6.0 million plus a possible future one time contingent earnout payment of up to $12.36 million based on earned revenues over the subsequent twenty-four month period following the effective date of the acquisition. This contingent earnout liability is currently estimated to have a fair value of $596 thousand. The Company funded the HealthCare Magic acquisition from available cash reserves on hand. The Company accounted for this acquisition by recording $5.6 million of goodwill, $452 thousand of intangible assets pertaining to customer relationships, $100 thousand of intangible assets pertaining to acquired technology, $59 thousand on intangible assets pertaining to trademarks and tradenames, and $226 thousand of intangible assets pertaining to non-compete agreements.
	Vertex - On November 3, 2014, Ebix acquired Vertex, Incorporated ("Vertex"), with an effective date of October 1, 2014, in a share purchase agreement for total cash purchase consideration in the amount of $27.25 million and a possible contingent earnout of $2 million based on earned revenues over the subsequent twenty-four month period following the date of the acquisition. Vertex is a specialized software and services firm focused primarily on the life and annuity insurance marketplace since 1991. Ebix acquired all of the outstanding capital stock of Vertex and funded the purchase using a mix of internal cash reserves and the bank credit line available to Ebix. The Company accounted for this acquisition by recording $27.7 million of goodwill, $2.5 million of intangible assets pertaining to customer relationships, and $235 thousand of intangible assets pertaining to acquired technology. The valuation and purchase price allocation for the Vertex acquisition remains preliminary and will be finalized prior to June 30, 2015.
	Oakstone - Effective December 2, 2014, Ebix acquired Oakstone Publishing, LLC ("Oakstone") in a membership interest purchase agreement for total net cash consideration in the amount of $23.72 million ($31.37 million less a closing net working capital adjustment of $7.65 million). Oakstone is leading provider of continuing education, certification materials for physicians, dentists and allied healthcare professionals, as well as wellness resources for various organizations. Ebix acquired all of the outstanding membership interests of Oakstone and funded the purchase using a mix of internal cash reserves and the bank credit line available to Ebix. The Company accounted for this acquisition by recording $28.8 million of goodwill, $1.7 million of intangible assets pertaining to customer relationships, $501 thousand of intangible assets pertaining to acquired technology, and a $6.5 million deferred revenue liability. The valuation and purchase price allocation for the Oakstone acquisition remains preliminary and will be finalized prior to June 30, 2015.
	i3 - On December 1, 2014, Ebix acquired the DCM Group Inc. (d.b.a. i3 Software) ("i3") in an asset purchase agreement for total cash consideration in the amount of $2 million and a possible contingent earnout of up to $4 million based on earned revenues over the subsequent twenty-four month period following the date of the acquisition. i3 is a provider of software services and solutions to the insurance industry. Ebix acquired all of the assets of i3 and funded the purchase using internal cash reserves. The Company accounted for this acquisition by recording $3.7 million of goodwill, $225 thousand of intangible assets pertaining to customer relationships, and $75 thousand of intangible assets pertaining to acquired technology. The valuation and purchase price allocation for the i3 acquisition remains preliminary and will be finalized prior to June 30, 2015.
	2013 Acquisitions
	On April 7, 2013, the Company executed and completed one business acquisition of Qatarlyst. The Company accounted for this acquisition by recording $11.1 million of goodwill, $4.8 million of intangible assets pertaining to customer relationships, and $635 thousand of intangible assets pertaining to acquired technology.
	The following table summarizes the fair value of the consideration transferred, net assets acquired and liabilities assumed as a result of the acquisitions that occurred during 2014 and 2013:
			December 31,
	(in thousands)		2014			2013
	Fair value of total consideration transferred
	Cash		$	59,514		$	5,025
	Contingent earn-out consideration arrangement		4,312			9,425
	Previous cash consideration in investment of step up acquisition, CurePet		2,000			—
	Cash consideration offset against open receivable balances due to Ebix, Inc. from CurePet		1,350			—
	Total		$	67,176		$	14,450
	Fair value of assets acquired and liabilities assumed
	Cash		$	323		$	285
	Other current assets		5,263			485
	Property, plant, and equipment		670			144
	Other long term assets		54			507
	Intangible assets		6,872			5,396
	Deferred tax liability		(1,040		)	(947		)
	Current and other liabilities		(13,469		)	(2,556		)
	Net assets acquired, excludes goodwill		(1,327		)	3,314
	Goodwill		68,503			11,136
	Total net assets acquired		$	67,176		$	14,450
	The following table summarizes the separately identified intangible assets acquired as a result of the acquisitions that occurred during 2014 and 2013:
			December 31,
			2014					2013
						Weighted				Weighted
						Average				Average
	Intangible asset category		Fair Value			Useful Life		Fair Value		Useful Life
			(in thousands)			(in years)		(in thousands)		(in years)
	Customer relationships		$	5,275		9.9		$	4,761	11
	Developed technology		1,236			4.2		635		5
	Non-compete agreements		226			7		—		0
	Trademarks		135			5.5		—		0
	Total acquired intangible assets		$	6,872		8.8		$	5,396	10.3
	Estimated aggregate future amortization expense for the intangible assets recorded as part of the business acquisitions described above and other prior acquisitions is as follows:
	Estimated Amortization Expenses (in thousands):
	For the year ending December 31, 2015	$	7,357
	For the year ending December 31, 2016	6,794
	For the year ending December 31, 2017	6,388
	For the year ending December 31, 2018	5,668
	For the year ending December 31, 2019	5,384
	Thereafter	17,780
		$	49,371
	The Company recorded $7.4 million, $7.3 million, and $6.1 million of amortization expense related to acquired intangible assets for the years ended December 31, 2014, 2013, and 2012, respectively.

Pro_Forma_Financial_Informatio

Pro Forma Financial Information (re: 2014 and 2013 acquisitions)	12 Months Ended
	Dec. 31, 2014
Pro Forma Financial Information [Abstract]
Pro Forma Financial Information (re: 2014 and 2013 acquisitions)	Pro Forma Financial Information (re: 2014 and 2013 acquisitions)
	This unaudited pro forma financial information is provided for informational purposes only and does not project the Company’s results of operations for any future period.
	The aggregated unaudited pro forma financial information pertains to all of the Company's acquisitions made during 2014 and 2013, which includes the acquisitions of CurePet, HealthCare Magic, Vertex, Oakstone, i3, and Qatarlyst as presented in the table below is provided for informational purposes only and does not project the Company's expected results of operations for any future period. No effect has been given in this pro forma information for future synergistic benefits that may still be realized as a result of combining these companies or costs that may yet be incurred in integrating their operations. The 2014 and 2013 pro forma financial information below assumes that all such business acquisitions were made on January 1, 2013, whereas the Company's reported financial statements for 2014 only includes the operating results from the businesses since the effective date that they were acquired by Ebix, and thusly includes only eleven months of CurePet, eight months of HealthCare Magic, three months of Vertex, and one month each for Oakstone and i3. Similarly, the 2013 pro forma financial information below includes a full year of results for HealthCare Magic, Vertex, Oakstone, i3 , and Qatarlyst as if they had been acquired on January 1, 2013, whereas the Company's reported financial statements for the 2013 includes no actual financial results for HealthCare Magic, Vertex, Oakstone, i3, and nine months of financial results for Qatarlyst.
			As Reported		Pro Forma		As Reported		Pro Forma
			2014		2014		2013		2013
					(unaudited)				(unaudited)
			(In thousands, except per share amounts)
	Revenue		$	214,321	$	262,733	$	204,710	$	260,452
	Net Income		$	63,558	$	61,745	$	59,274	$	52,809
	Basic EPS		$	1.68	$	1.63	$	1.58	$	1.4
	Diluted EPS		$	1.67	$	1.62	$	1.53	$	1.37
	In the above table, the unaudited pro forma revenue for the year ended December 31, 2014 increased by $2.3 million from the unaudited pro forma revenue for 2013 of $260.5 million to $262.7 million , representing a 0.9% increase. The reported revenue in the amount of $214.3 million for the year ended December 31, 2014 increased by $9.6 million or 4.7% from the $204.7 million of reported revenue for the year ended December 31, 2013.
	The above pro forma analysis is based on the following premises:
	•	2014 and 2013 pro forma revenue contains actual revenue of the acquired entities before acquisition date, as reported by the sellers, as well as actual revenue of the acquired entities after acquisition. Growth in revenues of the acquired entities after acquisition date are only reflected for the period after their acquisition.
	•	Revenue billed to existing clients from the cross selling of acquired products has been assigned to the acquired section of our business.
	•	Any existing products sold to new customers acquired through the acquisition customer base, has also been assigned to the acquired section of our business.
	•	2013 pro forma revenues include revenues from some product lines whose sale was discontinued after the acquisition date and revenues from some customers whose contracts were discontinued. This is typically done for efficiency and/or competitive reasons.
	•	The impact from fluctuations of the exchange rates for the foreign currencies in the countries in which we conduct operations also partially affected reported revenues. During each of the years 2014, 2013, and 2012 the change in foreign currency exchange rates decreased reported consolidated operating revenues by $(3.2) million, $(3.8) million, and $(1.2) million, respectively.

Commercial_Bank_Financing_Faci

Commercial Bank Financing Facility	12 Months Ended
	Dec. 31, 2014
Debt Disclosure [Abstract]
Commercial Bank Financing Facility	Commercial Bank Financing Facility
	On August 5, 2014, Ebix entered into a credit agreement providing for a $150 million secured syndicated credit facility (the “Regions Secured Syndicated Credit Facility”) with Regions Financial Corporation ("Regions") as administrative agent and Regions with MUFG Union Bank N.A., and Silicon Valley Bank as joint lenders. The financing is comprised of a five-year, $150 million secured revolving credit facility, with an option to expand to $200 million upon request and with additional lender commitments. This new $150 million credit facility with Regions, as administrative agent, replaces the former syndicated $100 million facility that the Company had in place with Citi Bank, N.A. which was paid in full upon the undertaking of this new loan facility with Regions. The initial interest rate applicable to the Secured Syndicated Credit Facility is LIBOR plus 1.75% or currently 1.94%. Under the Regions Secured Syndicated Credit Facility the maximum interest rate that could be charged depending upon the Company's leverage ratio is LIBOR plus 2.25%. The underlying financing agreement contains financial covenants regarding the Company's fixed charge coverage ratio and leverage ratio, as well as certain restrictive covenants pertaining to such matters as the incurrence of new debt and the consummation of new business acquisitions. The Company currently is in compliance with all such financial and restrictive covenants. As of December 31, 2014 the Company's consolidated balance sheet includes $1.3 million of remaining deferred financing costs which are being amortized over the remaining life of the underlying credit facility. This debt is collateralized by essentially all assets of the Company
	On May 19, 2014, Ebix and certain of its subsidiaries entered into a Third Amendment (the “Third Amendment”) to the Credit Agreement, dated April 26, 2012 (as previously amended), among the Company, Wells Fargo Capital Finance, LLC, as a lender, RBS Citizens, N.A. as a lender, and Citibank, N.A., ("CitiBank") as Administrative Agent and as a lender (the “Credit Agreement”). The Third Amendment amended the Company’s obligations with respect to certain covenants under the Credit Agreement, to provide flexibility to the Company to make certain specified business acquisitions, while allowing the Company to make early payments towards reduction of its bank debt. Furthermore, the Third Amendment amended the Credit Agreement by reducing the revolving commitments of the lenders to $7.84 million as of May 19, 2014, for which the Company made a principal payment in the amount of $15.0 million, and was paid in full on August 5, 2014 upon the undertaking of the aforementioned new loan facility with Regions.
	On April 26, 2012, Ebix entered into a credit agreement providing for a $100 million secured syndicated credit facility (the “Secured Syndicated Credit Facility”) with Citibank, N.A. ("Citibank") as administrative agent and Citibank, N.A., Wells Fargo Capital Finance, LLC, and RBS Citizens, N.A. as joint lenders. The financing was comprised of a four-year, $45 million secured revolving credit facility, a $45 million secured term loan which amortized over a four year period with quarterly principal and interest payments commencing on June 30, 2012 and a final payment of all remaining outstanding principal and accrued interest due on April 26, 2016, and an accordion feature that provided for the expansion of the credit facility by an additional $10 million. The $100 million credit facility with Citibank, N.A., as administrative agent, replaced the former $55 million facility that the Company had in place with Bank of America, N.A. The initial interest rate applicable to the Secured Syndicated Credit Facility was LIBOR plus 1.50% and stood at 1.67% at December 31, 2013. Under the Secured Syndicated Credit Facility the maximum interest rate that could be charged depending upon the Company's leverage ratio is LIBOR plus 2.00%. The credit facility was used by the Company to fund working capital requirements primarily in support of current operations, organic growth, and accretive business acquisitions. The Company incurred $744 thousand of origination costs in connection with this new credit facility, and amortized these costs into interest expense over the four-year life of the credit agreement. This syndicated credit facility with Citibank was fully repaid and replaced with a new credit syndicated credit facility with Regions Bank, as discussed above.
	At December 31, 2014, the outstanding balance on the revolving line of credit with Regions was $120.47 million and the facility carried an interest rate of 1.94%. This balance is included in the long-term liabilities section of the Consolidated Balance Sheets. During 2014, the average and maximum outstanding balances on the revolving line of credit were $40.5 million and $120.47 million, respectively, and the weighted average interest rate was 1.78%. At December 31, 2013 the outstanding balance on the revolving line of credit was $22.8 million and the facility carried an interest rate of 1.67%.
	In August 2014 the outstanding balance on the term loan with Citibank was zero as it was paid in full upon the undertaking of the aforementioned new loan facility with Regions. During the twelve months ended December 31, 2014, $7.6 million of scheduled payments were made against this pre-existing term loan.

Commitments_and_Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2014
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies
	Contingencies-In connection with the shareholder class action styled In re: Ebix, Inc. Securities Litigation, Civil Action No. 1:11-CV-02400-RWS (N.D. Ga.), which as previously disclosed was settled in 2014 and is now concluded, there have been three derivative complaints brought by certain shareholders on behalf of the Company, which name certain of the Company's officers and its entire board of directors as Defendants. The first such derivative action was brought by an alleged shareholder named Paul Nauman styled Nauman v. Raina, et al., Civil Action File No. 2011-cv-205276 (Superior Court of Fulton County, Georgia), filed September 1, 2011. The second such derivative action was brought by an alleged shareholder named Gilbert Spagnola styled Spagnola v. Bhalla, et al., Civil Action No. 1:13-CV-00062-RWS (N.D. Ga.), filed January 7, 2013. The third such derivative action was brought by an alleged shareholder named Hotel Trades Council and Hotel Association of New York City, Inc. Pension Fund styled Hotel Trades Council and Hotel Association of New York City, Inc. Pension Fund v. Raina, et al., Civil Action No. 1:13-CV-00246-RWS (N.D. Ga.), filed January 23, 2013. These derivative actions are based on substantially the same factual allegations in the now settled shareholder class action suit, but also variously claim breach of fiduciary duties, abuse of control, gross mismanagement, the wasting of corporate assets, negligence, unjust enrichment by the Company's directors, and violation of Section 14 of the Exchange Act. The Nauman case was stayed pending the completion of expert discovery in the shareholder class action suit. On April 12, 2013, the Federal Court entered an Order consolidating the Spagnola and Hotel derivative cases under the style In re Ebix, Inc. Derivative Litigation, File No. 1:13-CV-00062-RWS (N.D. Ga.), appointing Hotel Trades Council and Hotel Association of New York City, Inc. Pension Fund as Lead Derivative Plaintiff, and appointing the law firm Cohen Milstein Sellers & Toll PLLC as Lead Derivative Counsel and The Law Offices of David A. Bain LLC as Liaison Counsel. Lead Derivative Plaintiff filed its Consolidated Shareholder Derivative and Class Action Complaint on May 20, 2013. Thereafter, the Federal Court entered a Consent Order on June 4, 2013, setting a schedule for Lead Derivative Plaintiff to amend its Complaint in light of the anticipated preliminary proxy related to a proposed transaction announced on May 1, 2013 with affiliates of Goldman Sachs & Co. On September 23, 2014, following several months of extensive arms-length negotiations, the parties to both the Federal Court and Fulton Superior Court derivative actions entered into a Stipulation of Settlement, which, together with the exhibits annexed thereto, sets forth the terms and conditions for a proposed settlement of both the derivative actions and for dismissal of both the derivative actions with prejudice upon the terms and conditions set forth therein. On September 30, 2014, the Federal Court entered an Order preliminarily approving the proposed settlement. On December 2, 2014, following a final fairness hearing, the Federal Court entered a Final Order and Judgment Approving Settlement and Dismissing Actions with Prejudice. On December 12, 2014, the Fulton Superior Court entered a Stipulation and Order of Dismissal With Prejudice. As part of the settlement, the Company has agreed to adopt, implement, and/or maintain certain corporate governance measures and to pay attorneys’ fees and expenses to Plaintiffs’ Counsel in the amount of $690 thousand. The appeal period has passed and these matters are now concluded. During the week of January 19th 2015 the Company paid the $690 thousand of legal fees, of which $350 thousand was accrued to expense in Q3 2014, and the remaining $340 thousand was recognized and accrued to expense in Q4 2014.
	On December 3, 2012, the Company received a subpoena and letter from the Securities and Exchange Commission (“SEC”) dated November 30, 2012, stating that the SEC is conducting a formal, non-public investigation styled In the Matter of Ebix, Inc. (A-3318) and seeking documents primarily related to the issues raised in the In re: Ebix, Inc. Securities Litigation. On April 16, 2013, the Company received a second subpoena from the SEC seeking additional documents. The Company has cooperated with the SEC to provide the requested documents.
	On June 6, 2013, the Company was notified that the U.S. Attorney for the Northern District of Georgia had opened an investigation into allegations of intentional misconduct that had been brought to its attention from the pending shareholder class action lawsuit against the Company's directors and officers, the media and other sources. The Company is cooperating with the U.S. Attorney's office.
	Following our announcement on May 1, 2013 of the Company's execution of a merger agreement with affiliates of Goldman Sachs & Co., twelve putative class action complaints challenging the proposed merger were filed in the Delaware Court of Chancery. These complaints name as Defendants some combination of the Company, its directors, Goldman Sachs & Co. and affiliated entities. On June 10, 2013, the twelve complaints were consolidated by the Delaware Court of Chancery, now captioned In re Ebix, Inc. Stockholder Litigation, CA No. 8526-VCN. On June 19, 2013, the Company announced that the merger agreement had been terminated pursuant to a Termination and Settlement Agreement. After Defendants moved to dismiss the consolidated proceeding, Lead Plaintiffs amended their operative complaint to drop their claims against Goldman Sachs & Co. and focus their allegations on an Acquisition Bonus Agreement (“ABA”) between the Company and Robin Raina. On September 26, 2013, Defendants moved to dismiss the Amended Consolidated Complaint. On July 24, 2014, the Court issued its Memorandum Opinion. The only surviving counts are as follows: (i) Counts II and IV, but only to the extent the Plaintiffs seek non-monetary relief for alleged material misstatements related to the ABA base price in the 2010 Proxy Statement; (ii) Count II, but only to the extent it challenges the continued existence of the ABA as an alleged unreasonable anti-takeover device; and, (iii) Count V, but only to the extent that it relates to the compensation the Board received under the Company’s 2010 Stock Incentive Plan. On September 15, 2014, the Court entered an Order implementing its Memorandum Opinion. On January 16, 2015, the Court entered an Order permitting Plaintiffs to file a Second Amended and Supplemented Complaint. On February 10, 2015, Defendants filed a Motion to Dismiss the Second Amended and Supplemented Complaint, which is pending. The Company denies any liability and intends to defend the action vigorously.
	The Company has been sued by Microsoft for alleged copyright infringement, breach of contract, and unjust enrichment. Microsoft Corporation and Microsoft Licensing GP v. Ebix, Inc., Case No. 1:13-CV-01655-CAP (N.D.Ga), filed May 15, 2013. The Company filed a Motion to Dismiss on July 10, 2013. In response, Microsoft filed an Amended Complaint. The Company filed a Motion to Dismiss the Amended Complaint on August 29, 2013. On February 14, 2014, the Court denied the Company’s Motion to Dismiss. The Company cooperated with Microsoft in an audit of all of the Company's Microsoft licenses. The parties reached a confidential settlement and, on September 18, 2014, filed a Notice of Confidential Settlement in Principle and Stipulated Motion for 45-Day Extension of Time to finalize the various provisions of the settlement, which was granted by Order dated September 19, 2014. On October 13, 2014, the parties filed a Joint Stipulation of Dismissal with prejudice.
	The Company is involved in various other claims and legal actions arising in the ordinary course of business. In the opinion of management, the ultimate likely disposition of these matters will not have a material adverse effect on the Company’s consolidated financial position, results of operations or liquidity.
	Lease Commitments—The Company leases office space under non-cancelable operating leases with expiration dates ranging through 2021, with various renewal options. Capital leases range from three to five years and are primarily for computer equipment. There were multiple assets under various individual capital leases at December 31, 2014 and 2013.
	Commitments for minimum rentals under non-cancellable leases, debt obligations, and future purchase obligations as of December 31, 2014 were as follows:
	Year	Debt			Capital Leases		Operating Leases			Future Purchase Obligations
		(in thousands)
	2015	$	943		$	—	$	5,863		$	3,715
	2016	600			—		4,136			541
	2017	—			—		3,886			541
	2018	—			—		3,120			541
	2019	120,465			—		2,088			406
	Thereafter	—			—		1,340			—
	Total	$	122,008		$	—	$	20,433		$	5,744
	Less: sublease income						(1,296		)
	Net lease payments						$	19,137
	Less: amount representing interest				—
	Present value of obligations under capital leases				$	—
	Less: current portion	(943		)	—
	Long-term obligations	$	121,065		$	—
	Rental expense for office facilities and certain equipment subject to operating leases for 2014, 2013, and 2012 was $6.3 million, $6.5 million and $5.9 million, respectively.
	Sublease income for 2014, 2013 and 2012 was $381 thousand, $55 thousand, and $5 thousand, respectively.
	Self Insurance—For most of the Company’s U.S. employees the Company is currently self-insured for its health insurance program and has a stop loss policy that limits the individual liability to $120 thousand per person and the aggregate liability to 125% of the expected claims based upon the number of participants and historical claims. As of December 31, 2014 and 2013, the amount accrued on the Company’s consolidated balance sheet for the self-insured component of the Company’s employee health insurance was $250 thousand and $302 thousand, respectively. The maximum potential estimated cumulative liability for the annual contract period, which ends in September 2015, is $2.9 million.

Sharebased_Compensation

Share-based Compensation	12 Months Ended
	Dec. 31, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Share-based Compensation	Share-based Compensation
	Stock Options—The Company accounts for compensation expense associated with stock options issued to employees, Directors, and non-employees based on their fair value, which is calculated using an option pricing model, and is recognized over the service period, which is usually the vesting period. At December 31, 2014, the Company had one equity based compensation plan. No stock options were granted to employees or non-employees during 2014, 2013 and 2012; however, options were granted to Directors in 2013 and 2012. Stock compensation expense of $305 thousand, $474 thousand and $539 thousand was recognized during the years ending December 31, 2014, 2013 and 2012, respectively, on outstanding and unvested options.
	No options were granted during 2014. Previous year grants were estimated on the date of grant using the Black-Scholes option pricing model. The following table includes the weighted- average assumptions used in estimating the fair values and the resulting weighted-average fair value of stock options granted in the periods presented:
		Year Ended December 31, 2014				Year Ended December 31, 2013				Year Ended December 31, 2012
	Weighted average fair values of stock options granted	$	—			$	5.7			$	5.47
	Expected volatility	—		%		59.9		%		47.9		%
	Expected dividends	—		%		2.01		%		1.18		%
	Weighted average risk-free interest rate	—		%		0.65		%		0.33		%
	Expected life of stock options (in years)	0				3.5				3.5
	A summary of stock option activity for the years ended December 31, 2014, 2013 and 2012 is as follows:
		Shares			Weighted				Weighted		Aggregate Intrinsic
					Average				Average		Value
					Exercise Price				Remaining
									Contractual
									Term (Years)
											(in thousands)
	Outstanding at January 1, 2012	3,315,175			$	2.51			1.56		$	64,959
	Granted	45,000			$	16.94
	Exercised	(1,361,542	)		$	0.75
	Canceled	—			$	—
	Outstanding at December 31, 2012	1,998,633			$	4.03			1.17		$	24,171
	Granted	45,000			$	14.89
	Exercised	(1,251,633	)		$	1.73
	Canceled	—			$	—
	Outstanding at December 31, 2013	792,000			$	8.28			1		$	5,093
	Granted	—			$	—
	Exercised	(450,000	)		$	1.75
	Canceled	(135,000	)		$	17.58
	Outstanding at December 31, 2014	207,000			$	16.41			1.88		$	121
	Exercisable at December 31, 2014	139,500			$	16.35			1.43		$	89
	The aggregate intrinsic value for stock options outstanding and exercisable is defined as the difference between the market value of the Company’s stock as of the end of the period and the exercise price of the stock options. The total intrinsic value of stock options exercised during 2014, 2013 and 2012 was $5.3 million, $11.4 million, $24.8 million, respectively.
	Cash received or the value of stocks cancelled from option exercises under all share-based payment arrangements for the years ended December 31, 2014, 2013 and 2012, was $788 thousand, $2.2 million and $1.0 million, respectively.
	A summary of non-vested options and changes for the years ended December 31, 2014, 2013 and 2012 is as follows:
		Non-Vested Number of Shares			Weighted
					Average
					Exercise Price
	Non-vested balance at January 1, 2012	180,005			$	17.17
	Granted	45,000			$	16.94
	Vested	(90,005	)		$	14.6
	Canceled	—			$	—
	Non-vested balance at December 31, 2012	135,000			$	18.8
	Granted	45,000			$	14.89
	Vested	(67,500	)		$	18.66
	Canceled	—			$	—
	Non-vested balance at December 31, 2013	112,500			$	17.32
	Granted	—			$	—
	Vested	(45,000	)		$	18.53
	Canceled	—			$	—
	Non-vested balance at December 31, 2014	67,500			$	16.52
	The following table summarizes information about stock options outstanding by price range as of December 31, 2014:
			Options Outstanding									Options Exercisable
	Range of Exercise Prices		Number Outstanding			Weighted-Average Remaining Contractual Life (Years)		Weighted-Average Exercise Price				Number of Shares	Weighted-Average Exercise Price
	$2.18-$2.36		27,000			1.41		$	2.27			27,000	$	2.27
	$14.89-$16.94		90,000			2.98		$	15.92			33,750	$	16.26
	$20.58-$21.70		90,000			0.93		$	21.14			78,750	$	21.22
			207,000			1.88		$	16.41			139,500	$	16.35
	Restricted Stock—Pursuant to the Company’s restricted stock agreements, the restricted stock granted generally vests as follows: one third after one year, and the remaining in eight equal quarterly installments. The restricted stock also vests with respect to any unvested shares upon the applicable employee’s death, disability or retirement, the Company’s termination of the employee other than for cause, or for a change in control of the Company. A summary of the status of the Company’s non-vested restricted stock grant shares is presented in the following table:
		Shares			Weighted-Average Grant Date
					Fair Value
	Non vested at January 1, 2012	145,081			$	20.13
	Granted	73,061			$	23.26
	Vested	(90,379	)		$	18.89
	Forfeited	(6,607	)		$	24.1
	Non vested at December 31, 2012	121,156			$	22.74
Granted	32,842			$	15.91
Vested	(76,576	)		$	22.56
Forfeited	(2,157	)		$	23.42
Non vested at December 31, 2013	75,265			$	19.92
Granted	171,781			$	16.96
Vested	(52,388	)		$	20.35
Forfeited	(6,136	)		$	18.91
Non vested at December 31, 2014	188,522			$	17.13
As of December 31, 2014 there was $2.5 million of total unrecognized compensation cost related to non-vested share based compensation arrangements granted under the 2006 and 2010 Incentive Compensation Program. That cost is expected to be recognized over a weighted-average period of 2.09 years. The total fair value of shares vested during the years ended December 31, 2014, 2013 and 2012 was $1.1 million, $1.7 million, and $1.7 million, respectively.
In the aggregate the total compensation expense recognized in connection with the restricted grants was $1.5 million, $1.5 million and $1.5 million during each of the years ending December 31, 2014, 2013 and 2012, respectively.
As of December 31, 2014 the Company has 5.7 million shares of common stock reserved for possible future stock option and restricted stock grants.

Income_Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2014
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes
	Income before income taxes consisted of:
		Year Ended December 31, 2014				Year Ended December 31, 2013				Year Ended December 31, 2012
		(In thousands)
	Domestic	$	8,807			$	5,497			$	6,604
	Foreign	68,645				64,655				71,425
	Total	$	77,452			$	70,152			$	78,029
	The income tax provision consisted of:
		Year Ended December 31, 2014				Year Ended December 31, 2013				Year Ended December 31, 2012
		(In thousands)
	Current:
	Federal	$	1,335			$	266			$	342
	State	270				167				320
	Foreign	4,847				4,532				3,660
		6,452				4,965				4,322
	Deferred:
	Federal	1,118				(632		)		2,382
	State	43				(351		)		31
	Foreign	(263		)		(760		)		(1,557		)
		898				(1,743		)		856
	Provision for income taxes from ongoing operations at effective tax rate	$	7,350			$	3,222			$	5,178
	Discrete Items:
	Certain discrete tax impacts from foreign subsidiaries	(1,677		)		839				837
	NOL carryforward adjustment	(810		)		—				—
	IRS Settlement - net of ASC 740 (formerly "FIN 48") reserve reversals	480				—				—
	2013 income tax return amendment	1,891				—				—
	Additional reserves for uncertain tax positions (ASC 740, formerly "FIN 48")	9,798				6,817				2,745
	Reconciliation of the tax payable liability accounts for our various subsidiaries to the income tax returns filed or to be filed in those jurisdictions	(3,138		)		—				(1,300		)
	Provision for income taxes from discrete items	6,544				7,656				2,282
	Total provision for income taxes	$	13,894			$	10,878			$	7,460
	The income tax provision at the Federal statutory rate differs from the effective rate because of the following items:
		Year Ended December 31, 2014			Year Ended December 31, 2013			Year Ended December 31, 2012
	Statutory tax rate	35	%		35	%		35	%
	Tax impact of foreign subsidiaries (primarily in Singapore)	(4.0	)%		(6.9	)%		(8.1	)%
	State income taxes, net of federal benefit	0.3	%		(0.3	)%		0.4	%
	Tax holiday - India (Permanent Difference)	(12.7	)%		(15.2	)%		(15.6	)%
	Passive income exemption - Sweden (permanent difference)	(3.2	)%		(3.5	)%		(3.1	)%
	Acquisition contingent earnout liability adjustments	(4.6	)%		(5.0	)%		(0.4	)%
	Singapore enhanced R&D deductions	(1.1	)%		(1.2	)%		(1.3	)%
	Other	(0.2	)%		1.7	%		(0.2	)%
	Effective tax rate from ongoing operations	9.5	%		4.6	%		6.7	%
	Discrete Items:
	Certain discrete tax impacts from foreign subsidiaries	(2.2	)%		1.2	%		1.1	%
	NOL carryforward adjustment	(1.0	)%		—	%		—	%
	IRS Settlement - net of ASC 740 (formerly "FIN 48") reserve reversals	0.6	%		—	%		—	%
	2013 income tax return amendment	2.4	%		—	%		—	%
	Net ASC 740 (formerly "FIN 48") reserve additions for uncertain tax positions	12.7	%		9.7	%		3.5	%
	Reconciliation of the tax payable liability accounts for our various subsidiaries to the income tax returns filed in those jurisdictions	(4.1	)%		—	%		(1.7	)%
	Effective tax rate after discrete items	17.9	%		15.5	%		9.6	%
	Current deferred income tax assets and liabilities and long-term deferred tax assets and liabilities are presented on a net basis separately in the December 31, 2014 and 2013 accompanying Consolidated Balance Sheets. The individual balances in current and long-term deferred tax assets and liabilities are as follows:
		2014				2013
		(In thousands)
	Current deferred income tax assets	$	2,310			$	961
	Long-term deferred income tax assets	43,235				44,924
	Total deferred income tax assets	45,545				45,885
	Current deferred income tax liabilities	(197		)		(705		)
	Long-term deferred income tax liabilities	(23,342		)		(24,308		)
	Net deferred income tax asset	$	22,006			$	20,872
	Deferred income taxes reflect the impact of temporary differences between amounts of assets and liabilities for financial reporting purposes and such amounts as measured by the applicable local jurisdiction tax laws. Temporary differences and carry forwards which comprise the deferred tax assets and liabilities as of December 31, 2014 and 2013 were as follows:
		December 31, 2014								December 31, 2013
		Deferred								Deferred
		Assets				Liabilities				Assets			Liabilities
		(In thousands)
	Depreciation and amortization	$	254			$	—			$	580		$	—
Share-based compensation	817				—				781			—
Accruals and prepaids	2,342				470				3,415			788
Bad debts	600				—				394			—
Acquired intangible assets	—				23,069				—			24,225
Net operating loss carryforwards	16,595				—				19,698			—
Tax credit carryforwards (primarily MAT in India)	24,937				—				21,017			—
	45,545				23,539				45,885			25,013
Valuation allowance	—				—				—			—
Total deferred taxes	$	45,545			$	23,539			$	45,885		$	25,013
For the year ending December 31, 2014, the Company's total recognized income tax expense of $13.9 million includes the effects of several discrete items. Specifically, these discrete items were primarily the adverse net effects of the settlement of the IRS audit for the years 2008 thru 2012 amounting to $0.5 million, the amendment and refiling of the Company U.S. federal income tax return for the year 2013 which amounted to $1.9 million, and additional ASC 740 (formerly "FIN 48") provisioning for uncertain income tax return positions amounting to $9.8 million, partially offset by a benefit of $3.1 million from reconciling the tax payable liability accounts for our various subsidiaries to the income tax returns filed in those jurisdictions, and additional deductible interest expense in Singapore providing a tax benefit of $1.7 million. Thusly, the tax expense excluding such discrete items was $7.4 million, reflecting an effective tax rate of 9.5%.
As of December 31, 2014, the Company has remaining available domestic net operating loss (“NOL”) carry-forwards of $42.0 million (net of $5.7 million utilized to offset domestic taxable income for 2014), which are available to offset future federal and certain state income taxes. The Company reviews its NOL positions to validate that all NOL carry-forwards will be utilized before they begin to expire. Portions of these remaining NOL's will expire during the years 2020 through 2027.
The Company's consolidated worldwide effective tax rate is relatively low because of the effect of conducting significant operating activities in certain foreign jurisdictions with low tax rates and where a large portion of its taxable income is generated. Furthermore, the Company's worldwide product development operations and intellectual property ownership is centralized in its India and Singapore subsidiaries, respectively. Our operations in India benefit from a tax holiday, which affect our various operating facilities in that country. The tax holiday expired for one of our facilities in April of 2014, and will expire for our other facilities in the years 2015 through 2018. As such a significant component of the income generated by our India operations, other than passive interest  income, is not taxed. After the expiration of the full tax holiday all of the income generated by our India operations will be taxed at 50% of the normal 33.99% corporate tax rate for a period of five years. This tax holiday had the effect of reducing tax expense by approximately $9.9 million or approximately $0.17 per diluted share in 2014 with $3.82 million of Minimum Alternative Tax ("MAT") tax prepaid/accrued against 2014 income during the year ended December 31, 2014, for future taxes to be paid in India.
The Company also has a relatively low income tax rate in Singapore in which our operations are taxed at a 10% marginal tax rate as a result of concessions granted by the local Singapore Economic Development Board ("EDB") for the benefit of in-country intellectual property owners. The concessionary 10% income tax rate will expire during 2015, at which time our Singapore operations will be subject to the prevailing corporate tax rate in Singapore, which is currently 17%, unless the Company reaches a subsequent agreement to extend the incentive period and the then applicable concessionary rate. The concessionary tax rate granted by the EDB as compared to the statutory tax in effect in Singapore reduces income tax expense by approximately $2.5 million or approximately $0.07 per diluted share in 2014.
The pre-tax income from the applicable statutory tax rates in each jurisdiction in which the Company had operations for the year ending December 31, 2014 were as follows:
(dollar amounts in thousands)	United States				Canada				Latin America			Australia			Singapore			New Zealand			India			Mauritius			Europe(United Kingdom)			Sweden			Total
Pre-tax income	$	8,807			$	115			$	1,590		$	5,091		$	16,015		$	1,000		$	28,194		$	(370	)	$	9,940		$	7,070		$	77,452
Statutory tax rate	35		%		30.5		%		34		%	30		%	10		%	28		%	—		%	—		%	24		%	—		%
The income from the Company's operations in India is subject to MAT at a 20.97% rate. The tax paid under the MAT provisions is carried forward for a period of up to ten years following the end of the year in which the MAT tax has been paid as a set off against future tax liabilities computed under the regular corporate income tax provisions using the statutory 33.99% corporate income tax rate. During the year ended December 31, 2014, the Company paid/accrued $3.82 million in MAT tax. The accompanying Consolidated Balance Sheets as of December 31, 2014 and 2013 includes a long-term deferred tax asset in the amount of $22.46 million and $18.64 million , respectively, associated with cumulative future MAT tax credit entitlement.
The Company has not recognized a deferred U.S. tax liability and associated income tax expense for the undistributed earnings of its foreign subsidiaries which we consider indefinitely invested because those foreign earnings will remain permanently reinvested in those subsidiaries to fund ongoing operations and growth. Hypothetically if those earnings were to be not considered indefinitely invested, approximately $71.9 million of deferred U.S. income taxes would had to have been provided as of December 31, 2014.
On January 6, 2015, Ebix reached a resolution with the Internal Revenue Service with respect to the previously disclosed audit of Ebix’s income tax returns for the taxable years 2008 through 2012.  The original audit was extended to 2012, which is now part of that resolution dated December 30, 2014. The assessment resulted in a cash payment of $20.5 million, including interest of $1.6 million, and a ($1.5) million impact on net income for the fourth quarter of 2014 after taking into account the company’s previously established and disclosed provisions for uncertain tax positions. This resolution includes all issues for the taxable years 2008 through 2012.
The Company and its subsidiaries file income tax returns in the U.S. federal jurisdiction, and various states and foreign jurisdictions. With the exception of NOL carryforwards, the Company is no longer subject to U.S. federal or state tax examinations by tax authorities for years before 2013. Regarding our foreign operations as of December 31, 2014, the tax years that remain open and possibly subject to examination by the tax authorities in those jurisdictions are Australia (2008 to 2013), Singapore and Brazil (2008 to 2013), New Zealand (2010 to 2013), and India (2009 to 2013).
The Company follows the provisions of FASB accounting guidance on accounting for uncertain income tax positions. Accordingly liabilities are recognized for a tax position, where based solely on its technical merits, it is believed to be more likely than not fully sustainable upon examination. This liability is included in other long-term liabilities in the accompanying consolidated balance sheets. A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:
	December 31, 2014				December 31, 2013				December 31, 2012
	(in thousands)
Beginning Balance	$	12,742			$	5,925			$	3,180
Additions for tax positions related to current year	451				6,546				2,482
Additions for tax positions of prior years	9,348				271				263
Reductions for tax position of prior years	(19,521		)		—				—
Ending Balance	$	3,020			$	12,742			$	5,925
In the above table the $19.5 million of reductions to the Company reserves for uncertain tax positions primarily pertains to applicable reserves that were released and applied to the accounting for the settlement of the U.S. Internal Revenue Service's audit of the Company 2008 through 2012 income tax returns, and has been reclassified to income taxes payable within the accounts payable and accrued liability line as of December 31, 2014 in the accompanying Consolidated Balance sheet. The Company recognizes interest accrued and penalties related to unrecognized tax benefits as part of income tax expense. Interest assessed upon settlement of a tax return audit is classified as interest expense. As of December 31, 2014 approximately $680 thousand of estimated interest and penalties, which is part of the $3.02 million ending balance in the preceding table, is included in other long-term liabilities in the accompanying Consolidated Balance Sheet.
The Company has applied the new provisions under FAS update No. 2013-11, Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, A Similar Tax Loss, or a Tax Credit Carryforward Exists. Under these provisions, an unrecognized tax benefit, or a portion of an unrecognized tax benefit, should be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward in most cases. This provision has been applied and $1.1 million and $8.4 million of unrecognized tax benefits have been applied against NOL carryforward amounts as of December 31, 2014 and 2013, respectively.

Stock_Repurchases

Stock Repurchases	12 Months Ended
	Dec. 31, 2014
Stock Repurchases [Abstract]
Stock Repurchases	Stock Repurchases
	Effective June 21, 2013 the Company's Board of Directors unanimously approved an additional authorized share repurchase plan of $100 million. The Board directed that the repurchases be funded with available cash balances and cash generated by the Company's operating activities, and be completed in the subsequent twenty-four months if possible.
	Effective June 30, 2011 the Board of Directors of Ebix, Inc. unanimously approved an increase in the size of the Company's authorized share repurchase plan to acquire up to $100 million of the Company’s current outstanding shares of common stock. Under the terms of the Board’s authorization, the Company retains the right to repurchase up to $100 million in shares but does not have to repurchase this entire amount. The repurchase plan’s terms have been structured to comply with the SEC’s Rule 10b-18, and are subject to market conditions and applicable legal requirements. The program does not obligate the Company to acquire any specific number of shares and may be suspended or terminated at any time. All purchases are made in the open market. Treasury stock is recorded at its acquired cost. During 2014 the Company repurchased 2,146,488 shares of its common stock under this plan for total consideration of $31.9 million. During 2013 the Company repurchased 250,900 shares of its common stock under this plan for total consideration of $2.5 million. In addition, during 2012 the Company repurchased 983,818 shares of its common stock under this plan for total consideration of $18.4 million. As of December 31, 2014 the Company had $71 million remaining in its share repurchase authorization.

Derivative_Instruments

Derivative Instruments	12 Months Ended
	Dec. 31, 2014
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Instruments	Derivative Instruments
	In connection with the acquisition of PlanetSoft effective June 1, 2012, Ebix issued a put option to PlanetSoft's three shareholders. The put option, which expired in June 2014, was exercisable during the 30-day period immediately following the two-year anniversary date of the business acquisition, which if exercised would have enabled them to sell the underlying 296,560 shares of Ebix common stock they received as part of the purchase consideration, back to the Company at a price of $16.86 per share, which represented the per-share value established on the effective date of the closing of Ebix's acquisition of PlanetSoft. In accordance with the relevant authoritative accounting literature a portion of the total purchase consideration was allocated to this put liability based on its initial fair value, which was determined to be $1.4 million using a Black-Scholes model. The inputs used in the valuation of the put option include term, stock price volatility, current stock price, exercise price, and the risk free rate of return. The Company classified the put option, for which the fair value is re-measured on a recurring basis at each reporting date as a Level 2 instrument (i.e. wherein fair is partially determined and based on observable inputs other than quoted market prices), which we believe is the most appropriate level within the fair value hierarchy based on the inputs used to determine its fair value at the measurement date. During the months of July and August 2014 the former shareholders of PlanetSoft elected to exercise their put option rights with respect to the then remaining 209,656 shares of Ebix common stock they still held. Accordingly the shareholders put those shares back to the Company at $16.86 per share plus interest at the rate of 20% as per the PlanetSoft acquisition agreement. The total consideration, which included one month of interest, paid by the Company in connection with the exercise of these put options was $3.6 million.

Accounts_Payable_and_Accrued_E

Accounts Payable and Accrued Expenses	12 Months Ended
	Dec. 31, 2014
Accounts Payable and Accrued Liabilities, Current [Abstract]
Accounts Payable and Accrued Expenses	Accounts Payable and Accrued Expenses
	Accounts payable and accrued expenses at December 31, 2014 and December 31, 2013, consisted of the following:
		2014		2013
		(In thousands)
	Trade accounts payable	$	11,879	$	4,515
	Accrued professional fees	1,258		1,046
	Income taxes payable	22,627		8,173
	Sales taxes payable	2,601		4,038
	Interest payable pertaining to IRS settlement	1,650		—
	Other accrued liabilities	106		46
	Total	$	40,121	$	17,818

Other_Current_Assets

Other Current Assets	12 Months Ended
	Dec. 31, 2014
Prepaid Expense and Other Assets, Current [Abstract]
Other Current Assets	Other Current Assets
	Other current assets at December 31, 2014 and December 31, 2013 consisted of the following:
		2014		2013
		(In thousands)
	Prepaid expenses	$	5,618	$	3,824
	Sales taxes receivable from customers	121		220
	Due from prior owners of acquired businesses for working capital settlements	938		720
	Research and development tax credits receivable	1,152		720
	Other	238		64
	Total	$	8,067	$	5,548

Property_and_Equipment

Property and Equipment	12 Months Ended
	Dec. 31, 2014
Property, Plant and Equipment [Abstract]
Property and Equipment	Property and Equipment
	Property and equipment at December 31, 2014 and 2013 consisted of the following:
		2014			2013
		(In thousands)
	Computer equipment	$	13,830		$	12,417
	Buildings	3,912			3,119
	Land	3,924			59
	Leasehold improvements	1,448			2,648
	Furniture, fixtures and other	4,279			5,035
	Construction in Progress (building for new global corporate headquarters in the Atlanta metropolitan area)	10,441			—
		37,834			23,278
	Less accumulated depreciation and amortization	(13,173		)	(14,750		)
		$	24,661		$	8,528
	Depreciation expense was $2.3 million, $2.8 million and $3.1 million, for the years ended December 31, 2014, 2013 and 2012, respectively.

Other_Liabilities

Other Liabilities	12 Months Ended
	Dec. 31, 2014
Other Liabilities Disclosure [Abstract]
Other Liabilities	Other Liabilities
	Other liabilities at December 31, 2014 and December 31, 2013 consisted of the following:
		2014			2013
		(In thousands)
	Reserve for potential uncertain income tax return positions	$	3,020		$	12,742
	Unfavorable lease liability, long term portion	294			394
	Portion of an unrecognized tax benefit netted against deferred tax asset for a net operating loss carryforward	(1,135		)	(8,422		)
	Other	—			5
	Total	$	2,179		$	4,719

Cash_Option_Profit_Sharing_Pla

Cash Option Profit Sharing Plan and Trust	12 Months Ended
	Dec. 31, 2014
Cash Option Profit Sharing Plan and Trust [Abstract]
Cash Option Profit Sharing Plan and Trust	Cash Option Profit Sharing Plan and Trust
	The Company maintains a 401(k) Cash Option Profit Sharing Plan, which allows participants to contribute a percentage of their compensation to the Profit Sharing Plan and Trust up to the Federal maximum. The Company’s contributions to the Plan were $473 thousand, $368 thousand and $364 thousand for the years ending December 31, 2014, 2013 and 2012, respectively.

Geographic_Information

Geographic Information	12 Months Ended
	Dec. 31, 2014
Segment Reporting [Abstract]
Geographic Information	Geographic Information
	The Company operates with one reportable segment whose results are regularly reviewed by the Company's chief operating decision maker as to performance and allocation of resources. External customer revenues in the tables below were attributed to a particular country based on whether the customer had a direct contract with the Company which was executed in that particular country for the sale of the Company's products/services with an Ebix subsidiary located in that country.
	The following enterprise wide information relates to the Company's geographic locations (all amounts in thousands):
	Year Ended December 31, 2014
		United States		Canada		Latin America		Australia		Singapore		New Zealand		India		Europe		Total
	External Revenues	$	147,971	$	5,239	$	7,036	$	36,319	$	4,384	$	2,578	$	1,929	$	8,865	$	214,321
	Long-lived assets	$	383,233	$	7,835	$	9,380	$	583	$	68,526	$	334	$	34,691	$	25,868	$	530,450
	Year Ended December 31, 2013
		United States		Canada		Latin America		Australia		Singapore		New Zealand		India		Europe		Total
	External Revenues	$	139,519	$	7,431	$	5,508	$	38,260	$	3,114	$	2,311	$	650	$	7,917	$	204,710
	Long-lived assets	$	309,732	$	8,784	$	10,886	$	803	$	68,987	$	97	$	23,784	$	28,442	$	451,515
	Year Ended December 31, 2012
		United States		Canada		Latin America		Australia		Singapore		New Zealand		India		Europe		Total
	External Revenues	$	140,933	$	6,395	$	8,227	$	36,330	$	2,827	$	2,205	$	233	$	2,220	$	199,370
	Long-lived assets	$	317,338	$	9,738	$	12,726	$	1,267	$	70,173	$	240	$	11,784	$	12,011	$	435,277

Related_Party_Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2014
Related Party Transactions [Abstract]
Related Party Transactions	Related Party Transactions
	We consider Regions Bank ("Regions") to be a related party because Regions provides financing to the Company via a syndicated commercial banking facility (refer to Note 5 to these Consolidated Financial Statements), and because Regions is also a customer to whom the Company sells products and services. Revenues recognized from Regions were $281 thousand, $292 thousand, and $170 thousand for each of the years ending December 31, 2014, 2013, and 2012, respectively. Accounts receivable due from Regions were $50 thousand and $39 thousand at December 31, 2014 and 2013, respectively.

Quarterly_Financial_Informatio

Quarterly Financial Information (unaudited)	12 Months Ended
	Dec. 31, 2014
Quarterly Financial Information Disclosure [Abstract]
Quarterly Financial Information (unaudited)	Quarterly Financial Information (unaudited)
	The following is the unaudited quarterly financial information for 2014, 2013 and 2012:
		First		Second		Third		Fourth
		Quarter		Quarter		Quarter		Quarter
		(in thousands, except share data)
	Year Ended December 31, 2014
	Total revenues	$	51,404	$	51,476	$	50,808	$	60,633
	Gross Profit	41,792		41,512		40,533		43,096
	Operating income	19,405		17,461		21,738		21,068
	Net income	15,417		13,579		18,015		16,547
	Net income per common share:
	Basic	$	0.4	$	0.35	$	0.47	$	0.45
	Diluted	$	0.4	$	0.35	$	0.47	$	0.45
	Year Ended December 31, 2013
	Total revenues	$	52,566	$	51,004	$	50,293	$	50,847
	Gross Profit	42,675		40,646		40,157		40,761
	Operating income	19,305		19,294		18,601		17,806
	Net income	17,344		13,542		13,143		15,245
	Net income per common share:
	Basic	$	0.47	$	0.36	$	0.35	$	0.4
	Diluted	$	0.45	$	0.35	$	0.34	$	0.4
	Year Ended December 31, 2012
	Total revenues	$	43,827	$	47,716	$	53,804	$	54,023
	Gross Profit	34,798		38,559		44,304		43,576
	Operating income	18,329		17,711		20,708		20,260
	Net income	15,685		18,067		18,072		18,745
	Net income per common share:
	Basic	$	0.43	$	0.49	$	0.49	$	0.5
	Diluted	$	0.4	$	0.47	$	0.46	$	0.48
	In some instances the sum of the quarterly basic and diluted net income per share amounts may not agree to the full year basic and diluted net income per share amounts reported on the Consolidated Statements of Income because of rounding.

Minority_Business_Investment

Minority Business Investment	12 Months Ended
	Dec. 31, 2014
Investments, All Other Investments [Abstract]
Minority Business Investment	Minority Business Investment
	During 2012, Ebix acquired a minority 19.8% interest in CurePet, Inc. ("CurePet") for cash consideration in the amount of $2.0 million. CurePet is a developmental-stage enterprise that has completed an insurance exchange that connects pet owners, referring veterinarians, animal hospitals, academic institutes, and suppliers of medical and general pet supplies, while providing a wide variety of services related to pet insurance to each constituent including practice management, electronic medical records, and billing. CurePet had previously been a customer of Ebix, and as such during 2013 and 2012 the Company recognized $1.2 million and $1.5 million, respectively, of revenue from CurePet. Ebix also had a revenue share arrangement with CurePet pertaining to certain customer revenues recognized by CurePet; for 2014, there have been no revenue sharing earned or accrued. The Company had been accounting for its minority investment in CurePet using the cost method. Based on this independent evaluation it was concluded that the fair value of this minority business investment was greater than the Company's carrying value of the investment, and therefore the investment was not impaired as of December 31, 2013. As disclosed in Note 3 "Business Acquisitions", effective January 27, 2014, Ebix acquired the entire business of CurePet in an asset purchase agreement with the total purchase consideration being in the amount of $6.35 million of which $5.0 million pertains to a contingent earnout liability based on earned revenues over the subsequent thirty-six month period following the date of the acquisition. This contingent earnout liability is currently estimated to have a fair value of zero. During the twelve months ended December 31, 2014 the CurePet business generated $324 thousand of revenue which is included in the Company’s consolidated revenues reported for the same period.

Temporary_Equity_Temporary_Equ

Temporary Equity Temporary Equity	12 Months Ended
	Dec. 31, 2014
Temporary Equity Disclosure [Abstract]
Temporary Equity	Temporary Equity
	The $5.0 million of temporary equity reported on the Company's consolidated balance sheet as of December 31, 2013 is in connection with the June 1, 2012 acquisition of PlanetSoft. As part of the consideration paid for PlanetSoft in accordance with terms of the merger agreement the former PlanetSoft shareholders received 296,560 shares of Ebix common stock valued at $16.86 per share or $5.0 million in the aggregate. In regards to these shares of Ebix common stock, and as discussed in Note 10 "Derivative Instruments," the Company issued a put option to PlanetSoft's three shareholders. The put option, which expired in June 2014, was exercisable during the thirty-day period immediately following the two-year anniversary date of the business acquisition, which if exercised would have enabled them to sell the underlying 296,560 shares of Ebix common stock they received as part of the purchase consideration, back to the Company at a price of $16.86 per share. Accordingly and in compliance with Accounting Standards Codification ("ASC") 480 "Accounting for Redeemable Equity Instruments," in that the common stock is redeemable for cash at the option of the holders, and not within control of the Company, it is presented outside of the stockholders equity section of the consolidated balance sheet, and shown as a separate line referred to as "temporary equity" on the consolidated balance sheet appearing after liabilities, and before the stockholders' equity section. In July and August 2014 the former shareholders of PlanetSoft elected to exercise their put option rights with respect to the remaining 209,656 shares of Ebix common stock they still held. Accordingly the shareholders have since put those shares back to the Company at $16.86 per share plus interest at the rate of 20% for the period after the exercise until the cash consideration was paid by the Company, as per the PlanetSoft acquisition agreement. The total consideration, which included interest, paid by the Company in connection with the exercise of these put options was $3.6 million.

Subsequent_Events

Subsequent Events	12 Months Ended
	Dec. 31, 2014
Subsequent Events [Abstract]
Subsequent Events	Subsequent Events
	Dividends
	The Company continued with its quarterly cash dividend to the holders of its common stock, whereby a dividend in the amount of $0.075 per common share will be paid March 16, 2015 to shareholders of record on February 27, 2015.
	Repurchases of Common Stock
	Since December 31, 2014 and through March 16, 2015 the Company has purchased an additional 929,976 shares of its outstanding common stock for aggregate consideration in the amount of $22.28 million. All share repurchases were done in accordance with Rule 10b-18 of the Securities Act of 1934 as to the timing, pricing, and volume of such transactions, and were completed using available cash resources and cash generated from the Company's operating activities.
	IRS Audit Resolution
	On January 6, 2015, Ebix announced that it had reached a resolution with the Internal Revenue Service with respect to the previously disclosed audit of Ebix’s income tax returns for the taxable years 2008 through 2012. The original audit was extended to 2012, which is now part of that resolution dated December 30, 2014. The assessment resulted in a January 2015 cash payment of $20.5 million, including interest of $1.6 million, and a ($1.5) million impact on net income for the fourth quarter of 2014 after taking into account certain of the Company’s previously established and disclosed provisions for uncertain tax positions. This resolution includes all issues for the taxable years 2008 through 2012. The balance of this assessment is included in accounts payable and accrued liabilities in the Company's Consolidated Balance Sheet.
	Director Grants
	On January 12, 2015, the board of directors granted the Company's seven non-employee directors a total of 42,000 stock options of which one-fourth will vest on January 12, 2016, and the remaining options will vest ratably each quarter in the years 2016, 2017, 2018 and 2019. Such grants were made pursuant to board's policy.
	Amendment to Syndicated Commercial Banking Credit Agreement
	On February 3, 2015, Ebix, Inc. (the “Company”) and certain of its subsidiaries entered into the First Amendment (the “First Amendment”) to the Regions Secured Credit Facility (the “Credit Agreement”), dated August 5, 2014, among the Company, Regions Financial Corporation as Administrative Agent (“Regions”), with Regions, MUFG Union Bank N.A., and Silicon Valley Bank as joint lenders. The First Amendment amends the Credit Agreement by increasing the maximum amount by which the Aggregate Revolving Commitments may be increased to $90 million from the pre-existing limit of $50 million, increases the amount of base facility to $190 million from the pre-existing amount of $150 million, which together with the $50 million accordion feature increases the total Credit Agreement capacity amount to $240 million from the prior amount of $200 million, and expands the syndicated bank group to four participants by adding Fifth Third Bank.
	Business Acquisition
	On March 3, 2015 Ebix announced the acquisition of Via Media Health Communications Private Limited ("Via Media Health"), effective March 1, 2015. Via Media Health is one of India’s leading health content & communication companies. Ebix acquired Via Media Health for upfront cash consideration in the amount of $1.24 million, plus a possible future one time contingent earnout payment of up to $372 thousand based on earned revenues over the subsequent twelve month period following the effective date of the acquisition, and a possible one time future performance bonus depending upon revenue growth realized in the business over the subsequent twenty-four month period following the effective date of the acquisition.
	Land Acquisition
	On January 30, 2015 the Company acquired approximately six acres of land adjacent to its new worldwide headquarters facility being built out in Johns Creek, Georgia. The Company paid $2.0 million for the land and funded the purchase from proceeds from its revolving commercial banking credit facility.

Schedule_II_Valuation_and_Qual

Schedule II - Valuation and Qualifying Accounts Schedule II - Valuation and Qualifying Accounts	12 Months Ended
	Dec. 31, 2014
Valuation and Qualifying Accounts [Abstract]
Schedule II - Valuation and Qualifying Accounts	Schedule II
	Ebix, Inc.
	Schedule II—Valuation and Qualifying Accounts
	for the Years ended December 31, 2014, December 31, 2013 and December 31, 2012
	Allowance for doubtful accounts receivable (in thousands)
		Year Ended December 31, 2014			Year Ended December 31, 2013			Year Ended December 31, 2012
	Beginning balance	$	1,049		$	1,157		$	1,719
	Provision for doubtful accounts	1,600			1,147			442
	Write-off of accounts receivable against allowance	(1,022		)	(1,276		)	(1,004		)
	Other	(8		)	21			—
	Ending balance	$	1,619		$	1,049		$	1,157

Description_of_Business_and_Su1

Description of Business and Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2014
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation— The consolidated financial statements include the accounts of Ebix and its wholly owned subsidiaries. The effect of inter-company balances and transactions has been eliminated.
Use of Estimates	Use of Estimates—The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America ("GAAP") requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and reported amounts of revenue and expenses during those reporting periods. Management has made material estimates primarily with respect to revenue recognition and deferred revenue, accounts receivable, acquired intangible assets, annual impairment reviews of goodwill, indefinite-lived intangible assets, and investments. contingent earnout liabilities in connection with business acquisitions, and the provision for income taxes. Actual results may be materially different from those estimates.
Reclassification	Reclassification—Certain of the reported balances and results for prior year or prior quarters, including the notes thereto, have been reclassified to conform to the current year presentation. The change in reserve for potential uncertain income tax return positions had been previously netted against the provision for deferred taxes line in the consolidated statements of cash flows, it is now shown separately. Also, beginning in 2014 the Company has applied the new provisions under Financial Accounting Standard ("FAS") update No. 2013-11, Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, A Similar Tax Loss, or a Tax Credit Carryforward Exists and as more fully described in Note 8 "Income Taxes". A portion of potential uncertain income tax return positions previously reported in "Other Liabilities" on the consolidated balance sheets are now netted against the "Deferred tax asset, net" line in the long term asset section of the consolidated balance sheets. Finally the excess tax benefits from share-based compensation is now reported as a component of financing cash flows rather than being netted against the provision for deferred taxes as a component of operating cash flows in the consolidated statements of cash flows.
Segment Reporting	Segment Reporting—Since the Company, from the perspective of its chief operating decision maker, allocates resources and evaluates business performance as a single entity that provides software and related services to a single industry on a worldwide basis, the Company reports as a single segment.
Cash and Cash Equivalents	Cash and Cash Equivalents—The Company considers all highly liquid investments with an original maturity of three months or less at the time of purchase to be cash equivalents. Such investments are stated at cost, which approximates fair value. The Company does maintain cash balances in banking institutions in excess of federally insured amounts and therefore is exposed to the related potential credit risk associated with such cash deposits.
Short-term Investments	Short-term Investments—The Company’s short-term investments consist of certificates of deposits with established commercial banking institutions with readily determinable fair values. Ebix accounts for investments that are reasonably expected to be realized in cash, sold or consumed during the year as short-term investments that are available-for-sale. The carrying amount of investments in marketable securities approximates their fair value.
Fair Value of Financial Instruments	Fair Value of Financial Instruments—The Company follows the relevant GAAP guidance regarding the determination and measurement of the fair value of financial instruments in which fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction valuation hierarchy which requires an entity to maximize the use of observable inputs when measuring fair value. The guidance describes the following three levels of inputs that may be used in the methodology to measure fair value:
	•	Level 1 — Quoted prices available in active markets for identical investments as of the reporting date;
	•	Level 2 — Inputs other than quoted prices in active markets, which are either directly or indirectly observable as of the reporting date; and,
	•	Level 3 — Unobservable inputs, which are to be used in situations where there is little or no market activity for the asset or liability and wherein the reporting entity makes estimates and assumptions related to the pricing of the asset or liability including assumptions regarding risk.
	A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.
	As of December 31, 2014 and 2013 the Company has the following financial instruments to which it had to consider fair values and had to make fair assessments:
	•	Common share-based put option for which the fair value was measured as Level 2 instrument.
	•	Short-term investments for which the fair values are measured as a Level 1 instrument.
	•	Contingent accrued earn-out business acquisition consideration liabilities for which fair values are measured as Level 3 instruments. These contingent consideration liabilities were recorded at fair value on the acquisition date and are remeasured periodically based on the then assessed fair value and adjusted if necessary. The increases or decreases in the fair value of contingent consideration payable can result from changes in anticipated revenue levels and changes in assumed discount periods and rates. As the fair value measure is based on significant inputs that are not observable in the market, they are categorized as Level 3.
	Other financial instruments not measured at fair value on the Company's consolidated balance sheets at December 31, 2014 and 2013 but which require disclosure of their fair values include: cash and cash equivalents, accounts receivable, accounts payable and accrued expenses, accrued payroll and related benefits, capital lease obligations, debt under the former revolving line of credit and term loans with Citibank, and debt under the existing revolving line of credit with Regions Bank . The estimated fair value of such instruments at December 31, 2014 and 2013 reasonably approximates their carrying value as reported on the consolidated balance sheets.
Revenue Recognition and Deferred Revenue	Revenue Recognition and Deferred Revenue—The Company derives its revenues primarily from professional and support services, which includes revenue generated from subscription and transaction fees pertaining to services delivered over our exchanges or from our application service provider (“ASP”) platforms, software development projects and associated fees for consulting, implementation, training, and project management provided to customers using our systems, and risk compliance solutions ("RCS"). Sales and value-added taxes are not included in revenues, but rather are recorded as a liability until the taxes assessed are remitted to the respective taxing authorities.
	The Company follows the relevant technical accounting guidance regarding revenue recognition as issued by the Financial Accounting Standards Board ("FASB") and the Securities and Exchange Commission's ("SEC"). The Company considers revenue earned and realizable when: (a) persuasive evidence of the sales arrangement exists, (b) the arrangement fee is fixed or determinable, (c) service delivery or performance has occurred, (d) customer acceptance has been received or is reasonably assured, if contractually required, and (e) collectability of the arrangement fee is probable. The Company typically uses signed contractual agreements as persuasive evidence of a sales arrangement. We apply the provisions of the relevant FASB accounting pronouncements related to all transactions involving the license of software where the software deliverables are considered more than inconsequential to the other elements in the arrangement. For contracts that contain multiple deliverables, we analyze the revenue arrangements in accordance with the appropriate authoritative guidance, which provides criteria governing how to determine whether goods or services that are delivered separately in a bundled sales arrangement should be considered as separate units of accounting for the purpose of revenue recognition. Deliverables are accounted for separately if they meet all of the following criteria: a) the delivered item has value to the customer on a stand-alone basis; b) there is objective and reliable evidence of the fair value for all arrangement deliverables; and c) if the arrangement includes a general right of return relative to the delivered items, the delivery or performance of the undelivered items is probable and substantially controlled by the Company. Under the relevant accounting guidance, when multiple-deliverables included in an arrangement are to be separated into different units of accounting, the arrangement consideration is allocated to the identified separate units of accounting based on their relative fair values. We determine the relative selling price for a deliverable based on vendor-specific objective evidence of selling price (“VSOE”), if available, or third-party evidence ("TPE") in the alternative if available, or finally our best estimate of selling price (“BESP”), if VSOE or TPE is not available.
	The Company begins to recognize revenue from license fees for its exchange (SAAS) and ASP products upon granting customer access to the respective processing platform. Transaction services fee revenue for this use of our exchanges or ASP platforms is recognized as the transactions occur and are generally billed in arrears. Revenues from RCS arrangements, which include data entry and call center services, and insurance certificate creation and tracking services, are recognized as the services are performed. Service fees for hosting arrangements are recognized over the requisite service period. Revenue derived from the licensing of third party software products in connection with sales of the Company’s software licenses is recognized upon delivery together with the Company’s licensed software products. Fees for training, data conversion, installation, and consulting services fees are recognized as revenue when the services are performed. Revenue for maintenance and support services are recognized ratably over the term of the support agreement.
	Software development arrangements involving significant customization, modification or production are accounted for in accordance with the appropriate technical accounting guidance issued by the FASB using the percentage-of-completion method. The Company recognizes revenue using periodic reported actual hours worked as a percentage of total expected hours required to complete the project arrangement and applies the percentage to the total arrangement fee.
	Deferred revenue includes payments or billings that have been received or made prior to performance and, in certain cases, cash collections and primarily pertain to maintenance and support fees, initial setup or registration fees under hosting agreements, software license fees received in advance of delivery and acceptance, and software development fees paid in advance of completion and delivery.
Accounts Receivable and the Allowance for Doubtful Accounts Receivable
	of unbilled receivables. The unbilled receivables pertain to certain professional service engagements and system development projects for which the timing of billing is tied to contractual milestones. The Company adheres to such contractually stated performance milestones and accordingly issues invoices to customers as per contract billing schedules. Accounts receivable are written off against the allowance for doubtful accounts receivable when the Company has exhausted all reasonable collection efforts. Management specifically analyzes the aging of accounts receivable and historical bad debts, write-offs, customer concentrations, customer credit-worthiness, current economic trends, and changes in our customer payment patterns when evaluating the adequacy of the allowance for doubtful accounts receivable.
	Accounts Receivable and the Allowance for Doubtful Accounts Receivable—
Costs of Services Provided	Costs of Services Provided—Costs of services provided consist of data processing costs, customer support costs including personnel costs to maintain our proprietary databases, costs to provide customer call center support, hardware and software expense associated with transaction processing systems and exchanges, telecommunication and computer network expense, and occupancy costs associated with facilities where these functions are performed. Depreciation expense is not included in costs of services provided.
Goodwill and Indefinite-lived Intangible Assets	The Company’s indefinite-lived assets are associated with the estimated fair value of the contractual customer relationships existing with the property and casualty insurance carriers in Australia using our property and casualty ("P&C") data exchange and with certain large corporate customers using our client relationship management (“CRM”) platform in the United States. Prior to these underlying business acquisitions Ebix had pre-existing contractual relationships with these carriers and corporate clients. The contracts are renewable at little or no cost, and Ebix intends to continue to renew these contracts indefinitely and has the ability to do so. The proprietary technology supporting the P&C data exchange and CRM platform that is used to deliver services to these carriers and corporate clients, cannot feasibly be effectively replaced in the foreseeable future, and accordingly the cash flows forthcoming from these customers are expected to continue indefinitely. With respect to the determination of the indefinite life, the Company considered the expected use of these intangible assets, historical experience in renewing or extending similar arrangements, and the effects of competition, and concluded that there were no indications from these factors to suggest that the expected useful life of these customer relationships would be finite. The Company concluded that no legal, regulatory, contractual, or competitive factors limited the useful life of these intangible assets and therefore their life was considered to be indefinite, and accordingly the Company expects these customer relationships to remain the same for the foreseeable future. The fair values of these indefinite-lived intangible assets were based on the analysis of discounted cash flow (“DCF”) models extended out fifteen to twenty years. In that indefinite-lived does not imply an infinite life, but rather means that the subject customer relationships are expected to extend beyond the foreseeable time horizon, we utilized fifteen to twenty year DCF projections, as the valuation models that were applied consider a fifteen to twenty year time frame to be an indefinite period. Indefinite-lived intangible assets are not amortized, but rather are tested for impairment annually. We perform our annual impairment testing of indefinite-lived intangible assets as of September 30th of each year. During the years ended December 31, 2014, 2013, and 2012, we had no impairments to the recorded balances of our indefinite-lived intangible assets. We perform the impairment test for our indefinite-lived intangible assets by comparing the asset’s fair value to its carrying value. An impairment charge is recognized if the asset’s estimated fair value is less than its carrying value.
Purchased Intangible Assets	Purchased Intangible Assets—Purchased intangible assets represent the estimated fair value of acquired intangible assets from the businesses that we acquire in the U.S. and foreign countries in which we operate. These purchased intangible assets include customer relationships, developed technology, informational databases, and trademarks. We amortize these intangible assets on a straight-line basis over their estimated useful lives, as follows:
		Life
	Category	(yrs)
	Customer relationships	20-Jul
	Developed technology	12-Mar
	Trademarks	15-Mar
	Non-compete agreements	5
	Database	10
Income Taxes	Income Taxes— The Company follows the asset and liability method of accounting for income taxes pursuant to the pertinent guidance issued by the FASB. Deferred income taxes are recorded to reflect the tax consequences on future years of differences between the tax basis of assets and liabilities, and operating loss and tax credit carry forwards, and their financial reporting amounts at each period end using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. In assessing the realizability of the deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. A valuation allowance is recorded, if necessary, for the portion of the deferred tax assets that are not expected to be realized based on the levels of historical taxable income and projections for future taxable income over the periods in which the temporary differences will be deductible.
	The Company follows the provisions of FASB accounting guidance on accounting for uncertain income tax positions. The guidance utilizes a two-step approach for evaluating tax positions. Recognition (“Step 1”) occurs when an enterprise concludes that a tax position, based solely on its technical merits is more likely than not to be sustained upon examination. Measurement (“Step 2”) is only addressed if Step 1 has been satisfied. Under Step 2, the tax benefit is measured at the largest amount of benefit, determined on a cumulative probability basis that is more likely than not to be realized upon final settlement. As used in this context, the term “more likely than not” is interpreted to mean that the likelihood of occurrence is greater than 50%.
Foreign Currency Translation	Foreign Currency Translation—The functional currency for the Company's foreign subsidiaries in India and Singapore is the U.S. dollar because the intellectual property research and development activities provided by its Singapore subsidiary, and the product development and information technology enabled services activities for the insurance industry provided by its India subsidiary, both in support of Ebix's operating divisions across the world, are transacted in U.S. dollars.
	The functional currency of the Company's other foreign subsidiaries is the local currency of the country in which the subsidiary operates. The assets and liabilities of these foreign subsidiaries are translated into U.S. dollars at the rates of exchange at the balance sheet dates. Income and expense accounts are translated at the average exchange rates in effect during the period. Gains and losses resulting from translation adjustments are included as a component of accumulated other comprehensive loss in the accompanying consolidated balance sheets. Foreign exchange transaction gains and losses that are derived from transactions denominated in a currency other than the subsidiary's functional currency are included in the determination of net income.
Advertising	Advertising—Advertising costs are expensed as incurred. Advertising costs amounted to $1.7 million, $1.0 million, and $1.4 million in 2014, 2013, and 2012, respectively, and are included in sales and marketing expenses in the accompanying Consolidated Statements of Income.
Sales Commissions	Sales Commissions —Certain sales commission paid with respect to subscription-based revenues are deferred and subsequently amortized into operating expenses ratably over the term of the related customer subscription contracts. As of December 31, 2014 and 2013, $398 thousand and $434 thousand, respectively, of sales commissions were deferred and included in other current assets on the accompanying Consolidated Balance Sheets. During the years ended December 31, 2014 and 2013 the Company amortized $913 thousand and $915 thousand, respectively, of previously deferred sales commissions and included this expense in sales and marketing costs on the accompanying Consolidated Statements of Income.
Property and Equipment	Property and Equipment—Property and equipment is stated at cost less accumulated depreciation and amortization. Depreciation and amortization are computed using the straight-line method over the assets estimated useful lives. Leasehold improvements are amortized over the shorter of the expected life of the improvements or the remaining lease term. Repairs and maintenance are charged to expense as incurred and major improvements that extend the life of the asset are capitalized and depreciated over the expected remaining life of the related asset. Gains and losses resulting from sales or retirements are recorded as incurred, at which time related costs and accumulated depreciation are removed from the Company’s accounts. Fixed assets acquired in acquisitions are recorded at fair value. The estimated useful lives applied by the Company for property and equipment are as follows:
		Life
	Asset Category	(yrs)
	Computer equipment	5
	Furniture, fixtures and other	7
	Buildings	30
	Leasehold improvements	Life of the lease

Description_of_Business_and_Su2

Description of Business and Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2014
Accounting Policies [Abstract]
Business Combination, Segment Allocation	The following table summarizes the goodwill recorded in connection with the acquisitions that occurred during 2014 and 2013:
	Company acquired		Date acquired		(in thousands)
	CurePet, Inc. ("CurePet")		Jan-14		$	2,687
	HealthCare Magic Private Limited ("HealthCare Magic")		May-14		5,619
	Vertex, Incorporated ("Vertex")		Oct-14		27,728
	Oakstone Publishing, LLC ("Oakstone")		Dec-14		28,769
	DCM Group Inc. (d.b.a. i3 Software) ("i3")		Dec-14		3,700
	Total during 2014				$	68,503
	Qatarlyst ("Qatarlyst")		Apr-13		$	11,136
	Total during 2013				$	11,136
Schedule of Revenue by Product/Service Groups	Presented in the table below is the breakout of our revenue streams for each of those product/service groups for the years ended December 31, 2014 , 2013 and 2012.
		For the Year Ended
		December 31,
	(dollar amounts in thousands)		2014				2013				2012
	Exchanges		$	169,437			$	163,925			$	159,678
	Broker Systems		17,948				18,378				18,612
	Risk Compliance Solutions (“RCS”), fka Business Process Outsourcing (“BPO”)		21,813				15,678				16,140
	Carrier Systems		5,123				6,729				4,940
	Totals		$	214,321			$	204,710			$	199,370
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis	Additional information regarding the Company's assets and liabilities that are measured at fair value on a recurring basis is presented in the following tables:
			Fair Values at Reporting Date Using*
	Descriptions		Balance at December 31, 2014			Quoted Prices in Active Markets for Identical Assets or Liabilities (Level 1)			Significant Other Observable Inputs (Level 2)			Significant Unobservable Inputs (Level 3)
			(In thousands)
	Assets
	Available-for-sale securities:
	Commercial bank certificates of deposits		$	281		$	281		$	—		$	—
	Total assets measured at fair value		$	281		$	281		$	—		$	—
	Liabilities
	Derivatives:
	Common share-based put option (a)		$	—		$	—		$	—		$	—
	Contingent accrued earn-out acquisition consideration (b)		5,367			—			—			5,367
	Total liabilities measured at fair value		$	5,367		$	—		$	—		$	5,367
	(a) In connection with the acquisition of PlanetSoft effective June 1, 2012, Ebix issued a put option to the PlanetSoft's three shareholders. The put option, which expired in June 2014, was exercisable during the thirty-day period immediately following the two-year anniversary date of the business acquisition, which if exercised would enable them to sell the underlying 296,560 shares of Ebix common stock they received as part of the purchase consideration, back to the Company at a price of $16.86 per share, which represents the per-share value established on the effective date of the closing of Ebix's acquisition of PlanetSoft. The inputs used in the valuation of the put option include term, stock price volatility, current stock price, exercise price, and the risk free rate of return. During the months of July and August 2014 the former shareholders of PlanetSoft elected to exercise their put option rights with respect to the remaining 209,656 shares of Ebix common stock they still held. Accordingly the shareholders put those shares back to the Company at $16.86 per share plus interest at the rate of 20% as per the PlanetSoft acquisition agreement. The total consideration paid by the Company in connection with the exercise of these put options was $3.6 million.
	(b) The income valuation approach is applied and the valuation inputs include the contingent payment arrangement terms, projected cash flows, rate of return, and probability assessments.
	* During the year ended December 31, 2014 there were no transfers between fair value Levels 1, 2 or 3.
			Fair Values at Reporting Date Using*
	Descriptions		Balance at December 31, 2013			Quoted Prices in Active Markets for Identical Assets or Liabilities (Level 1)			Significant Other Observable Inputs (Level 2)			Significant Unobservable Inputs (Level 3)
			(In thousands)
	Assets
	Available-for-sale securities:
	Commercial bank certificates of deposits		$	801		801			—			—
	Total assets measured at fair value		$	801		$	801		$	—		$	—
	Liabilities
	Derivatives:
	Common share-based put option (a)		$	845		—			845			—
	Contingent accrued earn-out acquisition consideration (b)		14,420			—			—			14,420
	Total liabilities measured at fair value		$	15,265		$	—		$	845		$	14,420
	(a) In connection with the acquisition of PlanetSoft effective June 1, 2012, Ebix issued a put option to the PlanetSoft's three shareholders. The put option, which expires in June 2014, is exercisable during the thirty-day period immediately following the two-year anniversary date of the business acquisition, which if exercised would enable them to sell the underlying 296,560 shares of Ebix common stock they received as part of the purchase consideration, back to the Company at a price of $16.86 per share. The inputs used in the valuation of the put option include term, stock price volatility, current stock price, exercise price, and the risk free rate of return. During the months of July and August 2014 the former shareholders of PlanetSoft elected to exercise their put option rights with respect to the remaining 209,656 shares of Ebix common stock they still held. Accordingly the shareholders put those shares back to the Company at $16.86 per share plus interest at the rate of 20% as per the PlanetSoft acquisition agreement. The total consideration paid by the Company in connection with the exercise of these put options was $3.6 million.
	(b) The income valuation approach is applied and the valuation inputs include the contingent payment arrangement terms, projected cash flows, rate of return, and probability assessments.
	* During the year ended December 31, 2013 there were no transfers between fair value Levels 1, 2 or 3.
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation	For the Company's assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3), the following table provides a reconciliation of the beginning and ending balances for each category therein, and gains or losses recognized during the year.
	Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
	Contingent Liability for Accrued Earn-out Acquisition Consideration		Balance at December 31, 2014				Balance at December 31, 2013
			(in thousands)
	Beginning balance		$	14,420			17,495
	Total remeasurement adjustments:
	(Gains) or losses included in earnings **		(10,237		)		(10,253		)
	(Gains) or losses recorded against goodwill		—				—
	Foreign currency translation adjustments ***		(314		)		730
	Acquisitions and settlements
	Business acquisitions		4,312				9,425
	Settlements		(2,814		)		(2,977		)
	Ending balance		$	5,367			$	14,420
	The amount of total (gains) or losses for the year included in earnings or changes to net assets, attributable to changes in unrealized (gains) or losses relating to assets or liabilities still held at year-end.		$	(8,911	)		$	(9,954	)
	** recorded as a component of reported general and administrative expenses
	*** recorded as a component of other comprehensive income within stockholders' equity
Fair Value, Significant Unobservable Inputs Used in Measurement of Contingent Consideration Liabilities	The significant unobservable inputs used in the fair value measurement of the Company's contingent consideration liabilities designated as Level 3 are as follows:
	(in thousands)		Fair Value at  December 31, 2014		Valuation Technique		Significant Unobservable
							Input
	Contingent acquisition consideration:		$5,367		Discounted cash flow		Expected future annual revenue streams and probability of achievement
	(Vertex, i3 Software, HealthCare Magic, and Qatarlyst acquisitions)
	(in thousands)		Fair Value at  December 31, 2013		Valuation Technique		Significant Unobservable
							Input
	Contingent acquisition consideration:		$14,420		Discounted cash flow		Expected future annual revenue streams and probability of achievement
	(Taimma, PlanetSoft, TriSystems, and Qatarlyst acquisitions)
Schedule of Goodwill	Changes in the carrying amount of goodwill for the years ended December 31, 2014 and 2013 are as follows:
		December 31, 2014				December 31, 2013
		(in thousands)
	Beginning Balance	$	337,068			$	326,748
	Additions, net (see Note 3)	68,503				11,136
	Foreign currency translation adjustments	(3,351		)		(816		)
	Ending Balance	$	402,220			$	337,068
Schedule of Finite-Lived Intangible Assets by Major Class, Estimated Useful Lives	We amortize these intangible assets on a straight-line basis over their estimated useful lives, as follows:
		Life
	Category	(yrs)
	Customer relationships	20-Jul
	Developed technology	12-Mar
	Trademarks	15-Mar
	Non-compete agreements	5
	Database	10
Schedule of Intangible Assets, Excluding Goodwill	Intangible assets as of December 31, 2014 and December 31, 2013, are as follows:
		December 31,
		2014				2013
		(In thousands)
	Finite-lived intangible assets:
	Customer relationships	$	66,783			$	62,408
	Developed technology	15,664				14,630
	Trademarks	2,751				2,646
	Non-compete agreements	751				538
	Backlog	140				140
	Database	212				212
	Total intangibles	86,301				80,574
	Accumulated amortization	(36,930		)		(29,840		)
	Finite-lived intangibles, net	$	49,371			$	50,734
	Indefinite-lived intangibles:
	Customer/territorial relationships	$	30,887			$	30,887
Useful Lives of Property and Equipment Used in Computation of Depreciation	The estimated useful lives applied by the Company for property and equipment are as follows:
		Life
	Asset Category	(yrs)
	Computer equipment	5
	Furniture, fixtures and other	7
	Buildings	30
	Leasehold improvements	Life of the lease

Earnings_per_Share_Tables

Earnings per Share (Tables)	12 Months Ended
	Dec. 31, 2014
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Diluted, by Common Class	The basic and diluted earnings per share (“EPS”), and the basic and diluted weighted average shares outstanding for all periods as presented in the accompanying Consolidated Statements of Income are shown below :
		For the year ended
		December 31,
		(In thousands, except per share amounts)
	Earnings per share:	2014			2013			2012
	Basic earnings per common share	$	1.68		$	1.58		$	1.91
	Diluted earnings per common share	$	1.67		$	1.53		$	1.8
	Basic weighted average shares outstanding	37,809			37,588			36,948
	Diluted weighted average shares outstanding	38,040			38,642			39,100
Schedule of Weighted Average Number of Shares	Diluted shares outstanding are determined as follows for each years ending December 31, 2014, 2013, and 2012:
		For the year ended
		December 31,
		(in thousands)
		2014		2013			2012
	Basic weighted average shares outstanding	37,809		37,588			36,948
	Incremental shares for common stock equivalents	231		1,054			2,152
	Diluted shares outstanding	38,040		38,642			39,100

Business_Acquisitions_Tables

Business Acquisitions (Tables)	12 Months Ended
	Dec. 31, 2014
Business Combinations [Abstract]
Schedule of Net Assets Acquired in Business Acquisitions	The following table summarizes the fair value of the consideration transferred, net assets acquired and liabilities assumed as a result of the acquisitions that occurred during 2014 and 2013:
			December 31,
	(in thousands)		2014			2013
	Fair value of total consideration transferred
	Cash		$	59,514		$	5,025
	Contingent earn-out consideration arrangement		4,312			9,425
	Previous cash consideration in investment of step up acquisition, CurePet		2,000			—
	Cash consideration offset against open receivable balances due to Ebix, Inc. from CurePet		1,350			—
	Total		$	67,176		$	14,450
	Fair value of assets acquired and liabilities assumed
	Cash		$	323		$	285
	Other current assets		5,263			485
	Property, plant, and equipment		670			144
	Other long term assets		54			507
	Intangible assets		6,872			5,396
	Deferred tax liability		(1,040		)	(947		)
	Current and other liabilities		(13,469		)	(2,556		)
	Net assets acquired, excludes goodwill		(1,327		)	3,314
	Goodwill		68,503			11,136
	Total net assets acquired		$	67,176		$	14,450
Schedule of Identified Intangible Assets Acquired as Part of Business Acquisitions	The following table summarizes the separately identified intangible assets acquired as a result of the acquisitions that occurred during 2014 and 2013:
			December 31,
			2014					2013
						Weighted				Weighted
						Average				Average
	Intangible asset category		Fair Value			Useful Life		Fair Value		Useful Life
			(in thousands)			(in years)		(in thousands)		(in years)
	Customer relationships		$	5,275		9.9		$	4,761	11
	Developed technology		1,236			4.2		635		5
	Non-compete agreements		226			7		—		0
	Trademarks		135			5.5		—		0
	Total acquired intangible assets		$	6,872		8.8		$	5,396	10.3
Schedule of Intangible Assets, Future Amortization Expense	Estimated aggregate future amortization expense for the intangible assets recorded as part of the business acquisitions described above and other prior acquisitions is as follows:
	Estimated Amortization Expenses (in thousands):
	For the year ending December 31, 2015	$	7,357
	For the year ending December 31, 2016	6,794
	For the year ending December 31, 2017	6,388
	For the year ending December 31, 2018	5,668
	For the year ending December 31, 2019	5,384
	Thereafter	17,780
		$	49,371

Pro_Forma_Financial_Informatio1

Pro Forma Financial Information (re: 2014 and 2013 acquisitions) (Tables)	12 Months Ended
	Dec. 31, 2014
Pro Forma Financial Information [Abstract]
Unaudited Pro Forma Financial Information
		As Reported		Pro Forma		As Reported		Pro Forma
		2014		2014		2013		2013
				(unaudited)				(unaudited)
		(In thousands, except per share amounts)
	Revenue	$	214,321	$	262,733	$	204,710	$	260,452
	Net Income	$	63,558	$	61,745	$	59,274	$	52,809
	Basic EPS	$	1.68	$	1.63	$	1.58	$	1.4
	Diluted EPS	$	1.67	$	1.62	$	1.53	$	1.37

Commitments_and_Contingencies_

Commitments and Contingencies (Tables)	12 Months Ended
	Dec. 31, 2014
Commitments and Contingencies Disclosure [Abstract]
Schedule Of Future Principal Debt Payments and Minimum Lease Payments Under Non-Cancelable Operating And Capital Leases	Commitments for minimum rentals under non-cancellable leases, debt obligations, and future purchase obligations as of December 31, 2014 were as follows:
	Year	Debt			Capital Leases		Operating Leases			Future Purchase Obligations
		(in thousands)
	2015	$	943		$	—	$	5,863		$	3,715
	2016	600			—		4,136			541
	2017	—			—		3,886			541
	2018	—			—		3,120			541
	2019	120,465			—		2,088			406
	Thereafter	—			—		1,340			—
	Total	$	122,008		$	—	$	20,433		$	5,744
	Less: sublease income						(1,296		)
	Net lease payments						$	19,137
	Less: amount representing interest				—
	Present value of obligations under capital leases				$	—
	Less: current portion	(943		)	—
	Long-term obligations	$	121,065		$	—

Sharebased_Compensation_Tables

Share-based Compensation (Tables)	12 Months Ended
	Dec. 31, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Schedule of Share-based Payment Award, Valuation Assumptions	The following table includes the weighted- average assumptions used in estimating the fair values and the resulting weighted-average fair value of stock options granted in the periods presented:
		Year Ended December 31, 2014				Year Ended December 31, 2013				Year Ended December 31, 2012
	Weighted average fair values of stock options granted	$	—			$	5.7			$	5.47
	Expected volatility	—		%		59.9		%		47.9		%
	Expected dividends	—		%		2.01		%		1.18		%
	Weighted average risk-free interest rate	—		%		0.65		%		0.33		%
	Expected life of stock options (in years)	0				3.5				3.5
Schedule of Stock Options Activity	A summary of stock option activity for the years ended December 31, 2014, 2013 and 2012 is as follows:
		Shares			Weighted				Weighted		Aggregate Intrinsic
					Average				Average		Value
					Exercise Price				Remaining
									Contractual
									Term (Years)
											(in thousands)
	Outstanding at January 1, 2012	3,315,175			$	2.51			1.56		$	64,959
	Granted	45,000			$	16.94
	Exercised	(1,361,542	)		$	0.75
	Canceled	—			$	—
	Outstanding at December 31, 2012	1,998,633			$	4.03			1.17		$	24,171
	Granted	45,000			$	14.89
	Exercised	(1,251,633	)		$	1.73
	Canceled	—			$	—
	Outstanding at December 31, 2013	792,000			$	8.28			1		$	5,093
	Granted	—			$	—
	Exercised	(450,000	)		$	1.75
	Canceled	(135,000	)		$	17.58
	Outstanding at December 31, 2014	207,000			$	16.41			1.88		$	121
	Exercisable at December 31, 2014	139,500			$	16.35			1.43		$	89
Schedule of Nonvested Share Activity	A summary of non-vested options and changes for the years ended December 31, 2014, 2013 and 2012 is as follows:
		Non-Vested Number of Shares			Weighted
					Average
					Exercise Price
	Non-vested balance at January 1, 2012	180,005			$	17.17
	Granted	45,000			$	16.94
	Vested	(90,005	)		$	14.6
	Canceled	—			$	—
	Non-vested balance at December 31, 2012	135,000			$	18.8
	Granted	45,000			$	14.89
	Vested	(67,500	)		$	18.66
	Canceled	—			$	—
	Non-vested balance at December 31, 2013	112,500			$	17.32
	Granted	—			$	—
	Vested	(45,000	)		$	18.53
	Canceled	—			$	—
	Non-vested balance at December 31, 2014	67,500			$	16.52
Schedule of Shares Authorized under Stock Option Plans, by Exercise Price Range	The following table summarizes information about stock options outstanding by price range as of December 31, 2014:
			Options Outstanding									Options Exercisable
	Range of Exercise Prices		Number Outstanding			Weighted-Average Remaining Contractual Life (Years)		Weighted-Average Exercise Price				Number of Shares	Weighted-Average Exercise Price
	$2.18-$2.36		27,000			1.41		$	2.27			27,000	$	2.27
	$14.89-$16.94		90,000			2.98		$	15.92			33,750	$	16.26
	$20.58-$21.70		90,000			0.93		$	21.14			78,750	$	21.22
			207,000			1.88		$	16.41			139,500	$	16.35
Schedule of Nonvested Restricted Stock Activity	A summary of the status of the Company’s non-vested restricted stock grant shares is presented in the following table:
		Shares			Weighted-Average Grant Date
					Fair Value
	Non vested at January 1, 2012	145,081			$	20.13
	Granted	73,061			$	23.26
	Vested	(90,379	)		$	18.89
	Forfeited	(6,607	)		$	24.1
	Non vested at December 31, 2012	121,156			$	22.74
	Granted	32,842			$	15.91
	Vested	(76,576	)		$	22.56
	Forfeited	(2,157	)		$	23.42
	Non vested at December 31, 2013	75,265			$	19.92
	Granted	171,781			$	16.96
	Vested	(52,388	)		$	20.35
	Forfeited	(6,136	)		$	18.91
	Non vested at December 31, 2014	188,522			$	17.13

Income_Taxes_Tables

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2014
Income Tax Disclosure [Abstract]
Schedule of Income before Income Tax, Domestic and Foreign	Income before income taxes consisted of:
		Year Ended December 31, 2014				Year Ended December 31, 2013				Year Ended December 31, 2012
		(In thousands)
	Domestic	$	8,807			$	5,497			$	6,604
	Foreign	68,645				64,655				71,425
	Total	$	77,452			$	70,152			$	78,029
Schedule of Components of Income Tax Expense (Benefit)	The income tax provision consisted of:
		Year Ended December 31, 2014				Year Ended December 31, 2013				Year Ended December 31, 2012
		(In thousands)
	Current:
	Federal	$	1,335			$	266			$	342
	State	270				167				320
	Foreign	4,847				4,532				3,660
		6,452				4,965				4,322
	Deferred:
	Federal	1,118				(632		)		2,382
	State	43				(351		)		31
	Foreign	(263		)		(760		)		(1,557		)
		898				(1,743		)		856
	Provision for income taxes from ongoing operations at effective tax rate	$	7,350			$	3,222			$	5,178
	Discrete Items:
	Certain discrete tax impacts from foreign subsidiaries	(1,677		)		839				837
	NOL carryforward adjustment	(810		)		—				—
	IRS Settlement - net of ASC 740 (formerly "FIN 48") reserve reversals	480				—				—
	2013 income tax return amendment	1,891				—				—
	Additional reserves for uncertain tax positions (ASC 740, formerly "FIN 48")	9,798				6,817				2,745
	Reconciliation of the tax payable liability accounts for our various subsidiaries to the income tax returns filed or to be filed in those jurisdictions	(3,138		)		—				(1,300		)
	Provision for income taxes from discrete items	6,544				7,656				2,282
	Total provision for income taxes	$	13,894			$	10,878			$	7,460
Schedule of Effective Income Tax Rate Reconciliation	The income tax provision at the Federal statutory rate differs from the effective rate because of the following items:
		Year Ended December 31, 2014			Year Ended December 31, 2013			Year Ended December 31, 2012
	Statutory tax rate	35	%		35	%		35	%
	Tax impact of foreign subsidiaries (primarily in Singapore)	(4.0	)%		(6.9	)%		(8.1	)%
	State income taxes, net of federal benefit	0.3	%		(0.3	)%		0.4	%
	Tax holiday - India (Permanent Difference)	(12.7	)%		(15.2	)%		(15.6	)%
	Passive income exemption - Sweden (permanent difference)	(3.2	)%		(3.5	)%		(3.1	)%
	Acquisition contingent earnout liability adjustments	(4.6	)%		(5.0	)%		(0.4	)%
	Singapore enhanced R&D deductions	(1.1	)%		(1.2	)%		(1.3	)%
	Other	(0.2	)%		1.7	%		(0.2	)%
	Effective tax rate from ongoing operations	9.5	%		4.6	%		6.7	%
	Discrete Items:
	Certain discrete tax impacts from foreign subsidiaries	(2.2	)%		1.2	%		1.1	%
	NOL carryforward adjustment	(1.0	)%		—	%		—	%
	IRS Settlement - net of ASC 740 (formerly "FIN 48") reserve reversals	0.6	%		—	%		—	%
	2013 income tax return amendment	2.4	%		—	%		—	%
	Net ASC 740 (formerly "FIN 48") reserve additions for uncertain tax positions	12.7	%		9.7	%		3.5	%
	Reconciliation of the tax payable liability accounts for our various subsidiaries to the income tax returns filed in those jurisdictions	(4.1	)%		—	%		(1.7	)%
	Effective tax rate after discrete items	17.9	%		15.5	%		9.6	%
Schedule of Deferred Tax Assets and Liabilities	The individual balances in current and long-term deferred tax assets and liabilities are as follows:
		2014				2013
		(In thousands)
	Current deferred income tax assets	$	2,310			$	961
	Long-term deferred income tax assets	43,235				44,924
	Total deferred income tax assets	45,545				45,885
	Current deferred income tax liabilities	(197		)		(705		)
	Long-term deferred income tax liabilities	(23,342		)		(24,308		)
	Net deferred income tax asset	$	22,006			$	20,872
Deferred Income Tax, Temporary Differences Between Amounts of Assets and Liabilities	Temporary differences and carry forwards which comprise the deferred tax assets and liabilities as of December 31, 2014 and 2013 were as follows:
		December 31, 2014								December 31, 2013
		Deferred								Deferred
		Assets				Liabilities				Assets			Liabilities
		(In thousands)
	Depreciation and amortization	$	254			$	—			$	580		$	—
	Share-based compensation	817				—				781			—
	Accruals and prepaids	2,342				470				3,415			788
	Bad debts	600				—				394			—
	Acquired intangible assets	—				23,069				—			24,225
	Net operating loss carryforwards	16,595				—				19,698			—
	Tax credit carryforwards (primarily MAT in India)	24,937				—				21,017			—
		45,545				23,539				45,885			25,013
	Valuation allowance	—				—				—			—
	Total deferred taxes	$	45,545			$	23,539			$	45,885		$	25,013
Schedule of Income Before Income Tax and Applicable Tax Rates, Domestic and Foreign	The pre-tax income from the applicable statutory tax rates in each jurisdiction in which the Company had operations for the year ending December 31, 2014 were as follows:
	(dollar amounts in thousands)	United States				Canada				Latin America			Australia			Singapore			New Zealand			India			Mauritius			Europe(United Kingdom)			Sweden			Total
	Pre-tax income	$	8,807			$	115			$	1,590		$	5,091		$	16,015		$	1,000		$	28,194		$	(370	)	$	9,940		$	7,070		$	77,452
	Statutory tax rate	35		%		30.5		%		34		%	30		%	10		%	28		%	—		%	—		%	24		%	—		%
Schedule of Unrecognized Tax Benefits Roll Forward	A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:
		December 31, 2014				December 31, 2013				December 31, 2012
		(in thousands)
	Beginning Balance	$	12,742			$	5,925			$	3,180
	Additions for tax positions related to current year	451				6,546				2,482
	Additions for tax positions of prior years	9,348				271				263
	Reductions for tax position of prior years	(19,521		)		—				—
	Ending Balance	$	3,020			$	12,742			$	5,925

Accounts_Payable_and_Accrued_E1

Accounts Payable and Accrued Expenses (Tables)	12 Months Ended
	Dec. 31, 2014
Accounts Payable and Accrued Liabilities, Current [Abstract]
Schedule of Accounts Payable and Accrued Expenses	Accounts payable and accrued expenses at December 31, 2014 and December 31, 2013, consisted of the following:
		2014		2013
		(In thousands)
	Trade accounts payable	$	11,879	$	4,515
	Accrued professional fees	1,258		1,046
	Income taxes payable	22,627		8,173
	Sales taxes payable	2,601		4,038
	Interest payable pertaining to IRS settlement	1,650		—
	Other accrued liabilities	106		46
	Total	$	40,121	$	17,818

Other_Current_Assets_Tables

Other Current Assets (Tables)	12 Months Ended
	Dec. 31, 2014
Prepaid Expense and Other Assets, Current [Abstract]
Schedule of Other Current Assets	Other current assets at December 31, 2014 and December 31, 2013 consisted of the following:
		2014		2013
		(In thousands)
	Prepaid expenses	$	5,618	$	3,824
	Sales taxes receivable from customers	121		220
	Due from prior owners of acquired businesses for working capital settlements	938		720
	Research and development tax credits receivable	1,152		720
	Other	238		64
	Total	$	8,067	$	5,548

Property_and_Equipment_Tables

Property and Equipment (Tables)	12 Months Ended
	Dec. 31, 2014
Property, Plant and Equipment [Abstract]
Property and Equipment	Property and equipment at December 31, 2014 and 2013 consisted of the following:
		2014			2013
		(In thousands)
	Computer equipment	$	13,830		$	12,417
	Buildings	3,912			3,119
	Land	3,924			59
	Leasehold improvements	1,448			2,648
	Furniture, fixtures and other	4,279			5,035
	Construction in Progress (building for new global corporate headquarters in the Atlanta metropolitan area)	10,441			—
		37,834			23,278
	Less accumulated depreciation and amortization	(13,173		)	(14,750		)
		$	24,661		$	8,528

Other_Liabilities_Tables

Other Liabilities (Tables)	12 Months Ended
	Dec. 31, 2014
Other Liabilities Disclosure [Abstract]
Other Liabilities	Other liabilities at December 31, 2014 and December 31, 2013 consisted of the following:
		2014			2013
		(In thousands)
	Reserve for potential uncertain income tax return positions	$	3,020		$	12,742
	Unfavorable lease liability, long term portion	294			394
	Portion of an unrecognized tax benefit netted against deferred tax asset for a net operating loss carryforward	(1,135		)	(8,422		)
	Other	—			5
	Total	$	2,179		$	4,719

Geographic_Information_Tables

Geographic Information (Tables)	12 Months Ended
	Dec. 31, 2014
Segment Reporting [Abstract]
Financial Information by Geographic Locations	The Company operates with one reportable segment whose results are regularly reviewed by the Company's chief operating decision maker as to performance and allocation of resources. External customer revenues in the tables below were attributed to a particular country based on whether the customer had a direct contract with the Company which was executed in that particular country for the sale of the Company's products/services with an Ebix subsidiary located in that country.
	The following enterprise wide information relates to the Company's geographic locations (all amounts in thousands):
	Year Ended December 31, 2014
		United States		Canada		Latin America		Australia		Singapore		New Zealand		India		Europe		Total
	External Revenues	$	147,971	$	5,239	$	7,036	$	36,319	$	4,384	$	2,578	$	1,929	$	8,865	$	214,321
	Long-lived assets	$	383,233	$	7,835	$	9,380	$	583	$	68,526	$	334	$	34,691	$	25,868	$	530,450
	Year Ended December 31, 2013
		United States		Canada		Latin America		Australia		Singapore		New Zealand		India		Europe		Total
	External Revenues	$	139,519	$	7,431	$	5,508	$	38,260	$	3,114	$	2,311	$	650	$	7,917	$	204,710
	Long-lived assets	$	309,732	$	8,784	$	10,886	$	803	$	68,987	$	97	$	23,784	$	28,442	$	451,515
	Year Ended December 31, 2012
		United States		Canada		Latin America		Australia		Singapore		New Zealand		India		Europe		Total
	External Revenues	$	140,933	$	6,395	$	8,227	$	36,330	$	2,827	$	2,205	$	233	$	2,220	$	199,370
	Long-lived assets	$	317,338	$	9,738	$	12,726	$	1,267	$	70,173	$	240	$	11,784	$	12,011	$	435,277

Quarterly_Financial_Informatio1

Quarterly Financial Information (unaudited) (Tables)	12 Months Ended
	Dec. 31, 2014
Quarterly Financial Information Disclosure [Abstract]
Schedule of Quarterly Financial Information	The following is the unaudited quarterly financial information for 2014, 2013 and 2012:
		First		Second		Third		Fourth
		Quarter		Quarter		Quarter		Quarter
		(in thousands, except share data)
	Year Ended December 31, 2014
	Total revenues	$	51,404	$	51,476	$	50,808	$	60,633
	Gross Profit	41,792		41,512		40,533		43,096
	Operating income	19,405		17,461		21,738		21,068
	Net income	15,417		13,579		18,015		16,547
	Net income per common share:
	Basic	$	0.4	$	0.35	$	0.47	$	0.45
	Diluted	$	0.4	$	0.35	$	0.47	$	0.45
	Year Ended December 31, 2013
	Total revenues	$	52,566	$	51,004	$	50,293	$	50,847
	Gross Profit	42,675		40,646		40,157		40,761
	Operating income	19,305		19,294		18,601		17,806
	Net income	17,344		13,542		13,143		15,245
	Net income per common share:
	Basic	$	0.47	$	0.36	$	0.35	$	0.4
	Diluted	$	0.45	$	0.35	$	0.34	$	0.4
	Year Ended December 31, 2012
	Total revenues	$	43,827	$	47,716	$	53,804	$	54,023
	Gross Profit	34,798		38,559		44,304		43,576
	Operating income	18,329		17,711		20,708		20,260
	Net income	15,685		18,067		18,072		18,745
	Net income per common share:
	Basic	$	0.43	$	0.49	$	0.49	$	0.5
	Diluted	$	0.4	$	0.47	$	0.46	$	0.48
	In some instances the sum of the quarterly basic and diluted net income per share amounts may not agree to the full year basic and diluted net income per share amounts reported on the Consolidated Statements of Income because of rounding.

Supplemental_Schedule_of_Nonca1

Supplemental Schedule of Noncash Financing Activities (Details) (USD $)	0 Months Ended
	4-May-12	Jun. 02, 2012	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Jan. 27, 2014
Other Significant Noncash Transactions [Line Items]
Derivative Liability			$5,367,000	$14,420,000	$17,495,000
Curepet, Inc.
Other Significant Noncash Transactions [Line Items]
Purchase Price of Business Acquisition, Cost of Acquired Entity						6,350,000
Derivative Liability			0			5,000,000
Non-Cash portion of Acquired Entity						1,350,000
Cost Method Investment, Ownership Percentage	19.80%
Payments to acquire cost method investment	2,000,000
Planetsoft
Other Significant Noncash Transactions [Line Items]
Purchase Price of Business Acquisition, Cost of Acquired Entity		40,000,000
Business acquisition, number of common shares issued		296,560
Fair value of equity issued in business acquisition		$5,000,000

Description_of_Business_and_Su3

Description of Business and Summary of Significant Accounting Policies (Segment Reporting) (Details) (USD $)	3 Months Ended												12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
													ProductService_Groups
Segment Reporting Information [Line Items]
Total revenue, international percentage													31.00%	31.80%	29.30%
Number of product/service groups													4
Operating revenue	$60,633	$50,808	$51,476	$51,404	$50,847	$50,293	$51,004	$52,566	$54,023	$53,804	$47,716	$43,827	$214,321	$204,710	$199,370
Exchanges
Segment Reporting Information [Line Items]
Operating revenue													169,437	163,925	159,678
Broker Systems
Segment Reporting Information [Line Items]
Operating revenue													17,948	18,378	18,612
RCS
Segment Reporting Information [Line Items]
Operating revenue													21,813	15,678	16,140
Carrier Systems
Segment Reporting Information [Line Items]
Operating revenue													$5,123	$6,729	$4,940

Description_of_Business_and_Su4

Description of Business and Summary of Significant Accounting Policies (Short-term Investments) (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Investments, Debt and Equity Securities [Abstract]
Short-term investments	$281	$801

Description_of_Business_and_Su5

Description of Business and Summary of Significant Accounting Policies (Fair Value Reporting) (Details) (USD $)	12 Months Ended				0 Months Ended	1 Months Ended
	Dec. 31, 2014		Dec. 31, 2013		Jun. 02, 2012	Jun. 30, 2012	31-May-12
					Stockholders		Stockholders
Fair Value, Assets and Liabilities Measured on Recurring Basis [Abstract]
Total assets measured at fair value	$281,000	[1]	$801,000	[1]
Total liabilities measured at fair value	5,367,000	[1]	15,265,000	[1]
Long-term Investments			213,000
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation:
Beginning balance	14,420,000		17,495,000
(Gains) or losses included in earnings	-10,237,000	[2]	-10,253,000	[2]
Foreign currency translation adjustments	-314,000	[3]	730,000	[3]
Business acquisitions	4,312,000		9,425,000
Settlements	-2,814,000		-2,977,000
Ending balance	5,367,000		14,420,000
Fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings, unrealized still held at year end	-8,911,000		-9,954,000
Fair Value Inputs, Discount Rate	1.75%
Put Option
Fair Value, Assets and Liabilities Measured on Recurring Basis [Abstract]
Derivative liabilities	0	[1],[4]	845,000	[1],[4]
Contingent Accrued Earn-out Acquisition Consideration
Fair Value, Assets and Liabilities Measured on Recurring Basis [Abstract]
Derivative liabilities	5,367,000	[1],[5]	14,420,000	[1],[5]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation:
Ending balance	5,400,000		14,400,000
Certificates of Deposit
Fair Value, Assets and Liabilities Measured on Recurring Basis [Abstract]
Available-for-sale securities	281,000	[1]	801,000	[1]
Certificates of Deposit | Other Assets
Fair Value, Assets and Liabilities Measured on Recurring Basis [Abstract]
Deposits, Fair Value Disclosure			213,000
Fair Value, Inputs, Level 1
Fair Value, Assets and Liabilities Measured on Recurring Basis [Abstract]
Total assets measured at fair value	281,000	[1]	801,000	[1]
Fair Value, Inputs, Level 1 | Certificates of Deposit
Fair Value, Assets and Liabilities Measured on Recurring Basis [Abstract]
Available-for-sale securities	281,000	[1]	801,000	[1]
Fair Value, Inputs, Level 2
Fair Value, Assets and Liabilities Measured on Recurring Basis [Abstract]
Total liabilities measured at fair value	0	[1]	845,000	[1]
Fair Value, Inputs, Level 2 | Put Option
Fair Value, Assets and Liabilities Measured on Recurring Basis [Abstract]
Derivative liabilities	0	[1],[4]	845,000	[1],[4]
Fair Value, Inputs, Level 3
Fair Value, Assets and Liabilities Measured on Recurring Basis [Abstract]
Total liabilities measured at fair value	5,367,000	[1]	14,420,000	[1]
Fair Value, Inputs, Level 3 | Contingent Accrued Earn-out Acquisition Consideration
Fair Value, Assets and Liabilities Measured on Recurring Basis [Abstract]
Derivative liabilities	5,367,000	[1],[5]	14,420,000	[1],[5]
Planetsoft
Fair Value, Assets and Liabilities Measured on Recurring Basis [Abstract]
Number of shareholders					3		3
Put option, exercise period						30 days
Put option, vesting period required prior to exercise						2 years
Business acquisition, number of common shares issued					296,560
Business acquisition, price per share					$16.86
Put option, price to repurchase shares, discount						10.00%
Fair Value, Measurements, Recurring | Planetsoft | Fair Value, Inputs, Level 2
Fair Value, Assets and Liabilities Measured on Recurring Basis [Abstract]
Put option liability					$1,400,000		1,400,000
[1]	During the year ended December 31, 2014 and 2013, respectively, there were no transfers between fair value levels 1, 2, or 3.
[2]	Recorded as an adjustment to reported general and administrative expenses
[3]	Recorded as a component of other comprehensive income within stockholders' equity
[4]	In connection with the acquisition of PlanetSoft effective June 1, 2012, Ebix issued a put option to the PlanetSoft's three shareholders. The put option, which expired in June 2014, was exercisable during the thirty-day period immediately following the two-year anniversary date of the business acquisition, which if exercised would enable them to sell the underlying 296,560 shares of Ebix common stock they received as part of the purchase consideration, back to the Company at a price of $16.86 per share, which represents the per-share value established on the effective date of the closing of Ebix's acquisition of PlanetSoft.The inputs used in the valuation of the put option include term, stock price volatility, current stock price, exercise price, and the risk free rate of return. During the months of July and August 2014 the former shareholders of PlanetSoft elected to exercise their put option rights with respect to the remaining 209,656 shares of Ebix common stock they still held. Accordingly the shareholders put those shares back to the Company at $16.86 per share plus interest at the rate of 20% as per the PlanetSoft acquisition agreement. The total consideration paid by the Company in connection with the exercise of these put options was $3.6 million.
[5]	The income valuation approach is applied and the valuation inputs include the contingent payment arrangement terms, projected cash flows, rate of return, and probability assessments.

Description_of_Business_and_Su6

Description of Business and Summary of Significant Accounting Policies (Accounts Receivables and Allowances) (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Accounts, Notes, Loans and Financing Receivable [Line Items]
Accounts Receivable, Net, Current	$41,100,000	$39,070,000
Allowance for doubtful accounts	1,619,000	1,049,000
Deferred revenue included in accounts receivables	5,800,000	6,700,000
Bad debt expense	1,600,000	1,147,000	442,000
Billed Revenues
Accounts, Notes, Loans and Financing Receivable [Line Items]
Accounts Receivable, Net, Current	32,400,000	31,200,000
Unbilled Revenues
Accounts, Notes, Loans and Financing Receivable [Line Items]
Accounts Receivable, Net, Current	$8,500,000	$7,900,000

Description_of_Business_and_Su7

Description of Business and Summary of Significant Accounting Policies (Goodwill) (Details) (USD $)	12 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Sep. 30, 2014	Jan. 27, 2014	21-May-14	Nov. 03, 2014	Apr. 07, 2013	Dec. 02, 2014	Dec. 01, 2014
Goodwill [Line Items]
Business acquisition, purchase price allocation, goodwill	$402,220	$337,068
Goodwill [Roll Forward]
Goodwill, beginning balance	337,068	326,748	337,068
Additions, net	68,503	11,136
Foreign currency translation adjustments	-3,351	-816
Goodwill, ending balance	402,220	337,068
Fair Value Inputs, Discount Rate	1.75%
Qatarlyst
Goodwill [Roll Forward]
Additions, net		11,136
Curepet, Healthcare Magic, Vertex, Oakstone, I3 [Member]
Goodwill [Roll Forward]
Additions, net	68,503
Final Allocation | Curepet, Inc.
Goodwill [Line Items]
Business acquisition, purchase price allocation, goodwill				2,687
Goodwill [Roll Forward]
Goodwill, beginning balance				2,687
Goodwill, ending balance				2,687
Final Allocation | Healthcare Magic
Goodwill [Line Items]
Business acquisition, purchase price allocation, goodwill					5,619
Goodwill [Roll Forward]
Goodwill, beginning balance					5,619
Goodwill, ending balance					5,619
Final Allocation | Qatarlyst
Goodwill [Line Items]
Business acquisition, purchase price allocation, goodwill		11,136				27,728	11,136
Goodwill [Roll Forward]
Goodwill, beginning balance						27,728	11,136
Goodwill, ending balance		11,136				27,728	11,136
Final Allocation | Oakstone
Goodwill [Line Items]
Business acquisition, purchase price allocation, goodwill								28,769
Goodwill [Roll Forward]
Goodwill, beginning balance								28,769
Goodwill, ending balance								28,769
Final Allocation | I3
Goodwill [Line Items]
Business acquisition, purchase price allocation, goodwill									3,700
Goodwill [Roll Forward]
Goodwill, beginning balance									3,700
Goodwill, ending balance									3,700
Final Allocation | Curepet, Healthcare Magic, Vertex, Oakstone, I3 [Member]
Goodwill [Line Items]
Business acquisition, purchase price allocation, goodwill	68,503
Goodwill [Roll Forward]
Goodwill, ending balance	$68,503
RCS
Goodwill [Roll Forward]
Fair Value Inputs, Discount Rate			16.00%
Minimum | RCS
Goodwill [Line Items]
Fair Value Inputs, Long-term Revenue Growth Rate			2.00%
Maximum | RCS
Goodwill [Line Items]
Fair Value Inputs, Long-term Revenue Growth Rate			3.00%

Description_of_Business_and_Su8

Description of Business and Summary of Significant Accounting Policies (Intangible Assets) (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Finite-Lived and Indefinite-Lived Intangible Assets [Line items]
Finite-Lived Intangible Assets, Gross	86,301	$80,574
Finite-lived intangible assets, accumulated amortization	-36,930	-29,840
Estimated future amortization expense	49,371	50,734
Customer Relationships
Finite-Lived and Indefinite-Lived Intangible Assets [Line items]
Finite-Lived Intangible Assets, Gross	66,783	62,408
Customer Relationships | Minimum
Finite-Lived and Indefinite-Lived Intangible Assets [Line items]
Finite-lived intangible asset, useful life	7 years
Customer Relationships | Maximum
Finite-Lived and Indefinite-Lived Intangible Assets [Line items]
Finite-lived intangible asset, useful life	20 years
Developed Technology
Finite-Lived and Indefinite-Lived Intangible Assets [Line items]
Finite-Lived Intangible Assets, Gross	15,664	14,630
Developed Technology | Minimum
Finite-Lived and Indefinite-Lived Intangible Assets [Line items]
Finite-lived intangible asset, useful life	3 years
Developed Technology | Maximum
Finite-Lived and Indefinite-Lived Intangible Assets [Line items]
Finite-lived intangible asset, useful life	12 years
Trademarks
Finite-Lived and Indefinite-Lived Intangible Assets [Line items]
Finite-Lived Intangible Assets, Gross	2,751	2,646
Trademarks | Minimum
Finite-Lived and Indefinite-Lived Intangible Assets [Line items]
Finite-lived intangible asset, useful life	3 years
Trademarks | Maximum
Finite-Lived and Indefinite-Lived Intangible Assets [Line items]
Finite-lived intangible asset, useful life	15 years
Noncompete Agreements
Finite-Lived and Indefinite-Lived Intangible Assets [Line items]
Finite-Lived Intangible Assets, Gross	751	538
Noncompete Agreements | Maximum
Finite-Lived and Indefinite-Lived Intangible Assets [Line items]
Finite-lived intangible asset, useful life	5 years
Backlog
Finite-Lived and Indefinite-Lived Intangible Assets [Line items]
Finite-Lived Intangible Assets, Gross	140	140
Database
Finite-Lived and Indefinite-Lived Intangible Assets [Line items]
Finite-Lived Intangible Assets, Gross	212	212
Database | Maximum
Finite-Lived and Indefinite-Lived Intangible Assets [Line items]
Finite-lived intangible asset, useful life	10 years
Customer/Territorial Relationships
Finite-Lived and Indefinite-Lived Intangible Assets [Line items]
Indefinite-lived intangible assets	30,887	$30,887

Description_of_Business_and_Su9

Description of Business and Summary of Significant Accounting Policies (Advertising and Sales Commission) (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Accounting Policies [Abstract]
Advertising Expense	$1,700,000	$1,000,000	$1,400,000
Deferred Sales Commission	398,000	434,000
Amortization of Deferred Sales Commissions	$913,000	$915,000

Recovered_Sheet1

Description of Business and Summary of Significant Accounting Policies (Fixed Assets) (Details) (Details)	12 Months Ended
	Dec. 31, 2014
Computer equipment
Property, Plant and Equipment [Line Items]
Property and equipment, estimated useful life	5 years
Furniture, fixtures and other
Property, Plant and Equipment [Line Items]
Property and equipment, estimated useful life	7 years
Buildings
Property, Plant and Equipment [Line Items]
Property and equipment, estimated useful life	30 years

Earnings_per_Share_Details

Earnings per Share (Details) (USD $)	3 Months Ended												12 Months Ended
	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Earnings Per Share, Basic and Diluted [Abstract]
Basic earnings per common share (in dollars per share)	$0.45	$0.47	$0.35	$0.40	$0.40	$0.35	$0.36	$0.47	$0.50	$0.49	$0.49	$0.43	$1.68	$1.58	$1.91
Diluted earnings per common share (in dollars per share)	$0.45	$0.47	$0.35	$0.40	$0.40	$0.34	$0.35	$0.45	$0.48	$0.46	$0.47	$0.40	$1.67	$1.53	$1.80
Basic weighted average shares outstanding (in shares)													37,809,000	37,588,000	36,948,000
Diluted weighted average shares outstanding (in shares)													38,040,000	38,642,000	39,100,000
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount													135,000	315,000	90,000
Weighted Average Number of Shares Outstanding, Diluted [Abstract]
Basic weighted average shares outstanding (in shares)													37,809,000	37,588,000	36,948,000
Incremental shares for common stock equivalents (in shares)													231,000	1,054,000	2,152,000
Diluted shares outstanding (in shares)													38,040,000	38,642,000	39,100,000

Business_Acquisitions_Narrativ

Business Acquisitions (Narrative) (Details) (USD $)

12 Months Ended

0 Months Ended

1 Months Ended

0 Months Ended

Dec. 31, 2014

Dec. 31, 2013

Dec. 31, 2012

Jan. 27, 2014

Jun. 02, 2012

Jun. 30, 2012

22-May-14

Nov. 03, 2014

Dec. 02, 2014

Apr. 07, 2013

21-May-14

Dec. 01, 2014

31-May-12

Business Acquisition [Line Items]

Business Acquisition, Earnout Accrual Adjustment

$10,237,000

$10,253,000

$699,000

Derivative Liability

5,367,000

14,420,000

17,495,000

Contingent liability for accrued earn-out acquisition consideration

4,480,000

10,283,000

Contingent liability for accrued earn-out acquisition consideration

887,000

4,137,000

Business acquisition, termination fee received for failed acquisition

971,000

Business acquisition, purchase price allocation, goodwill

402,220,000

337,068,000

326,748,000

Goodwill

402,220,000

337,068,000

326,748,000

Curepet, Inc.

Business Acquisition [Line Items]

Derivative Liability

0

5,000,000

Non-Cash portion of Acquired Entity

1,350,000

Derivative, Term of Contract

36 months

Purchase Price of Business Acquisition, Cost of Acquired Entity

6,350,000

Curepet, Inc. | Final Allocation

Business Acquisition [Line Items]

Business acquisition, purchase price allocation, goodwill

2,687,000

Goodwill

2,687,000

Qatarlyst

Business Acquisition [Line Items]

Number of Businesses Acquired

1

Business acquisition, cost of acquired entity, cash paid

5,025,000

Qatarlyst | Customer Relationships

Business Acquisition [Line Items]

Intangible Assets, Net (Excluding Goodwill)

4,800,000

Qatarlyst | Technology

Business Acquisition [Line Items]

Intangible Assets, Net (Excluding Goodwill)

635,000

Qatarlyst | Final Allocation

Business Acquisition [Line Items]

Business acquisition, purchase price allocation, goodwill

11,136,000

27,728,000

11,136,000

Goodwill

11,136,000

27,728,000

11,136,000

Planetsoft

Business Acquisition [Line Items]

Purchase Price of Business Acquisition, Cost of Acquired Entity

40,000,000

Business acquisition, number of common shares issued

296,560

Business acquisition, price per share

$16.86

Equity instruments

5,000,000

Put option, exercise period

30 days

Put option, vesting period required prior to exercise

2 years

Put option, price to repurchase shares

$16.86

Put option, price to repurchase shares, discount

10.00%

Fair value of equity issued in business acquisition

5,000,000

Healthcare Magic

Business Acquisition [Line Items]

Derivative Liability

596,000

Business acquisition, cost of acquired entity, cash paid

6,000,000

Healthcare Magic | Customer Relationships

Business Acquisition [Line Items]

Intangible Assets, Net (Excluding Goodwill)

452,000

Healthcare Magic | Technology

Business Acquisition [Line Items]

Intangible Assets, Net (Excluding Goodwill)

100,000

Healthcare Magic | Trademarks and Trade Names

Business Acquisition [Line Items]

Intangible Assets, Net (Excluding Goodwill)

59,000

Healthcare Magic | Noncompete Agreements

Business Acquisition [Line Items]

Intangible Assets, Net (Excluding Goodwill)

226,000

Healthcare Magic | Final Allocation

Business Acquisition [Line Items]

Business acquisition, purchase price allocation, goodwill

5,619,000

Goodwill

5,619,000

Vertex

Business Acquisition [Line Items]

Business acquisition, cost of acquired entity, cash paid

27,250,000

Vertex | Customer Relationships

Business Acquisition [Line Items]

Intangible Assets, Net (Excluding Goodwill)

2,500,000

Vertex | Technology

Business Acquisition [Line Items]

Intangible Assets, Net (Excluding Goodwill)

235,000

Vertex | Final Allocation

Business Acquisition [Line Items]

Business acquisition, purchase price allocation, goodwill

27,700,000

Goodwill

27,700,000

Oakstone

Business Acquisition [Line Items]

Business acquisition, cost of acquired entity, cash paid

31,370,000

Deferred Revenue

6,500,000

Payments to Acquire Businesses, Net

23,720,000

Net working capital adjustment

7,650,000

Oakstone | Customer Relationships

Business Acquisition [Line Items]

Intangible Assets, Net (Excluding Goodwill)

1,700,000

Oakstone | Technology

Business Acquisition [Line Items]

Intangible Assets, Net (Excluding Goodwill)

501,000

Oakstone | Final Allocation

Business Acquisition [Line Items]

Business acquisition, purchase price allocation, goodwill

28,769,000

Goodwill

28,769,000

I3

Business Acquisition [Line Items]

Business acquisition, cost of acquired entity, cash paid

2,000,000

I3 | Customer Relationships

Business Acquisition [Line Items]

Intangible Assets, Net (Excluding Goodwill)

225,000

I3 | Technology

Business Acquisition [Line Items]

Intangible Assets, Net (Excluding Goodwill)

75,000

I3 | Final Allocation

Business Acquisition [Line Items]

Business acquisition, purchase price allocation, goodwill

3,700,000

Goodwill

3,700,000

Fair Value, Inputs, Level 2 | Fair Value, Measurements, Recurring | Planetsoft

Business Acquisition [Line Items]

Put option liability

1,400,000

1,400,000

Contingent Accrued Earn-out Acquisition Consideration

Business Acquisition [Line Items]

Derivative Liability

5,400,000

14,400,000

Maximum | Curepet, Inc.

Business Acquisition [Line Items]

Derivative Liability

5,000,000

Maximum | Healthcare Magic

Business Acquisition [Line Items]

Derivative Liability

12,360,000

Maximum | Vertex

Business Acquisition [Line Items]

Derivative Liability

2,000,000

Maximum | I3

Business Acquisition [Line Items]

Derivative Liability

$4,000,000

Business_Acquisitions_Net_Asse

Business Acquisitions (Net Assets Acquired) (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Jan. 27, 2014
Business Acquisition [Line Items]
Goodwill	$68,503,000	$11,136,000
Qatarlyst
Business Acquisition [Line Items]
Cash		5,025,000
Contingent earn-out consideration arrangement		9,425,000
Total		14,450,000
Cash		285,000
Current assets		485,000
Property and equipment		144,000
Other assets		507,000
Intangible assets		5,396,000
Deferred tax liability		-947,000
Current and other liabilities		-2,556,000
Net assets acquired		3,314,000
Goodwill		11,136,000
Total net assets acquired		14,450,000
Curepet, Inc.
Business Acquisition [Line Items]
Non-Cash portion of Acquired Entity			1,350,000
Curepet, Healthcare Magic, Vertex, Oakstone, I3 [Member]
Business Acquisition [Line Items]
Cash	59,514,000
Contingent earn-out consideration arrangement	4,312,000
Previous cash consideration in investment of step up acquisition	2,000,000	0
Non-Cash portion of Acquired Entity	1,350,000	0
Total	67,176,000
Cash	323,000
Current assets	5,263,000
Property and equipment	670,000
Other assets	54,000
Intangible assets	6,872,000
Deferred tax liability	-1,040,000
Current and other liabilities	-13,469,000
Net assets acquired	-1,327,000
Goodwill	68,503,000
Total net assets acquired	$67,176,000

Business_Acquisitions_Intangib

Business Acquisitions (Intangible Assets Acquired) (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2014
Qatarlyst
Acquired Finite-Lived Intangible Assets [Line Items]
Total acquired intangible assets, Fair Value	$5,396
Acquired intangible assets, Weighted Average Useful Life (in years)	10 years 3 months
Qatarlyst | Customer Relationships
Acquired Finite-Lived Intangible Assets [Line Items]
Total acquired intangible assets, Fair Value	4,761
Acquired intangible assets, Weighted Average Useful Life (in years)	11 years 0 months
Qatarlyst | Developed Technology
Acquired Finite-Lived Intangible Assets [Line Items]
Total acquired intangible assets, Fair Value	635
Acquired intangible assets, Weighted Average Useful Life (in years)	5 years 0 months
Qatarlyst | Noncompete Agreements
Acquired Finite-Lived Intangible Assets [Line Items]
Total acquired intangible assets, Fair Value	0
Acquired intangible assets, Weighted Average Useful Life (in years)	0 years
Qatarlyst | Trademarks
Acquired Finite-Lived Intangible Assets [Line Items]
Total acquired intangible assets, Fair Value	0
Acquired intangible assets, Weighted Average Useful Life (in years)	0 years
Curepet, Healthcare Magic, Vertex, Oakstone, I3 [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Total acquired intangible assets, Fair Value		6,872
Acquired intangible assets, Weighted Average Useful Life (in years)		8 years 9 months
Curepet, Healthcare Magic, Vertex, Oakstone, I3 [Member] | Customer Relationships
Acquired Finite-Lived Intangible Assets [Line Items]
Total acquired intangible assets, Fair Value		5,275
Acquired intangible assets, Weighted Average Useful Life (in years)		9 years 11 months 10 days
Curepet, Healthcare Magic, Vertex, Oakstone, I3 [Member] | Developed Technology
Acquired Finite-Lived Intangible Assets [Line Items]
Total acquired intangible assets, Fair Value		1,236
Acquired intangible assets, Weighted Average Useful Life (in years)		4 years 1 month 30 days
Curepet, Healthcare Magic, Vertex, Oakstone, I3 [Member] | Noncompete Agreements
Acquired Finite-Lived Intangible Assets [Line Items]
Total acquired intangible assets, Fair Value		226
Acquired intangible assets, Weighted Average Useful Life (in years)		7 years
Curepet, Healthcare Magic, Vertex, Oakstone, I3 [Member] | Trademarks
Acquired Finite-Lived Intangible Assets [Line Items]
Total acquired intangible assets, Fair Value		$135
Acquired intangible assets, Weighted Average Useful Life (in years)		5 years 6 months 3 days

Business_Acquisitions_Future_A

Business Acquisitions (Future Amortization Expense) (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Acquired Intangible Assets, Amortization Expense, Fiscal Year Maturity [Abstract]
For the year ending December 31, 2015	$7,357,000
For the year ending December 31, 2016	6,794,000
For the year ending December 31, 2017	6,388,000
For the year ending December 31, 2018	5,668,000
For the year ending December 31, 2019	5,384,000
Thereafter	17,780,000
Estimated future amortization expense	49,371,000	50,734,000
Amortization expense, acquired intangible assets	$7,400,000	$7,300,000	$6,100,000

Pro_Forma_Financial_Informatio2

Pro Forma Financial Information (re: 2014 and 2013 acquisitions) (Details) (USD $)	3 Months Ended												12 Months Ended
	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Business Acquisition, Pro Forma Information [Abstract]
Revenue, As Reported	$60,633,000	$50,808,000	$51,476,000	$51,404,000	$50,847,000	$50,293,000	$51,004,000	$52,566,000	$54,023,000	$53,804,000	$47,716,000	$43,827,000	$214,321,000	$204,710,000	$199,370,000
Net Income, As Reported	16,547,000	18,015,000	13,579,000	15,417,000	15,245,000	13,143,000	13,542,000	17,344,000	18,745,000	18,072,000	18,067,000	15,685,000	63,558,000	59,274,000	70,569,000
Basic EPS, As Reported (in dollars per share)	$0.45	$0.47	$0.35	$0.40	$0.40	$0.35	$0.36	$0.47	$0.50	$0.49	$0.49	$0.43	$1.68	$1.58	$1.91
Diluted EPS, As Reported (in dollars per share)	$0.45	$0.47	$0.35	$0.40	$0.40	$0.34	$0.35	$0.45	$0.48	$0.46	$0.47	$0.40	$1.67	$1.53	$1.80
Increase (decrease) in reported revenue													9,600,000
Increase (decrease) in reported revenue, percentage													4.70%
Effect of Exchange Rate on Revenue													-3,200,000	-3,800,000	-1,200,000
Parent, Curepet, Healthcare Magic, Vertex, Oakstone, I3, Qatarlyst
Business Acquisition, Pro Forma Information [Abstract]
Revenue, Pro forma													262,733,000	260,452,000
Net Income, Pro Forma													61,745,000	52,809,000
Basic EPS, Pro Forma (in dollars per share)													$1.63	$1.40
Diluted EPS, Pro Forma (in dollars per share)													$1.62	$1.37
Increase (decrease) in unaudited pro forma revenue													$2,300,000
Increase (decrease) in unaudited pro forma revenue, percentage													0.90%

Commercial_Bank_Financing_Faci1

Commercial Bank Financing Facility (Details) (USD $)	0 Months Ended			12 Months Ended
	Aug. 05, 2014	20-May-14	Apr. 26, 2012	Dec. 31, 2014	19-May-14	Dec. 31, 2013
Secured Syndicated Credit Facility | Regions Bank
Line of Credit Facility [Line Items]
Debt instrument, face amount	$150,000,000
Deferred Costs, Credit Card Origination Costs, Amount				1,300,000
Secured Syndicated Credit Facility | Citi Bank
Line of Credit Facility [Line Items]
Debt instrument, face amount			100,000,000
Interest Rate at Period End				1.67%
Deferred Costs, Credit Card Origination Costs, Amount			744,000
Secured Syndicated Credit Facility | Revolving Credit Facility | Regions Bank
Line of Credit Facility [Line Items]
Debt Instrument, Term	5 years
Current Borrowing Capacity	150,000,000
Credit agreement, maximum borrowing capacity	200,000,000
Line of Credit Facility, Expansion	50,000,000
Line of credit, interest rate at period end				1.94%
Secured Syndicated Credit Facility | Revolving Credit Facility | Citi Bank
Line of Credit Facility [Line Items]
Revolving credit facility, term			4 years	4 years
Credit agreement, maximum borrowing capacity			45,000,000
Line of Credit Facility, Expansion			10,000,000
Credit agreement, amount outstanding				120,470,000	7,840,000	22,800,000
Repayments of Lines of Credit		15,000,000
Line of credit, interest rate at period end				1.94%
Credit agreement, average amount outstanding during period				40,500,000
Credit agreement, maximum amount outstanding during period				120,470,000
Weighted average interest rate				1.78%		1.67%
Seventh Amendment | BOA
Line of Credit Facility [Line Items]
Debt instrument, face amount			55,000,000
Secured Term Loan | Secured Syndicated Credit Facility | Citi Bank
Line of Credit Facility [Line Items]
Debt instrument, face amount			45,000,000
Credit agreement, amortization period				4 years
Repayments of term loan				7,600,000
Other Long-term Debt				$0
Minimum | Secured Syndicated Credit Facility | Regions Bank
Line of Credit Facility [Line Items]
Basis spread on variable interest rate	1.75%
Minimum | Secured Syndicated Credit Facility | Citi Bank
Line of Credit Facility [Line Items]
Basis spread on variable interest rate				1.50%
Maximum | Secured Syndicated Credit Facility | Regions Bank
Line of Credit Facility [Line Items]
Basis spread on variable interest rate	2.25%
Maximum | Secured Syndicated Credit Facility | Citi Bank
Line of Credit Facility [Line Items]
Basis spread on variable interest rate				2.00%

Commitments_and_Contingencies_1

Commitments and Contingencies (Minimum Rentals) (Details) (USD $)	Dec. 31, 2014
In Thousands, unless otherwise specified
Long-term Debt, Fiscal Year Maturity [Abstract]
Long-term debt maturities, 2015	$943
Long-term debt maturities, 2016	600
Long-term debt maturities, 2017	0
Long-term debt maturities, 2018	0
Long-term debt maturities, 2019	120,465
Long-term debt maturities, Thereafter	0
Total Debt	122,008
Less: current portion	-943
Long-term obligations, Debt	121,065
Capital Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract]
Capital Leases, future minimum payments due, 2015	0
Capital Leases, future minimum payments due, 2016	0
Capital Leases, future minimum payments due, 2017	0
Capital Leases, future minimum payments due, 2018	0
Capital Leases, future minimum payments due, 2019	0
Capital Leases, future minimum payments due, Thereafter	0
Total capital lease obligations	0
Less: amount representing interest	0
Present value of obligations under capital leases	0
Less: current portion	0
Long-term obligations, Capital Leases	0
Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract]
Operating Leases, future minimum payments due, 2015	5,863
Operating Leases, future minimum payments due, 2016	4,136
Operating Leases, future minimum payments due, 2017	3,886
Operating Leases, future minimum payments due, 2018	3,120
Operating Leases, future minimum payments due, 2019	2,088
Operating Leases, future minimum payments due, Thereafter	1,340
Total operating lease obligations	20,433
Less: sublease income	-1,296
Net lease payments	19,137
Purchase Obligation, Fiscal Year Maturity [Abstract]
Purchase Obligation,future minimum payments due, 2015	3,715
Purchase Obligation,future minimum payments due, 2016	541
Purchase Obligation, future minimum payments due, 2017	541
Purchase Obligation, future minimum payments due, 2018	541
Purchase Obligation, future minimum payments due, 2019	406
Purchase Obligation, future minimum payments due, Thereafter	0
Total Purchase Obligation	$5,744

Commitments_and_Contingencies_2

Commitments and Contingencies (Narrative) (Details) (USD $)	3 Months Ended		12 Months Ended			0 Months Ended
	Dec. 31, 2014	Sep. 30, 2014	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Jan. 19, 2015
Commitments and Contingencies [Line Items]
Litigation Settlement, Amount			$690,000
Litigation Settlement, Expense	340,000	350,000
Nonoperating Income (Expense)			-690,000	-4,226,000	0
Rent expense, operating leases			6,300,000	6,500,000	5,900,000
Operating Leases, Rent Expense, Sublease Rentals			381,000	55,000	5,000
Self-insured health insurance, liability	250,000		250,000	302,000
Maximum
Commitments and Contingencies [Line Items]
Self-insured health insurance limit, per person			120,000
Self-insured health Insurance, aggregate liability based on participants and claims (percentage)			125.00%
Self-insured health insurance, estimated cumulative liability for annual contract	2,900,000		2,900,000
Computer equipment | Minimum
Commitments and Contingencies [Line Items]
Capital lease obligation, term			3 years
Computer equipment | Maximum
Commitments and Contingencies [Line Items]
Capital lease obligation, term			5 years
Subsequent Event
Commitments and Contingencies [Line Items]
Payments for Legal Settlements						$690,000

Sharebased_Compensation_Valuat

Share-based Compensation (Valuation Assumptions) (Details) (USD $)	12 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Share-based Compensation, Fair Value Assumptions [Abstract]
Weighted average fair values of stock options granted (in dollars per share)	$0	$5.70	$5.47
Expected volatility	0.00%	59.90%	47.90%
Expected dividends	0.00%	2.01%	1.18%
Weighted average risk-free interest rate	0.00%	0.65%	0.33%
Expected life of stock options (in years)	0 years	3 years 6 months	3 years 6 months
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock compensation expense	$305	$474	$539

Sharebased_Compensation_Stock_

Share-based Compensation (Stock Option Activity) (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Stock Options, Outstanding [Roll Forward]
Stock options outstanding, ending balance	207,000
Stock options, Exercisable	139,500
Stock Options, Outstanding, Weighted Average Exercise Price [Roll Forward]
Stock options, Weighted Average Exercise Price, beginning balance (in dollars per share)	$8.28	$4.03	$2.51
Stock options, Granted, Weighted Average Exercise Price (in dollars per share)	$0	$14.89	$16.94
Stock options, Exercised, Weighted Average Exercise Price (in dollars per share)	$1.75	$1.73	$0.75
Stock options, Canceled, Weighted Average Exercise Price (in dollars per share)	$17.58	$0	$0
Stock options, Weighted Average Exercise Price, ending balance (in dollars per share)	$16.41	$8.28	$4.03	$2.51
Stock options, Exercisable, Weighted Average Exercise Price (in dollars per share)	$16.35
Stock Options, Additional Disclosures [Abstract]
Stock options outstanding, Weighted Average Remaining Contractual Term (in years)	1 year 10 months 17 days	1 year	1 year 2 months 1 day	1 year 6 months 21 days
Stock options, Exercisable, Weighted Average Remaining Contractual Term (in years)	1 year 5 months 5 days
Stock options outstanding, Aggregate Intrinsic Value	$121,000	$5,093,000	$24,171,000	$64,959,000
Stock options, Exercisable, Aggregate Intrinsic Value	89,000
Proceeds from stock options exercised	788,000	2,161,000	1,020,000
Stock Options
Stock Options, Additional Disclosures [Abstract]
Stock options exercised in period, intrinsic value	$5,300,000	$11,400,000	$24,800,000
Within Plans
Stock Options, Outstanding [Roll Forward]
Stock options outstanding, beginning balance	792,000	1,998,633	3,315,175
Stock options, Granted	0	45,000	45,000
Stock options, Exercised	-450,000	-1,251,633	-1,361,542
Stock options, Canceled	-135,000	0	0
Stock options outstanding, ending balance	207,000	792,000	1,998,633
Stock options, Exercisable	139,500

Sharebased_Compensation_Nonves

Share-based Compensation (Nonvested Options) (Details) (Nonvested Option Shares, USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Nonvested Option Shares
Nonvested Awards, Number of Shares [Roll Forward]
Nonvested awards, Shares, beginning balance	112,500	135,000	180,005
Nonvested options, Granted	0	45,000	45,000
Nonvested options, Vested	-45,000	-67,500	-90,005
Nonvested options, Canceled	0	0	0
Nonvested awards, Shares, ending balance	67,500	112,500	135,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Exercise Price [Roll Forward]
Nonvested options, Weighted Average Exercise Price, beginning balance (in dollars per share)	$17.32	$18.80	$17.17
Nonvested options, Granted, Weighted Average Exercise Price (in dollars per share)	$0	$14.89	$16.94
Nonvested options, Vested, Weighted Average Exercise Price (in dollars per share)	$18.53	$18.66	$14.60
Nonvested options, Canceled, Weighted Average Exercise Price (in dollars per share)	$0	$0	$0
Nonvested options, Weighted Average Exercise Price, ending balance (in dollars per share)	$16.52	$17.32	$18.80

Sharebased_Compensation_Option

Share-based Compensation (Option Price Ranges) (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Stock options outstanding	207,000
Stock options outstanding, Weighted Average Remaining Contractual Term (in years)	1 year 10 months 17 days	1 year	1 year 2 months 1 day	1 year 6 months 21 days
Stock options outstanding, Weighted Average Exercise Price (in dollars per share)	$16.41	$8.28	$4.03	$2.51
Stock options exercisable	139,500
Stock options exercisable, Weighted Average Exercise Price (in dollars per share)	$16.35
$2.18-$2.36 Exercise Price Range
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Shares authorized under stock option plans, exercise price range, lower range limit	$2.18
Shares authorized under stock option plans, exercise price range, upper range limit	$2.36
Stock options outstanding, by exercise price range	27,000
Stock options outstanding, Weighted Average Remaining Contractual Term (in years)	1 year 4 months 27 days
Stock options outstanding, Weighted Average Exercise Price, by exercise price range (in dollars per share)	$2.27
Stock options exercisable, by exercise price range	27,000
Stock options exercisable, Weighted Average Exercise Price, by exercise price range (in dollars per share)	$2.27
$14.89-$16.94 Exercise Price Range
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Shares authorized under stock option plans, exercise price range, lower range limit	$14.89
Shares authorized under stock option plans, exercise price range, upper range limit	$16.94
Stock options outstanding, by exercise price range	90,000
Stock options outstanding, Weighted Average Remaining Contractual Term (in years)	2 years 11 months 23 days
Stock options outstanding, Weighted Average Exercise Price, by exercise price range (in dollars per share)	$15.92
Stock options exercisable, by exercise price range	33,750
Stock options exercisable, Weighted Average Exercise Price, by exercise price range (in dollars per share)	$16.26
$20.58-$21.70 Exercise Price Range
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Shares authorized under stock option plans, exercise price range, lower range limit	$20.58
Shares authorized under stock option plans, exercise price range, upper range limit	$21.70
Stock options outstanding, by exercise price range	90,000
Stock options outstanding, Weighted Average Remaining Contractual Term (in years)	0 years 11 months 6 days
Stock options outstanding, Weighted Average Exercise Price, by exercise price range (in dollars per share)	$21.14
Stock options exercisable, by exercise price range	78,750
Stock options exercisable, Weighted Average Exercise Price, by exercise price range (in dollars per share)	$21.22

Sharebased_Compensation_Nonves1

Share-based Compensation (Nonvested Restricted Stock) (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
	Installment
Nonvested Awards, Weighted Average Grant Date Fair Value [Roll Forward]
Common shares reserved for stock option and restricted stock grants	5,700,000
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting rate, initial year (percent)	33.33%
Quarterly award vesting installments after initial year	8
Nonvested Awards, Number of Shares [Roll Forward]
Nonvested awards, Shares, beginning balance	75,265	121,156	145,081
Nonvested awards, Shares Granted	171,781	32,842	73,061
Nonvested awards, Shares Vested	-52,388	-76,576	-90,379
Nonvested awards, Shares Forfeited	-6,136	-2,157	-6,607
Nonvested awards, Shares, ending balance	188,522	75,265	121,156
Nonvested Awards, Weighted Average Grant Date Fair Value [Roll Forward]
Nonvested awards outstanding, Weighted Average Grant Date Fair Value, beginning balance (in dollars per share)	$19.92	$22.74	$20.13
Nonvested awards, Granted, Weighted Average Grant Date Fair Value (in dollars per share)	$16.96	$15.91	$23.26
Nonvested awards, Vested, Weighted Average Grant Date Fair Value (in dollars per share)	$20.35	$22.56	$18.89
Nonvested awards, Forfeited, Weighted Average Grant Date Fair Value (in dollars per share)	$18.91	$23.42	$24.10
Nonvested awards outstanding, Weighted Average Grant Date Fair Value, ending balance (in dollars per share)	$17.13	$19.92	$22.74
Unrecognized compensation cost, share-based compensation arrangements	$2,500,000
Weighted average period to recognize nonvested awards (in years)	2 years 1 month 2 days
Fair value of shares vested during period	1,100,000	1,700,000	1,700,000
Stock compensation expense recognized on restricted grants	$1,500,000	$1,500,000	$1,500,000

Income_Taxes_Narrative_Details

Income Taxes (Narrative) (Details) (USD $)	12 Months Ended			0 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Jan. 06, 2015	Dec. 31, 2011
Operating Loss Carryforwards [Line Items]
Income Tax Expense (Benefit)	$13,894,000	$10,878,000	$7,460,000
Provision for income taxes from discrete items	6,544,000	7,656,000	2,282,000
Income Tax Expense (Benefit), before discrete items	7,350,000	3,222,000	5,178,000
Operating loss carryforwards, domestic	42,000,000
Operating Loss Carryforwards, Domestic, Utilized	5,700,000
Foreign	4,847,000	4,532,000	3,660,000
Deferred Tax Liabilities, Undistributed Foreign Earnings	71,900,000
Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense	680,000
Reserve for potential uncertain income tax return positions	3,020,000	12,742,000	5,925,000		3,180,000
Effective tax rate from ongoing operations	9.50%
Portion of an unrecognized tax benefit netted against deferred tax asset for a net operating loss carryforward	-1,135,000	-8,422,000
India
Operating Loss Carryforwards [Line Items]
Foreign tax holiday (percentage)	50.00%
Foreign statutory income tax rate	33.99%
Foreign income tax holiday, term	5 years
Income Tax Holiday, Aggregate Dollar Amount	9,900,000
Income Tax Holiday, Income Tax Benefits Per Share	$0.17
Deferred Tax Assets, Net of Valuation Allowance, Noncurrent	22,460,000	18,640,000
India | Minimum Alternative Tax (“MAT”)
Operating Loss Carryforwards [Line Items]
Foreign statutory income tax rate	20.97%
Foreign income tax holiday, term	10 years
Income Taxes Paid	3,820,000
Singapore
Operating Loss Carryforwards [Line Items]
Foreign statutory income tax rate	17.00%
Foreign effective income tax rate	10.00%
Income Tax Holiday, Aggregate Dollar Amount	2,500,000
Income Tax Holiday, Income Tax Benefits Per Share	$0.07
Subsequent Event
Operating Loss Carryforwards [Line Items]
Income Tax Audit, Cash Settlement				20,500,000
Income Tax Examination, Penalties and Interest Accrued				1,600,000
Tax Adjustments, Settlements, and Unusual Provisions				-1,500,000
IRS Settlement – net of FIN 48 reserve reversals [Member]
Operating Loss Carryforwards [Line Items]
Provision for income taxes from discrete items	480,000	0	0
2013 Income tax return amendment [Member]
Operating Loss Carryforwards [Line Items]
Provision for income taxes from discrete items	1,891,000	0	0
FIN 48 reserve additions [Member]
Operating Loss Carryforwards [Line Items]
Provision for income taxes from discrete items	9,798,000	6,817,000	2,745,000
Reconciliation of the tax payable liability accounts for our various subsidiaries to the income tax returns filed in those jurisdictions [Member]
Operating Loss Carryforwards [Line Items]
Provision for income taxes from discrete items	($3,138,000)	$0	($1,300,000)

Income_Taxes_PreTax_Income_Det

Income Taxes (Pre-Tax Income) (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Income Tax Disclosure [Abstract]
Domestic	$8,807	$5,497	$6,604
Foreign	68,645	64,655	71,425
Total	$77,452	$70,152	$78,029

Income_Taxes_Components_of_Inc

Income Taxes (Components of Income Tax Expense) (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Current Income Tax Expense (Benefit) [Abstract]
Federal	$1,335	$266	$342
State	270	167	320
Foreign	4,847	4,532	3,660
Current income tax provision	6,452	4,965	4,322
Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]
Federal	1,118	-632	2,382
State	43	-351	31
Foreign	-263	-760	-1,557
Deferred income tax provision	898	-1,743	856
Provision for income taxes from ongoing operations at effective tax rate	7,350	3,222	5,178
Provision for income taxes from discrete items	6,544	7,656	2,282
Total provision for income taxes	13,894	10,878	7,460
Certain discrete tax impacts from foreign subsidiaries [Member]
Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]
Provision for income taxes from discrete items	-1,677	839	837
Net operating loss carryforwards (NOL) [Member]
Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]
Provision for income taxes from discrete items	-810	0	0
IRS Settlement – net of FIN 48 reserve reversals [Member]
Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]
Provision for income taxes from discrete items	480	0	0
2013 Income tax return amendment [Member]
Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]
Provision for income taxes from discrete items	1,891	0	0
FIN 48 reserve additions [Member]
Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]
Provision for income taxes from discrete items	9,798	6,817	2,745
Reconciliation of the tax payable liability accounts for our various subsidiaries to the income tax returns filed in those jurisdictions [Member]
Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]
Provision for income taxes from discrete items	($3,138)	$0	($1,300)

Income_Taxes_Effective_Income_

Income Taxes (Effective Income Tax Rates Reconciliation) (Details)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Schedule Of Effective Income Tax Rates Reconciliation [Line Items]
Statutory tax rate	35.00%	35.00%	35.00%
State income taxes, net of federal benefit	0.30%	-0.30%	0.40%
Acquisition contingent earnout liability adjustments	-4.60%	-5.00%	-0.40%
Effective Income Tax Rate Reconciliation, Other Adjustments, Percent	0.20%	-1.70%	0.20%
Effective tax rate from ongoing operations	9.50%	4.60%	6.70%
Effective tax rate after discrete items	17.90%	15.50%	9.60%
Net operating loss carryforwards (NOL) [Member]
Schedule Of Effective Income Tax Rates Reconciliation [Line Items]
Discrete Items	-1.00%	0.00%	0.00%
IRS Settlement – net of FIN 48 reserve reversals [Member]
Schedule Of Effective Income Tax Rates Reconciliation [Line Items]
Discrete Items	0.60%	0.00%	0.00%
2013 Income tax return amendment [Member]
Schedule Of Effective Income Tax Rates Reconciliation [Line Items]
Discrete Items	2.40%	0.00%	0.00%
FIN 48 reserve additions [Member]
Schedule Of Effective Income Tax Rates Reconciliation [Line Items]
Discrete Items	12.70%	9.70%	3.50%
Reconciliation of the tax payable liability accounts for our various subsidiaries to the income tax returns filed in those jurisdictions [Member]
Schedule Of Effective Income Tax Rates Reconciliation [Line Items]
Discrete Items	-4.10%	0.00%	-1.70%
Singapore
Schedule Of Effective Income Tax Rates Reconciliation [Line Items]
Tax impact of foreign subsidiaries (primarily in Singapore)	-4.00%	-6.90%	-8.10%
Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent	1.10%	1.20%	1.30%
Singapore | Certain discrete tax impacts from foreign subsidiaries [Member]
Schedule Of Effective Income Tax Rates Reconciliation [Line Items]
Discrete Items	-2.20%	1.20%	1.10%
India
Schedule Of Effective Income Tax Rates Reconciliation [Line Items]
Tax holiday - India (Permanent Difference)	-12.70%	-15.20%	-15.60%
Sweden
Schedule Of Effective Income Tax Rates Reconciliation [Line Items]
Passive income exemption - Sweden (Permanent Difference)	-3.20%	-3.50%	-3.10%

Income_Taxes_Deferred_Tax_Liab

Income Taxes (Deferred Tax Liabilities and Assets) (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Income Tax Disclosure [Abstract]
Current deferred income tax assets	$2,310	$961
Long-term deferred income tax assets	43,235	44,924
Total deferred income tax assets	45,545	45,885
Current deferred income tax liabilities	-197	-705
Long-term deferred income tax liabilities	-23,342	-24,308
Net deferred income tax asset	$22,006	$20,872

Income_Taxes_Deferred_Income_T

Income Taxes (Deferred Income Taxes) (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Operating Loss Carryforwards [Line Items]
Total deferred income tax assets	$45,545	$45,885
Deferred tax liabilities, gross	23,539	25,013
Valuation allowance	0	0
Deferred tax assets, net of valuation allowance	45,545	45,885
Deferred tax liabilities, net	23,539	25,013
Depreciation and amortization
Operating Loss Carryforwards [Line Items]
Total deferred income tax assets	254	580
Deferred tax liabilities, gross	0	0
Share-based compensation
Operating Loss Carryforwards [Line Items]
Total deferred income tax assets	817	781
Deferred tax liabilities, gross	0	0
Accruals and prepaids
Operating Loss Carryforwards [Line Items]
Total deferred income tax assets	2,342	3,415
Deferred tax liabilities, gross	470	788
Bad Debts
Operating Loss Carryforwards [Line Items]
Total deferred income tax assets	600	394
Deferred tax liabilities, gross	0	0
Acquired intangible assets
Operating Loss Carryforwards [Line Items]
Total deferred income tax assets	0	0
Deferred tax liabilities, gross	23,069	24,225
Net operating loss carryforwards (NOL) [Member]
Operating Loss Carryforwards [Line Items]
Total deferred income tax assets	16,595	19,698
Deferred tax liabilities, gross	0	0
Tax credit carryforwards
Operating Loss Carryforwards [Line Items]
Total deferred income tax assets	24,937	21,017
Deferred tax liabilities, gross	$0	$0

Income_Taxes_PreTax_Income_and

Income Taxes (Pre-Tax Income and Applicable Tax Rates) (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Pre-Tax Income and Applicable Tax Rates [Line Items]
Income Tax Expense (Benefit)	$13,894	$10,878	$7,460
Domestic	8,807	5,497	6,604
Pre-tax income, Foreign	68,645	64,655	71,425
Total	77,452	70,152	78,029
Statutory tax rate	35.00%	35.00%	35.00%
United States
Pre-Tax Income and Applicable Tax Rates [Line Items]
Domestic	8,807
Statutory tax rate	35.00%
Canada
Pre-Tax Income and Applicable Tax Rates [Line Items]
Pre-tax income, Foreign	115
Statutory tax rate	30.50%
Latin America
Pre-Tax Income and Applicable Tax Rates [Line Items]
Pre-tax income, Foreign	1,590
Statutory tax rate	34.00%
Australia
Pre-Tax Income and Applicable Tax Rates [Line Items]
Pre-tax income, Foreign	5,091
Statutory tax rate	30.00%
Singapore
Pre-Tax Income and Applicable Tax Rates [Line Items]
Pre-tax income, Foreign	16,015
Statutory tax rate	10.00%
New Zealand
Pre-Tax Income and Applicable Tax Rates [Line Items]
Pre-tax income, Foreign	1,000
Statutory tax rate	28.00%
India
Pre-Tax Income and Applicable Tax Rates [Line Items]
Pre-tax income, Foreign	28,194
Statutory tax rate	0.00%
MAURITIUS
Pre-Tax Income and Applicable Tax Rates [Line Items]
Pre-tax income, Foreign	-370
Statutory tax rate	0.00%
Europe (United Kingdom)
Pre-Tax Income and Applicable Tax Rates [Line Items]
Pre-tax income, Foreign	9,940
Statutory tax rate	24.00%
Sweden
Pre-Tax Income and Applicable Tax Rates [Line Items]
Pre-tax income, Foreign	$7,070
Statutory tax rate	0.00%

Income_Taxes_Unrecognized_Tax_

Income Taxes (Unrecognized Tax Benefits) (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Income Tax Disclosure [Abstract]
Portion of an unrecognized tax benefit netted against deferred tax asset for a net operating loss carryforward	($1,135)	($8,422)
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Beginning Balance	12,742	5,925	3,180
Additions for tax positions related to current year	451	6,546	2,482
Additions for tax positions of prior years	9,348	271	263
Reductions for tax position of prior years	-19,521	0	0
Ending Balance	$3,020	$12,742	$5,925

Stock_Repurchases_Details

Stock Repurchases (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Jun. 21, 2013	Jun. 30, 2011
Stock Repurchases [Abstract]
Stock Repurchase Program, Authorized Repurchase Amount				$100,000,000	$100,000,000
Stock Repurchased During Period, Shares	2,146,488	250,900	983,818
Payments for Repurchase of Common Stock	-31,854,000	-2,492,000	-18,374,000
Stock Repurchase Program, Remaining Authorized Repurchase Amount	$71,000,000

Derivative_Instruments_Details

Derivative Instruments (Details) (USD $)	12 Months Ended			0 Months Ended	1 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Jun. 02, 2012	Jun. 30, 2012	31-May-12
				Stockholders		Stockholders
Derivative [Line Items]
Change in fair value of put option	$296,000	$341,000	$191,000
Derivative Liability, Current	0	845,000
Stock Redeemed or Called During Period, Shares	209,656
Temporary Equity, Redemption Price Per Share	$16.86
Derivative, Fixed Interest Rate	20.00%
Shares reaquired in connection with put option plus interest, Value	3,600,000
Planetsoft
Derivative [Line Items]
Number of shareholders				3		3
Put option, exercise period					30 days
Put option, vesting period required prior to exercise					2 years
Shares that may be repurchased under put option					296,560
Put option, price to repurchase shares				$16.86
Put option, price to repurchase shares, discount					10.00%
Planetsoft | Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 2
Derivative [Line Items]
Put option liability				$1,400,000		1,400,000

Accounts_Payable_and_Accrued_E2

Accounts Payable and Accrued Expenses (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Accounts Payable and Accrued Liabilities, Current [Abstract]
Trade accounts payable	$11,879	$4,515
Accrued professional fees	1,258	1,046
Income taxes payable	22,627	8,173
Sales taxes payable	2,601	4,038
Income Tax Examination, Interest Accrued	1,650	0
Other accrued liabilities	106	46
Accounts payable and accrued liabilities	$40,121	$17,818

Other_Current_Assets_Details

Other Current Assets (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Prepaid Expense and Other Assets, Current [Abstract]
Prepaid expenses	$5,618	$3,824
Sales taxes receivable from customers	121	220
Due from prior owners of acquired businesses for working capital settlements	938	720
Research and development tax credits receivable	1,152	720
Other	238	64
Total	$8,067	$5,548

Property_and_Equipment_Details

Property and Equipment (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$37,834,000	$23,278,000
Less accumulated depreciation and amortization	-13,173,000	-14,750,000
Property and equipment, net	24,661,000	8,528,000
Depreciation expense	2,300,000	2,800,000	3,100,000
Computer equipment
Property, Plant and Equipment [Line Items]
Property and equipment, gross	13,830,000	12,417,000
Buildings
Property, Plant and Equipment [Line Items]
Property and equipment, gross	3,912,000	3,119,000
Land
Property, Plant and Equipment [Line Items]
Property and equipment, gross	3,924,000	59,000
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property and equipment, gross	1,448,000	2,648,000
Furniture, fixtures and other
Property, Plant and Equipment [Line Items]
Property and equipment, gross	4,279,000	5,035,000
Construction in Progress
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$10,441,000	$0

Other_Liabilities_Details

Other Liabilities (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
In Thousands, unless otherwise specified
Other Liabilities Disclosure [Abstract]
Reserve for potential uncertain income tax return positions	$3,020	$12,742	$5,925	$3,180
Unfavorable lease liability, long term portion	294	394
Portion of an unrecognized tax benefit netted against deferred tax asset for a net operating loss carryforward	-1,135	-8,422
Other	0	5
Total	$2,179	$4,719

Cash_Option_Profit_Sharing_Pla1

Cash Option Profit Sharing Plan and Trust (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Cash Option Profit Sharing Plan and Trust [Abstract]
Contributions to 401(k) Cash Option Profit Sharing Plan	$473	$368	$364

Geographic_Information_Details

Geographic Information (Details) (USD $)	3 Months Ended												12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
													Reportable_Segments
Revenues from External Customers and Long-Lived Assets [Line Items]
Number of reportable segments													1
External Revenues	$60,633	$50,808	$51,476	$51,404	$50,847	$50,293	$51,004	$52,566	$54,023	$53,804	$47,716	$43,827	$214,321	$204,710	$199,370
Long-lived assets	530,450				451,515				435,277				530,450	451,515	435,277
United States
Revenues from External Customers and Long-Lived Assets [Line Items]
External Revenues													147,971	139,519	140,933
Long-lived assets	383,233				309,732				317,338				383,233	309,732	317,338
Canada
Revenues from External Customers and Long-Lived Assets [Line Items]
External Revenues													5,239	7,431	6,395
Long-lived assets	7,835				8,784				9,738				7,835	8,784	9,738
Latin America
Revenues from External Customers and Long-Lived Assets [Line Items]
External Revenues													7,036	5,508	8,227
Long-lived assets	9,380				10,886				12,726				9,380	10,886	12,726
Australia
Revenues from External Customers and Long-Lived Assets [Line Items]
External Revenues													36,319	38,260	36,330
Long-lived assets	583				803				1,267				583	803	1,267
Singapore
Revenues from External Customers and Long-Lived Assets [Line Items]
External Revenues													4,384	3,114	2,827
Long-lived assets	68,526				68,987				70,173				68,526	68,987	70,173
New Zealand
Revenues from External Customers and Long-Lived Assets [Line Items]
External Revenues													2,578	2,311	2,205
Long-lived assets	334				97				240				334	97	240
India
Revenues from External Customers and Long-Lived Assets [Line Items]
External Revenues													1,929	650	233
Long-lived assets	34,691				23,784				11,784				34,691	23,784	11,784
Europe
Revenues from External Customers and Long-Lived Assets [Line Items]
External Revenues													8,865	7,917	2,220
Long-lived assets	$25,868				$28,442				$12,011				$25,868	$28,442	$12,011

Related_Party_Transactions_Det

Related Party Transactions (Details) (Regions Bank, USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Regions Bank
Related Party Transaction [Line Items]
Revenue from related party	$281,000	$292,000	$170,000
Receivable due from related party	$50,000	$39,000

Quarterly_Financial_Informatio2

Quarterly Financial Information (unaudited) (Details) (USD $)	3 Months Ended												12 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Quarterly Financial Information Disclosure [Abstract]
Total revenues	$60,633	$50,808	$51,476	$51,404	$50,847	$50,293	$51,004	$52,566	$54,023	$53,804	$47,716	$43,827	$214,321	$204,710	$199,370
Gross Profit	43,096	40,533	41,512	41,792	40,761	40,157	40,646	42,675	43,576	44,304	38,559	34,798
Operating income	21,068	21,738	17,461	19,405	17,806	18,601	19,294	19,305	20,260	20,708	17,711	18,329	79,672	75,006	77,008
Net income	$16,547	$18,015	$13,579	$15,417	$15,245	$13,143	$13,542	$17,344	$18,745	$18,072	$18,067	$15,685	$63,558	$59,274	$70,569
Basic (in dollars per share)	$0.45	$0.47	$0.35	$0.40	$0.40	$0.35	$0.36	$0.47	$0.50	$0.49	$0.49	$0.43	$1.68	$1.58	$1.91
Diluted (in dollars per share)	$0.45	$0.47	$0.35	$0.40	$0.40	$0.34	$0.35	$0.45	$0.48	$0.46	$0.47	$0.40	$1.67	$1.53	$1.80

Minority_Business_Investment_D

Minority Business Investment (Details) (USD $)	0 Months Ended	3 Months Ended	12 Months Ended	0 Months Ended
	4-May-12	Mar. 31, 2012	Dec. 31, 2014	Jan. 27, 2014	Dec. 31, 2013	Dec. 31, 2012
Schedule of Cost-method Investments [Line Items]
Derivative Liability			$5,367,000		$14,420,000	$17,495,000
Curepet, Inc.
Schedule of Cost-method Investments [Line Items]
Cost Method Investment, Ownership Percentage	19.80%
Payments to acquire cost method investment	2,000,000
Revenue from related party		1,500,000	1,200,000
Revenues			324,000
Curepet, Inc.
Schedule of Cost-method Investments [Line Items]
Cost Method Investment, Ownership Percentage	19.80%
Payments to acquire cost method investment	2,000,000
Purchase Price of Business Acquisition, Cost of Acquired Entity				6,350,000
Derivative Liability			$0	$5,000,000
Derivative, Term of Contract				36 months

Temporary_Equity_Temporary_Equ1

Temporary Equity Temporary Equity (Details) (USD $)	12 Months Ended	0 Months Ended	1 Months Ended
	Dec. 31, 2014	Jun. 02, 2012	Jun. 30, 2012	31-May-12
		Stockholders		Stockholders
Temporary Equity [Line Items]
Stock Redeemed or Called During Period, Shares	209,656
Temporary Equity, Redemption Price Per Share	$16.86
Derivative, Fixed Interest Rate	20.00%
Shares reaquired in connection with put option plus interest, Value	$3,600,000
Planetsoft
Temporary Equity [Line Items]
Equity instruments		$5,000,000
Business acquisition, number of common shares issued		296,560
Business acquisition, price per share		$16.86
Number of shareholders		3		3
Put option, exercise period			30 days
Put option, vesting period required prior to exercise			2 years
Shares that may be repurchased under put option			296,560
Put option, price to repurchase shares		$16.86

Subsequent_Events_Details

Subsequent Events (Details) (USD $)

0 Months Ended

3 Months Ended

0 Months Ended

Feb. 12, 2015

Jan. 30, 2015

Jan. 19, 2015

Jan. 12, 2015

Jan. 06, 2015

Mar. 16, 2015

Mar. 03, 2015

Dec. 31, 2014

Dec. 31, 2013

Dec. 31, 2012

Aug. 05, 2014

Feb. 03, 2015

acre

directors

Subsequent Event [Line Items]

Derivative Liability

$5,367,000

$14,420,000

$17,495,000

Subsequent Event

Subsequent Event [Line Items]

Land Acreage

6

Common Stock, Dividends, Per Share, Declared

$0.08

Stock Repurchased and Retired During Period, Shares

929,976

Stock Repurchased During Period, Value

22,280,000

Income Tax Audit, Cash Settlement

20,500,000

Income Tax Examination, Penalties and Interest Accrued

1,600,000

Tax Adjustments, Settlements, and Unusual Provisions

-1,500,000

Number of non-employee directors

7

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period

42,000

Payments for Legal Settlements

690,000

Payments to Acquire Land Held-for-use

2,000,000

Regions Bank | Secured Syndicated Credit Facility

Subsequent Event [Line Items]

Debt instrument, face amount

150,000,000

Regions Bank | Secured Syndicated Credit Facility, First Amendment | Subsequent Event

Subsequent Event [Line Items]

Debt instrument, face amount

190,000,000

Line of Credit, Accordion

50,000,000

Line of Credit Facility, Expansion

90,000,000

Revolving Credit Facility | Regions Bank | Secured Syndicated Credit Facility

Subsequent Event [Line Items]

Credit agreement, maximum borrowing capacity

200,000,000

Line of Credit Facility, Expansion

50,000,000

Revolving Credit Facility | Regions Bank | Secured Syndicated Credit Facility, First Amendment | Subsequent Event

Subsequent Event [Line Items]

Credit agreement, maximum borrowing capacity

240,000,000

Via Media Health | Subsequent Event

Subsequent Event [Line Items]

Derivative, Term of Contract

12 months

Business acquisition, cost of acquired entity, cash paid

1,240,000

Maximum | Via Media Health | Subsequent Event

Subsequent Event [Line Items]

Derivative Liability

$372,000

Schedule_II_Valuation_and_Qual1

Schedule II - Valuation and Qualifying Accounts Schedule II - Valuation and Qualifying Accounts (Details) (Allowance for Doubtful Accounts Receivable [Member], USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Allowance for Doubtful Accounts Receivable [Member]
Movement in Valuation Allowances and Reserves [Roll Forward]
Beginning balance	$1,049	$1,157	$1,719
Provision for doubtful accounts	1,600	1,147	442
Write-off of accounts receivable against allowance	-1,022	-1,276	-1,004
Other	-8	21	0
Ending balance	$1,619	$1,049	$1,157